|
INTERMEDIATE FILAMENT BASED PROCESS
|
19
|
0.000363
|
4.76e-01
|
0.308
|
|
POSITIVE REGULATION OF GTPASE ACTIVITY
|
6
|
0.000694
|
-8.01e-01
|
0.308
|
|
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
19
|
0.000766
|
-4.50e-01
|
0.308
|
|
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE
|
10
|
0.000916
|
6.08e-01
|
0.308
|
|
INTERMEDIATE FILAMENT ORGANIZATION
|
17
|
0.001020
|
4.64e-01
|
0.308
|
|
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION
|
7
|
0.001060
|
-7.16e-01
|
0.308
|
|
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA
|
24
|
0.001070
|
-3.90e-01
|
0.308
|
|
REGULATION OF CELL CYCLE
|
37
|
0.001410
|
-3.09e-01
|
0.312
|
|
IMMUNE RESPONSE TO TUMOR CELL
|
6
|
0.001550
|
-7.48e-01
|
0.312
|
|
MITOTIC CELL CYCLE PHASE TRANSITION
|
21
|
0.001570
|
-4.02e-01
|
0.312
|
|
DNA METABOLIC PROCESS
|
34
|
0.001770
|
-3.15e-01
|
0.312
|
|
REGULATION OF T CELL MEDIATED IMMUNITY
|
12
|
0.002120
|
-5.15e-01
|
0.312
|
|
RESPONSE TO TUMOR CELL
|
9
|
0.002180
|
-5.92e-01
|
0.312
|
|
PROTEIN LOCALIZATION TO MITOCHONDRION
|
6
|
0.002550
|
-7.13e-01
|
0.312
|
|
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
15
|
0.002620
|
-4.52e-01
|
0.312
|
|
REGULATION OF COLLAGEN METABOLIC PROCESS
|
12
|
0.002630
|
-5.04e-01
|
0.312
|
|
CELL MOTILITY
|
210
|
0.002770
|
-1.36e-01
|
0.312
|
|
POSITIVE REGULATION OF KINASE ACTIVITY
|
8
|
0.003090
|
6.06e-01
|
0.312
|
|
MAINTENANCE OF LOCATION
|
26
|
0.003100
|
-3.39e-01
|
0.312
|
|
CELL CYCLE PHASE TRANSITION
|
22
|
0.003180
|
-3.67e-01
|
0.312
|
|
NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS
|
16
|
0.003250
|
-4.28e-01
|
0.312
|
|
PROTEIN N LINKED GLYCOSYLATION
|
10
|
0.003610
|
5.34e-01
|
0.321
|
|
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS
|
29
|
0.004180
|
-3.12e-01
|
0.321
|
|
REGULATION OF CELL CYCLE PHASE TRANSITION
|
19
|
0.004280
|
-3.82e-01
|
0.321
|
|
REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
19
|
0.004280
|
-3.82e-01
|
0.321
|
|
COLLAGEN BIOSYNTHETIC PROCESS
|
10
|
0.004350
|
-5.23e-01
|
0.321
|
|
POSITIVE REGULATION OF CELL KILLING
|
11
|
0.004420
|
-4.98e-01
|
0.321
|
|
HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT
|
8
|
0.004460
|
5.83e-01
|
0.321
|
|
INSULIN RECEPTOR SIGNALING PATHWAY
|
12
|
0.004610
|
4.75e-01
|
0.321
|
|
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS
|
6
|
0.004850
|
-6.66e-01
|
0.326
|
|
CELLULAR RESPONSE TO EXTERNAL STIMULUS
|
9
|
0.005620
|
-5.35e-01
|
0.355
|
|
ACTIN FILAMENT ORGANIZATION
|
66
|
0.005680
|
-2.04e-01
|
0.355
|
|
T CELL MEDIATED IMMUNITY
|
18
|
0.005940
|
-3.78e-01
|
0.355
|
|
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL
|
8
|
0.006150
|
5.61e-01
|
0.355
|
|
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY
|
22
|
0.006240
|
-3.41e-01
|
0.355
|
|
POSITIVE REGULATION OF BLOOD PRESSURE
|
5
|
0.006500
|
7.04e-01
|
0.355
|
|
REGULATION OF RESPONSE TO TUMOR CELL
|
5
|
0.006710
|
-7.01e-01
|
0.355
|
|
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION
|
19
|
0.006920
|
3.61e-01
|
0.355
|
|
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
21
|
0.007000
|
-3.44e-01
|
0.355
|
|
POSITIVE REGULATION OF PHOSPHORYLATION
|
21
|
0.007140
|
3.43e-01
|
0.355
|
|
POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY
|
10
|
0.007200
|
-4.93e-01
|
0.355
|
|
REGULATION OF NEUROINFLAMMATORY RESPONSE
|
7
|
0.007410
|
5.86e-01
|
0.356
|
|
PLATELET ACTIVATION
|
46
|
0.007720
|
-2.33e-01
|
0.362
|
|
CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
10
|
0.008060
|
-4.86e-01
|
0.370
|
|
NUCLEOTIDE BIOSYNTHETIC PROCESS
|
13
|
0.008460
|
-4.25e-01
|
0.379
|
|
RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS
|
12
|
0.009280
|
-4.36e-01
|
0.407
|
|
REGULATION OF FIBROBLAST MIGRATION
|
7
|
0.009560
|
-5.67e-01
|
0.407
|
|
REGULATION OF GTPASE ACTIVITY
|
7
|
0.010100
|
-5.63e-01
|
0.407
|
|
ACTIN FILAMENT BASED PROCESS
|
94
|
0.010200
|
-1.62e-01
|
0.407
|
|
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
5
|
0.010300
|
-6.64e-01
|
0.407
|
|
REGULATION OF BLOOD PRESSURE
|
18
|
0.010400
|
3.52e-01
|
0.407
|
|
CELL MIGRATION
|
193
|
0.010600
|
-1.20e-01
|
0.407
|
|
FIBROBLAST MIGRATION
|
9
|
0.010700
|
-4.93e-01
|
0.407
|
|
CELL ACTIVATION
|
140
|
0.011100
|
-1.35e-01
|
0.407
|
|
PROTEIN TRANSMEMBRANE TRANSPORT
|
6
|
0.011200
|
-5.99e-01
|
0.407
|
|
KERATINIZATION
|
18
|
0.011300
|
3.48e-01
|
0.407
|
|
REGULATION OF BINDING
|
9
|
0.012400
|
4.83e-01
|
0.427
|
|
PROTEIN LOCALIZATION TO ORGANELLE
|
57
|
0.012600
|
-1.97e-01
|
0.427
|
|
RNA TEMPLATED DNA BIOSYNTHETIC PROCESS
|
7
|
0.012900
|
-5.45e-01
|
0.427
|
|
TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
7
|
0.012900
|
-5.45e-01
|
0.427
|
|
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
20
|
0.013000
|
-3.24e-01
|
0.427
|
|
REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
21
|
0.013400
|
-3.15e-01
|
0.427
|
|
MEMBRANE INVAGINATION
|
11
|
0.013500
|
-4.32e-01
|
0.427
|
|
PHAGOCYTOSIS ENGULFMENT
|
11
|
0.013500
|
-4.32e-01
|
0.427
|
|
CELL SUBSTRATE ADHESION
|
66
|
0.013900
|
-1.81e-01
|
0.432
|
|
CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS
|
42
|
0.014500
|
2.23e-01
|
0.439
|
|
POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS
|
6
|
0.016000
|
5.70e-01
|
0.439
|
|
POSITIVE REGULATION OF MACROPHAGE MIGRATION
|
6
|
0.016000
|
5.70e-01
|
0.439
|
|
TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
11
|
0.016000
|
-4.22e-01
|
0.439
|
|
CELLULAR RESPONSE TO STRESS
|
107
|
0.016400
|
-1.43e-01
|
0.439
|
|
ATP BIOSYNTHETIC PROCESS
|
7
|
0.016400
|
-5.26e-01
|
0.439
|
|
TRANSMEMBRANE TRANSPORT
|
73
|
0.016400
|
-1.69e-01
|
0.439
|
|
VIRAL LIFE CYCLE
|
38
|
0.016500
|
-2.29e-01
|
0.439
|
|
MEMBRANE ORGANIZATION
|
57
|
0.016700
|
-1.89e-01
|
0.439
|
|
CALCIUM ION TRANSMEMBRANE TRANSPORT
|
22
|
0.016800
|
-2.98e-01
|
0.439
|
|
LEUKOCYTE MIGRATION
|
69
|
0.017000
|
-1.73e-01
|
0.439
|
|
T CELL MEDIATED CYTOTOXICITY
|
12
|
0.017100
|
-4.00e-01
|
0.439
|
|
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION
|
5
|
0.017200
|
-6.17e-01
|
0.439
|
|
GLYCOPROTEIN BIOSYNTHETIC PROCESS
|
18
|
0.017200
|
3.27e-01
|
0.439
|
|
LOCOMOTION
|
159
|
0.017400
|
-1.20e-01
|
0.439
|
|
PROTEIN CONTAINING COMPLEX ORGANIZATION
|
127
|
0.018200
|
-1.30e-01
|
0.448
|
|
REGULATION OF CELL CYCLE PROCESS
|
28
|
0.018300
|
-2.61e-01
|
0.448
|
|
SEQUESTERING OF CALCIUM ION
|
17
|
0.018400
|
-3.33e-01
|
0.448
|
|
RESPONSE TO INSULIN
|
24
|
0.018800
|
2.80e-01
|
0.453
|
|
ORGANIC ACID TRANSPORT
|
16
|
0.019400
|
-3.40e-01
|
0.461
|
|
CELLULAR DETOXIFICATION OF ALDEHYDE
|
6
|
0.019700
|
5.51e-01
|
0.463
|
|
CELL CYCLE G1 S PHASE TRANSITION
|
15
|
0.020000
|
-3.50e-01
|
0.464
|
|
CELLULAR RESPONSE TO HORMONE STIMULUS
|
52
|
0.020300
|
1.91e-01
|
0.464
|
|
PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS
|
16
|
0.020400
|
-3.38e-01
|
0.464
|
|
ANTIFUNGAL HUMORAL RESPONSE
|
5
|
0.021100
|
5.97e-01
|
0.471
|
|
ENDOCYTIC RECYCLING
|
8
|
0.021400
|
-4.72e-01
|
0.471
|
|
CELLULAR RESPONSE TO INSULIN STIMULUS
|
21
|
0.021500
|
2.93e-01
|
0.471
|
|
GLOMERULUS DEVELOPMENT
|
9
|
0.022200
|
-4.42e-01
|
0.473
|
|
ENDOTHELIAL CELL MIGRATION
|
43
|
0.022500
|
-2.06e-01
|
0.473
|
|
POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION
|
12
|
0.022800
|
-3.82e-01
|
0.473
|
|
CELL SUBSTRATE JUNCTION ORGANIZATION
|
22
|
0.023100
|
-2.83e-01
|
0.473
|
|
PROTEIN LOCALIZATION TO CELL JUNCTION
|
18
|
0.023200
|
-3.12e-01
|
0.473
|
|
REGULATION OF MYOBLAST DIFFERENTIATION
|
5
|
0.023500
|
-5.87e-01
|
0.473
|
|
CALCIUM ION TRANSPORT
|
32
|
0.023500
|
-2.35e-01
|
0.473
|
|
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL
|
17
|
0.023600
|
-3.20e-01
|
0.473
|
|
REGULATION OF INTESTINAL ABSORPTION
|
5
|
0.023900
|
-5.85e-01
|
0.473
|
|
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
21
|
0.024500
|
2.87e-01
|
0.473
|
|
NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
5
|
0.024600
|
-5.82e-01
|
0.473
|
|
NATURAL KILLER CELL ACTIVATION
|
8
|
0.024800
|
-4.60e-01
|
0.473
|
|
REGULATION OF MACROPHAGE CHEMOTAXIS
|
7
|
0.025400
|
4.90e-01
|
0.473
|
|
REGULATION OF MACROPHAGE MIGRATION
|
7
|
0.025400
|
4.90e-01
|
0.473
|
|
RECEPTOR LOCALIZATION TO SYNAPSE
|
7
|
0.025400
|
-4.90e-01
|
0.473
|
|
BIOMINERAL TISSUE DEVELOPMENT
|
15
|
0.025700
|
-3.35e-01
|
0.473
|
|
TYPE II INTERFERON PRODUCTION
|
14
|
0.025800
|
-3.47e-01
|
0.473
|
|
REGULATION OF MITOTIC CELL CYCLE
|
24
|
0.026000
|
-2.66e-01
|
0.473
|
|
INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
29
|
0.026100
|
-2.42e-01
|
0.473
|
|
REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS
|
9
|
0.026200
|
-4.30e-01
|
0.473
|
|
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
27
|
0.026800
|
2.50e-01
|
0.479
|
|
COMPLEMENT ACTIVATION
|
49
|
0.027300
|
1.87e-01
|
0.479
|
|
SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
25
|
0.027700
|
-2.58e-01
|
0.479
|
|
POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS
|
6
|
0.028700
|
-5.17e-01
|
0.479
|
|
POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
6
|
0.028700
|
-5.17e-01
|
0.479
|
|
REGULATION OF DNA BIOSYNTHETIC PROCESS
|
6
|
0.028700
|
-5.17e-01
|
0.479
|
|
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE
|
6
|
0.028700
|
-5.17e-01
|
0.479
|
|
REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING
|
6
|
0.028700
|
-5.17e-01
|
0.479
|
|
EPITHELIAL CELL DEVELOPMENT
|
28
|
0.028700
|
-2.42e-01
|
0.479
|
|
POSITIVE REGULATION OF HYDROLASE ACTIVITY
|
8
|
0.030300
|
-4.44e-01
|
0.493
|
|
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
16
|
0.030600
|
3.15e-01
|
0.493
|
|
CALCIUM ION HOMEOSTASIS
|
27
|
0.031000
|
-2.43e-01
|
0.493
|
|
CELL CELL ADHESION
|
135
|
0.031800
|
-1.16e-01
|
0.493
|
|
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION
|
11
|
0.032000
|
-3.76e-01
|
0.493
|
|
CELL ADHESION
|
213
|
0.032900
|
-9.66e-02
|
0.493
|
|
COLLAGEN METABOLIC PROCESS
|
22
|
0.033400
|
-2.65e-01
|
0.493
|
|
OXIDATIVE PHOSPHORYLATION
|
6
|
0.033500
|
-5.03e-01
|
0.493
|
|
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL
|
9
|
0.033900
|
-4.10e-01
|
0.493
|
|
CHROMOSOME ORGANIZATION
|
20
|
0.034300
|
-2.76e-01
|
0.493
|
|
TELOMERE ORGANIZATION
|
10
|
0.034700
|
-3.88e-01
|
0.493
|
|
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS
|
103
|
0.034900
|
-1.27e-01
|
0.493
|
|
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CAJAL BODY
|
5
|
0.035200
|
-5.45e-01
|
0.493
|
|
POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY
|
5
|
0.035200
|
-5.45e-01
|
0.493
|
|
PROTEIN LOCALIZATION TO NUCLEOPLASM
|
5
|
0.035200
|
-5.45e-01
|
0.493
|
|
REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY
|
5
|
0.035200
|
-5.45e-01
|
0.493
|
|
TELOMERASE RNA LOCALIZATION
|
5
|
0.035200
|
-5.45e-01
|
0.493
|
|
POSITIVE REGULATION OF FIBROBLAST MIGRATION
|
6
|
0.035500
|
-4.97e-01
|
0.493
|
|
NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
8
|
0.036300
|
4.29e-01
|
0.493
|
|
GLIAL CELL MIGRATION
|
5
|
0.036300
|
-5.42e-01
|
0.493
|
|
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN
|
6
|
0.036300
|
4.95e-01
|
0.493
|
|
CYTOSOLIC TRANSPORT
|
13
|
0.036300
|
-3.38e-01
|
0.493
|
|
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION
|
14
|
0.036500
|
-3.25e-01
|
0.493
|
|
REGULATION OF PROTEIN LOCALIZATION
|
89
|
0.036700
|
-1.35e-01
|
0.493
|
|
CELLULAR RESPONSE TO NITROGEN COMPOUND
|
57
|
0.036800
|
1.65e-01
|
0.493
|
|
REGULATION OF PH
|
7
|
0.036900
|
4.57e-01
|
0.493
|
|
INTEGRIN MEDIATED SIGNALING PATHWAY
|
36
|
0.037200
|
-2.05e-01
|
0.493
|
|
CELL PROJECTION ASSEMBLY
|
34
|
0.037400
|
-2.10e-01
|
0.493
|
|
RESPONSE TO GROWTH FACTOR
|
62
|
0.037500
|
-1.58e-01
|
0.493
|
|
DITERPENOID METABOLIC PROCESS
|
10
|
0.038000
|
3.81e-01
|
0.493
|
|
ISOPRENOID METABOLIC PROCESS
|
10
|
0.038000
|
3.81e-01
|
0.493
|
|
NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS
|
8
|
0.038100
|
-4.25e-01
|
0.493
|
|
HUMORAL IMMUNE RESPONSE
|
88
|
0.038200
|
1.34e-01
|
0.493
|
|
AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS
|
13
|
0.038200
|
-3.34e-01
|
0.493
|
|
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
11
|
0.038300
|
-3.63e-01
|
0.493
|
|
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
31
|
0.038600
|
-2.18e-01
|
0.493
|
|
DNA REPAIR
|
16
|
0.038600
|
-3.01e-01
|
0.493
|
|
AMINO ACID TRANSPORT
|
5
|
0.039000
|
-5.35e-01
|
0.495
|
|
REGULATION OF CHROMOSOME ORGANIZATION
|
11
|
0.039500
|
-3.61e-01
|
0.498
|
|
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS
|
13
|
0.040000
|
-3.31e-01
|
0.501
|
|
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
8
|
0.040200
|
-4.21e-01
|
0.501
|
|
NEUTROPHIL MIGRATION
|
21
|
0.041500
|
-2.60e-01
|
0.514
|
|
NEGATIVE REGULATION OF CATALYTIC ACTIVITY
|
18
|
0.042300
|
-2.79e-01
|
0.519
|
|
NEGATIVE REGULATION OF CELL ADHESION
|
48
|
0.042400
|
-1.74e-01
|
0.519
|
|
STEROID BIOSYNTHETIC PROCESS
|
12
|
0.042700
|
-3.40e-01
|
0.520
|
|
ZYMOGEN ACTIVATION
|
34
|
0.043100
|
2.04e-01
|
0.521
|
|
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS
|
5
|
0.044300
|
-5.21e-01
|
0.529
|
|
MITOPHAGY
|
5
|
0.044300
|
-5.21e-01
|
0.529
|
|
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL
|
14
|
0.045500
|
-3.11e-01
|
0.533
|
|
REGULATION OF PROTEIN STABILITY
|
36
|
0.045500
|
-1.96e-01
|
0.533
|
|
AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
11
|
0.045600
|
-3.50e-01
|
0.533
|
|
REGULATION OF CELL KILLING
|
17
|
0.045700
|
-2.83e-01
|
0.533
|
|
RESPONSE TO INTERLEUKIN 7
|
5
|
0.046600
|
-5.15e-01
|
0.540
|
|
REGULATION OF PROTEIN BINDING
|
6
|
0.047900
|
4.68e-01
|
0.552
|
|
REGULATION OF PLATELET ACTIVATION
|
20
|
0.048400
|
-2.58e-01
|
0.555
|
|
UNSATURATED FATTY ACID METABOLIC PROCESS
|
7
|
0.049100
|
-4.31e-01
|
0.557
|
|
CARBON DIOXIDE TRANSPORT
|
5
|
0.049700
|
5.08e-01
|
0.557
|
|
REGULATION OF MITOCHONDRION ORGANIZATION
|
11
|
0.050100
|
-3.43e-01
|
0.557
|
|
REGULATION OF DNA METABOLIC PROCESS
|
16
|
0.050600
|
-2.85e-01
|
0.557
|
|
REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE
|
5
|
0.050700
|
-5.06e-01
|
0.557
|
|
CHROMATIN ORGANIZATION
|
8
|
0.051200
|
-4.00e-01
|
0.557
|
|
CHROMATIN REMODELING
|
8
|
0.051200
|
-4.00e-01
|
0.557
|
|
REGULATION OF MITOCHONDRIAL DEPOLARIZATION
|
5
|
0.051700
|
-5.04e-01
|
0.557
|
|
REGULATION OF AUTOPHAGY
|
18
|
0.051700
|
-2.67e-01
|
0.557
|
|
MEIOTIC CELL CYCLE
|
12
|
0.052100
|
-3.26e-01
|
0.557
|
|
MITOCHONDRIAL DEPOLARIZATION
|
6
|
0.052300
|
-4.59e-01
|
0.557
|
|
CYTOLYSIS BY HOST OF SYMBIONT CELLS
|
8
|
0.052700
|
3.97e-01
|
0.557
|
|
OPSONIZATION
|
18
|
0.052700
|
2.66e-01
|
0.557
|
|
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE
|
14
|
0.052900
|
-3.01e-01
|
0.557
|
|
NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
6
|
0.053000
|
-4.58e-01
|
0.557
|
|
REGULATION OF HORMONE LEVELS
|
44
|
0.053700
|
1.72e-01
|
0.557
|
|
REGULATION OF SYSTEM PROCESS
|
54
|
0.054300
|
-1.56e-01
|
0.557
|
|
BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST
|
33
|
0.054300
|
-1.97e-01
|
0.557
|
|
RESPONSE TO CADMIUM ION
|
8
|
0.054400
|
3.95e-01
|
0.557
|
|
STEM CELL DEVELOPMENT
|
11
|
0.054500
|
3.37e-01
|
0.557
|
|
LONG CHAIN FATTY ACID METABOLIC PROCESS
|
5
|
0.054700
|
-4.98e-01
|
0.557
|
|
ORGANIC ANION TRANSPORT
|
17
|
0.054700
|
-2.72e-01
|
0.557
|
|
POSITIVE REGULATION OF T CELL PROLIFERATION
|
15
|
0.055800
|
2.88e-01
|
0.562
|
|
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION
|
5
|
0.056200
|
-4.95e-01
|
0.562
|
|
POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION
|
5
|
0.056200
|
-4.95e-01
|
0.562
|
|
MAINTENANCE OF PROTEIN LOCATION
|
8
|
0.056500
|
-3.91e-01
|
0.562
|
|
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
25
|
0.056700
|
-2.23e-01
|
0.562
|
|
CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS
|
33
|
0.058300
|
1.94e-01
|
0.562
|
|
ALDEHYDE CATABOLIC PROCESS
|
5
|
0.058500
|
4.90e-01
|
0.562
|
|
POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY
|
8
|
0.058600
|
-3.88e-01
|
0.562
|
|
REGULATION OF T CELL MEDIATED CYTOTOXICITY
|
8
|
0.058600
|
-3.88e-01
|
0.562
|
|
GLYCOPROTEIN METABOLIC PROCESS
|
28
|
0.058800
|
2.10e-01
|
0.562
|
|
PROTEIN LOCALIZATION TO SYNAPSE
|
8
|
0.059700
|
-3.86e-01
|
0.562
|
|
CELLULAR RESPONSE TO INTERLEUKIN 1
|
10
|
0.059900
|
3.46e-01
|
0.562
|
|
NEGATIVE REGULATION OF GLIOGENESIS
|
5
|
0.059900
|
-4.87e-01
|
0.562
|
|
PROCESS UTILIZING AUTOPHAGIC MECHANISM
|
39
|
0.060000
|
-1.78e-01
|
0.562
|
|
CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
6
|
0.060800
|
-4.44e-01
|
0.562
|
|
CELLULAR RESPONSE TO UNFOLDED PROTEIN
|
6
|
0.060800
|
-4.44e-01
|
0.562
|
|
RESPONSE TO HORMONE
|
82
|
0.061300
|
1.25e-01
|
0.562
|
|
VIRAL PROCESS
|
45
|
0.061500
|
-1.65e-01
|
0.562
|
|
NOTCH SIGNALING PATHWAY
|
13
|
0.061600
|
-3.02e-01
|
0.562
|
|
REGULATION OF OPSONIZATION
|
16
|
0.061900
|
2.72e-01
|
0.562
|
|
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN
|
6
|
0.062300
|
-4.41e-01
|
0.562
|
|
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN
|
6
|
0.062300
|
-4.41e-01
|
0.562
|
|
CELL JUNCTION MAINTENANCE
|
6
|
0.062600
|
4.41e-01
|
0.562
|
|
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
8
|
0.062800
|
-3.82e-01
|
0.562
|
|
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN
|
18
|
0.062800
|
-2.56e-01
|
0.562
|
|
MUSCLE CONTRACTION
|
29
|
0.063900
|
-2.02e-01
|
0.562
|
|
CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY
|
8
|
0.064500
|
-3.79e-01
|
0.562
|
|
GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS
|
5
|
0.064700
|
-4.79e-01
|
0.562
|
|
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT
|
10
|
0.064800
|
-3.39e-01
|
0.562
|
|
DNA BIOSYNTHETIC PROCESS
|
9
|
0.065100
|
-3.57e-01
|
0.562
|
|
RETROGRADE TRANSPORT ENDOSOME TO GOLGI
|
9
|
0.065500
|
-3.56e-01
|
0.562
|
|
LYMPHOCYTE ACTIVATION
|
77
|
0.065900
|
-1.27e-01
|
0.562
|
|
KERATINOCYTE DIFFERENTIATION
|
28
|
0.066000
|
2.04e-01
|
0.562
|
|
NEPHRON EPITHELIUM DEVELOPMENT
|
10
|
0.066100
|
-3.38e-01
|
0.562
|
|
CARBOXYLIC ACID TRANSMEMBRANE TRANSPORT
|
6
|
0.066200
|
-4.35e-01
|
0.562
|
|
GLYCEROPHOSPHOLIPID METABOLIC PROCESS
|
12
|
0.066400
|
-3.08e-01
|
0.562
|
|
POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY
|
8
|
0.066500
|
3.76e-01
|
0.562
|
|
CYTOKINE PRODUCTION
|
88
|
0.066600
|
-1.19e-01
|
0.562
|
|
MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS
|
7
|
0.067800
|
4.00e-01
|
0.562
|
|
ENDOSOMAL TRANSPORT
|
19
|
0.068100
|
-2.44e-01
|
0.562
|
|
ORGANELLE FISSION
|
20
|
0.068300
|
-2.38e-01
|
0.562
|
|
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS
|
15
|
0.068700
|
-2.74e-01
|
0.562
|
|
RESPONSE TO MUSCLE ACTIVITY
|
8
|
0.068800
|
-3.73e-01
|
0.562
|
|
POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
7
|
0.069200
|
-3.98e-01
|
0.562
|
|
POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
7
|
0.069200
|
-3.98e-01
|
0.562
|
|
REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
8
|
0.069600
|
3.72e-01
|
0.562
|
|
MACROPHAGE CHEMOTAXIS
|
11
|
0.069600
|
3.18e-01
|
0.562
|
|
MACROPHAGE MIGRATION
|
11
|
0.069600
|
3.18e-01
|
0.562
|
|
NEURAL CREST CELL DIFFERENTIATION
|
10
|
0.070100
|
3.33e-01
|
0.562
|
|
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
29
|
0.070200
|
1.97e-01
|
0.562
|
|
LUNG MORPHOGENESIS
|
7
|
0.070300
|
3.97e-01
|
0.562
|
|
POSITIVE REGULATION OF LIPID TRANSPORT
|
10
|
0.070500
|
-3.32e-01
|
0.562
|
|
BEHAVIOR
|
38
|
0.070500
|
1.73e-01
|
0.562
|
|
CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
33
|
0.070600
|
-1.85e-01
|
0.562
|
|
REGULATION OF PROGRAMMED CELL DEATH
|
136
|
0.070700
|
-9.71e-02
|
0.562
|
|
REGULATION OF ORGANIC ACID TRANSPORT
|
5
|
0.070900
|
-4.68e-01
|
0.562
|
|
LOCALIZATION WITHIN MEMBRANE
|
54
|
0.071200
|
-1.46e-01
|
0.562
|
|
MITOCHONDRION ORGANIZATION
|
19
|
0.072200
|
-2.41e-01
|
0.562
|
|
STEM CELL DIFFERENTIATION
|
15
|
0.072400
|
2.70e-01
|
0.562
|
|
INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
15
|
0.072700
|
-2.70e-01
|
0.562
|
|
ACTIN NUCLEATION
|
11
|
0.072900
|
-3.14e-01
|
0.562
|
|
T CELL HOMEOSTASIS
|
9
|
0.073200
|
-3.47e-01
|
0.562
|
|
HORMONE MEDIATED SIGNALING PATHWAY
|
9
|
0.073200
|
3.47e-01
|
0.562
|
|
RESPONSE TO FATTY ACID
|
6
|
0.073400
|
4.24e-01
|
0.562
|
|
POSITIVE REGULATION OF LIPID LOCALIZATION
|
13
|
0.073500
|
-2.89e-01
|
0.562
|
|
REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY
|
6
|
0.074200
|
-4.22e-01
|
0.562
|
|
REGULATION OF LOCOMOTION
|
135
|
0.074300
|
-9.62e-02
|
0.562
|
|
VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE
|
10
|
0.074400
|
-3.28e-01
|
0.562
|
|
REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
9
|
0.074400
|
-3.45e-01
|
0.562
|
|
CELL PROJECTION ORGANIZATION
|
100
|
0.074700
|
-1.09e-01
|
0.562
|
|
SEMI LUNAR VALVE DEVELOPMENT
|
5
|
0.075000
|
-4.61e-01
|
0.563
|
|
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY
|
5
|
0.075900
|
-4.60e-01
|
0.566
|
|
OSTEOCLAST DIFFERENTIATION
|
15
|
0.076500
|
-2.66e-01
|
0.566
|
|
LEUKOCYTE HOMEOSTASIS
|
14
|
0.076700
|
-2.75e-01
|
0.566
|
|
ALCOHOL BIOSYNTHETIC PROCESS
|
15
|
0.076800
|
-2.66e-01
|
0.566
|
|
LEUKOCYTE CELL CELL ADHESION
|
59
|
0.076900
|
-1.38e-01
|
0.566
|
|
RNA LOCALIZATION
|
6
|
0.077800
|
-4.17e-01
|
0.568
|
|
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
12
|
0.078500
|
2.95e-01
|
0.568
|
|
RESPONSE TO INTERLEUKIN 1
|
13
|
0.078700
|
2.84e-01
|
0.568
|
|
NEPHRON DEVELOPMENT
|
14
|
0.078800
|
-2.74e-01
|
0.568
|
|
VESICLE ORGANIZATION
|
19
|
0.078800
|
-2.35e-01
|
0.568
|
|
CD8 POSITIVE ALPHA BETA T CELL ACTIVATION
|
8
|
0.079100
|
-3.60e-01
|
0.568
|
|
CELL REDOX HOMEOSTASIS
|
9
|
0.079300
|
-3.40e-01
|
0.568
|
|
LOCOMOTORY BEHAVIOR
|
17
|
0.079400
|
2.48e-01
|
0.568
|
|
DNA REPLICATION
|
5
|
0.079600
|
-4.54e-01
|
0.568
|
|
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
5
|
0.079900
|
-4.54e-01
|
0.568
|
|
INTESTINAL ABSORPTION
|
7
|
0.080600
|
-3.83e-01
|
0.570
|
|
PHAGOCYTOSIS RECOGNITION
|
20
|
0.082000
|
2.27e-01
|
0.576
|
|
NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION
|
7
|
0.082100
|
-3.81e-01
|
0.576
|
|
NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY
|
6
|
0.082200
|
-4.11e-01
|
0.576
|
|
OLIGOSACCHARIDE METABOLIC PROCESS
|
6
|
0.082500
|
4.11e-01
|
0.576
|
|
PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS
|
8
|
0.084800
|
-3.54e-01
|
0.590
|
|
MICROTUBULE BASED PROCESS
|
53
|
0.085100
|
-1.41e-01
|
0.590
|
|
PHOSPHATIDYLCHOLINE METABOLIC PROCESS
|
10
|
0.085500
|
-3.16e-01
|
0.591
|
|
CELLULAR RESPONSE TO ABIOTIC STIMULUS
|
21
|
0.086600
|
-2.19e-01
|
0.591
|
|
CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
15
|
0.086800
|
2.58e-01
|
0.591
|
|
REGULATION OF TELOMERE MAINTENANCE
|
8
|
0.087100
|
-3.51e-01
|
0.591
|
|
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I
|
10
|
0.087500
|
-3.14e-01
|
0.591
|
|
POSITIVE REGULATION OF LOCOMOTION
|
90
|
0.087500
|
-1.10e-01
|
0.591
|
|
POSITIVE REGULATION OF MITOTIC CELL CYCLE
|
6
|
0.087600
|
-4.04e-01
|
0.591
|
|
EPIDERMAL CELL DIFFERENTIATION
|
31
|
0.087600
|
1.80e-01
|
0.591
|
|
FC GAMMA RECEPTOR SIGNALING PATHWAY
|
5
|
0.087900
|
-4.42e-01
|
0.592
|
|
COMPLEMENT ACTIVATION LECTIN PATHWAY
|
15
|
0.089600
|
2.55e-01
|
0.598
|
|
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND
|
100
|
0.089800
|
1.04e-01
|
0.598
|
|
PLATELET AGGREGATION
|
29
|
0.090100
|
-1.85e-01
|
0.598
|
|
NEGATIVE REGULATION OF COMPLEMENT ACTIVATION
|
6
|
0.090200
|
4.01e-01
|
0.598
|
|
VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS
|
7
|
0.090300
|
-3.71e-01
|
0.598
|
|
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT
|
14
|
0.090700
|
-2.63e-01
|
0.598
|
|
TISSUE HOMEOSTASIS
|
28
|
0.091100
|
-1.87e-01
|
0.598
|
|
PROTEIN STABILIZATION
|
28
|
0.091300
|
-1.87e-01
|
0.598
|
|
ERAD PATHWAY
|
8
|
0.092000
|
-3.46e-01
|
0.601
|
|
REGULATION OF CELL ACTIVATION
|
79
|
0.092500
|
-1.14e-01
|
0.602
|
|
REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
9
|
0.092700
|
-3.25e-01
|
0.602
|
|
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
8
|
0.094100
|
3.43e-01
|
0.604
|
|
POSITIVE REGULATION OF PLATELET ACTIVATION
|
9
|
0.094200
|
-3.24e-01
|
0.604
|
|
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS
|
5
|
0.094900
|
4.33e-01
|
0.604
|
|
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
17
|
0.095400
|
-2.36e-01
|
0.604
|
|
RENAL SYSTEM VASCULATURE DEVELOPMENT
|
7
|
0.095400
|
-3.66e-01
|
0.604
|
|
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
17
|
0.095900
|
-2.35e-01
|
0.604
|
|
POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
8
|
0.096000
|
-3.42e-01
|
0.604
|
|
POSITIVE REGULATION OF MUSCLE CONTRACTION
|
8
|
0.096300
|
-3.41e-01
|
0.604
|
|
GLYCEROLIPID BIOSYNTHETIC PROCESS
|
7
|
0.096300
|
-3.65e-01
|
0.604
|
|
POSITIVE REGULATION OF VIRAL GENOME REPLICATION
|
5
|
0.096600
|
-4.30e-01
|
0.604
|
|
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
6
|
0.097300
|
-3.92e-01
|
0.604
|
|
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY
|
8
|
0.097400
|
3.40e-01
|
0.604
|
|
POSITIVE REGULATION OF CELL CYCLE
|
13
|
0.098000
|
-2.67e-01
|
0.604
|
|
INTRACELLULAR TRANSPORT
|
81
|
0.098300
|
-1.11e-01
|
0.604
|
|
VIRAL GENOME REPLICATION
|
9
|
0.098300
|
-3.20e-01
|
0.604
|
|
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB
|
5
|
0.098300
|
-4.28e-01
|
0.604
|
|
ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB
|
5
|
0.098300
|
-4.28e-01
|
0.604
|
|
REGULATION OF TISSUE REMODELING
|
12
|
0.098400
|
-2.77e-01
|
0.604
|
|
RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
22
|
0.099300
|
-2.06e-01
|
0.605
|
|
SYMBIONT ENTRY INTO HOST
|
24
|
0.099500
|
-1.97e-01
|
0.605
|
|
EXPLORATION BEHAVIOR
|
5
|
0.100000
|
4.26e-01
|
0.605
|
|
INTERLEUKIN 8 PRODUCTION
|
20
|
0.100000
|
2.15e-01
|
0.605
|
|
MEMBRANE PROTEIN PROTEOLYSIS
|
9
|
0.100000
|
-3.18e-01
|
0.605
|
|
REGULATION OF ORGANELLE ORGANIZATION
|
90
|
0.100000
|
-1.05e-01
|
0.605
|
|
REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
5
|
0.102000
|
-4.24e-01
|
0.608
|
|
REGULATION OF HUMORAL IMMUNE RESPONSE
|
17
|
0.102000
|
2.32e-01
|
0.608
|
|
DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM
|
26
|
0.102000
|
1.88e-01
|
0.608
|
|
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
13
|
0.102000
|
-2.64e-01
|
0.608
|
|
ESTABLISHMENT OF LOCALIZATION IN CELL
|
110
|
0.103000
|
-9.59e-02
|
0.608
|
|
PROTEIN LOCALIZATION TO POSTSYNAPSE
|
5
|
0.103000
|
-4.22e-01
|
0.608
|
|
REGULATION OF MACROAUTOPHAGY
|
10
|
0.103000
|
-3.00e-01
|
0.608
|
|
TORC1 SIGNALING
|
5
|
0.103000
|
-4.22e-01
|
0.608
|
|
REGULATION OF GRANULOCYTE CHEMOTAXIS
|
12
|
0.104000
|
2.73e-01
|
0.610
|
|
POSITIVE REGULATION OF MUSCLE HYPERTROPHY
|
5
|
0.105000
|
4.20e-01
|
0.611
|
|
POSITIVE REGULATION OF DNA METABOLIC PROCESS
|
13
|
0.105000
|
-2.62e-01
|
0.611
|
|
LAMELLIPODIUM ORGANIZATION
|
18
|
0.105000
|
-2.23e-01
|
0.611
|
|
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY
|
8
|
0.106000
|
-3.32e-01
|
0.611
|
|
ORGANIC HYDROXY COMPOUND TRANSPORT
|
34
|
0.106000
|
-1.63e-01
|
0.611
|
|
SPROUTING ANGIOGENESIS
|
14
|
0.106000
|
-2.52e-01
|
0.611
|
|
POSITIVE REGULATION OF PROGRAMMED CELL DEATH
|
52
|
0.106000
|
-1.33e-01
|
0.611
|
|
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS
|
12
|
0.107000
|
-2.71e-01
|
0.611
|
|
NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION
|
5
|
0.107000
|
4.18e-01
|
0.611
|
|
MONOATOMIC CATION TRANSPORT
|
59
|
0.107000
|
-1.25e-01
|
0.611
|
|
POSITIVE REGULATION OF CHROMOSOME ORGANIZATION
|
8
|
0.108000
|
-3.30e-01
|
0.612
|
|
REGULATION OF HYDROLASE ACTIVITY
|
15
|
0.108000
|
-2.42e-01
|
0.613
|
|
NEGATIVE REGULATION OF OSSIFICATION
|
5
|
0.110000
|
-4.14e-01
|
0.616
|
|
NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION
|
22
|
0.110000
|
-1.99e-01
|
0.616
|
|
ENDOPLASMIC RETICULUM ORGANIZATION
|
6
|
0.110000
|
-3.78e-01
|
0.616
|
|
POSITIVE REGULATION OF STEROL TRANSPORT
|
9
|
0.110000
|
-3.09e-01
|
0.616
|
|
CELL CYCLE
|
59
|
0.110000
|
-1.24e-01
|
0.616
|
|
LYMPHOCYTE MEDIATED IMMUNITY
|
99
|
0.110000
|
-9.82e-02
|
0.616
|
|
REGULATION OF DIGESTIVE SYSTEM PROCESS
|
6
|
0.111000
|
-3.77e-01
|
0.616
|
|
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
28
|
0.112000
|
-1.76e-01
|
0.616
|
|
ADULT BEHAVIOR
|
6
|
0.112000
|
3.76e-01
|
0.616
|
|
CELL MORPHOGENESIS
|
93
|
0.112000
|
-1.01e-01
|
0.616
|
|
PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
19
|
0.112000
|
-2.13e-01
|
0.616
|
|
ACTIN FILAMENT NETWORK FORMATION
|
5
|
0.114000
|
-4.10e-01
|
0.620
|
|
POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY
|
6
|
0.114000
|
3.74e-01
|
0.620
|
|
STEROL BIOSYNTHETIC PROCESS
|
8
|
0.114000
|
-3.24e-01
|
0.620
|
|
ESTABLISHMENT OF PROTEIN LOCALIZATION
|
116
|
0.115000
|
-9.07e-02
|
0.620
|
|
REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
12
|
0.115000
|
-2.65e-01
|
0.620
|
|
MALE GAMETE GENERATION
|
26
|
0.115000
|
-1.81e-01
|
0.620
|
|
LIPID BIOSYNTHETIC PROCESS
|
35
|
0.115000
|
-1.57e-01
|
0.620
|
|
REGULATION OF REPRODUCTIVE PROCESS
|
10
|
0.117000
|
2.88e-01
|
0.629
|
|
NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS
|
5
|
0.117000
|
4.06e-01
|
0.629
|
|
POSITIVE REGULATION OF HORMONE SECRETION
|
9
|
0.118000
|
3.03e-01
|
0.629
|
|
CELLULAR RESPONSE TO OXYGEN RADICAL
|
8
|
0.118000
|
3.20e-01
|
0.629
|
|
RESPONSE TO OXYGEN RADICAL
|
8
|
0.118000
|
3.20e-01
|
0.629
|
|
MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
40
|
0.119000
|
-1.46e-01
|
0.629
|
|
NEGATIVE REGULATION OF CELL MATRIX ADHESION
|
7
|
0.119000
|
-3.42e-01
|
0.629
|
|
BICELLULAR TIGHT JUNCTION ASSEMBLY
|
6
|
0.120000
|
-3.67e-01
|
0.633
|
|
TIGHT JUNCTION ORGANIZATION
|
6
|
0.120000
|
-3.67e-01
|
0.633
|
|
REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
45
|
0.121000
|
1.37e-01
|
0.633
|
|
AUTOPHAGY OF MITOCHONDRION
|
6
|
0.121000
|
-3.67e-01
|
0.633
|
|
ENDOMEMBRANE SYSTEM ORGANIZATION
|
39
|
0.121000
|
-1.47e-01
|
0.634
|
|
APOPTOTIC SIGNALING PATHWAY
|
60
|
0.122000
|
-1.19e-01
|
0.634
|
|
ACTIVATION OF IMMUNE RESPONSE
|
84
|
0.122000
|
1.02e-01
|
0.634
|
|
MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS
|
7
|
0.122000
|
-3.39e-01
|
0.634
|
|
VITAMIN TRANSPORT
|
5
|
0.125000
|
-3.98e-01
|
0.644
|
|
MUSCLE SYSTEM PROCESS
|
40
|
0.125000
|
-1.43e-01
|
0.644
|
|
DETECTION OF BIOTIC STIMULUS
|
9
|
0.125000
|
-2.97e-01
|
0.644
|
|
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
25
|
0.126000
|
-1.79e-01
|
0.647
|
|
REGULATORY T CELL DIFFERENTIATION
|
8
|
0.126000
|
-3.14e-01
|
0.647
|
|
RESPONSE TO OXYGEN CONTAINING COMPOUND
|
149
|
0.127000
|
7.91e-02
|
0.648
|
|
POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
6
|
0.127000
|
-3.61e-01
|
0.649
|
|
ENDOCRINE PROCESS
|
8
|
0.128000
|
3.12e-01
|
0.649
|
|
GOLGI VESICLE TRANSPORT
|
23
|
0.129000
|
-1.85e-01
|
0.652
|
|
NEUROINFLAMMATORY RESPONSE
|
16
|
0.130000
|
2.21e-01
|
0.656
|
|
ACTION POTENTIAL
|
10
|
0.130000
|
2.78e-01
|
0.656
|
|
ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
6
|
0.131000
|
-3.58e-01
|
0.656
|
|
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
22
|
0.131000
|
-1.88e-01
|
0.656
|
|
INTERLEUKIN 10 PRODUCTION
|
5
|
0.131000
|
-3.91e-01
|
0.656
|
|
ENDOTHELIAL CELL CHEMOTAXIS
|
6
|
0.132000
|
-3.57e-01
|
0.658
|
|
GLAND MORPHOGENESIS
|
17
|
0.132000
|
-2.13e-01
|
0.658
|
|
LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
7
|
0.132000
|
3.30e-01
|
0.658
|
|
CILIUM MOVEMENT
|
13
|
0.133000
|
-2.42e-01
|
0.661
|
|
RESPONSE TO PH
|
5
|
0.135000
|
3.87e-01
|
0.666
|
|
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS
|
7
|
0.135000
|
3.28e-01
|
0.666
|
|
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
19
|
0.135000
|
-2.00e-01
|
0.666
|
|
REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY
|
6
|
0.136000
|
3.53e-01
|
0.666
|
|
NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
5
|
0.136000
|
3.86e-01
|
0.666
|
|
NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
5
|
0.136000
|
3.86e-01
|
0.666
|
|
POLYOL METABOLIC PROCESS
|
6
|
0.137000
|
-3.52e-01
|
0.666
|
|
KERATINOCYTE PROLIFERATION
|
6
|
0.138000
|
-3.51e-01
|
0.670
|
|
NEGATIVE REGULATION OF BINDING
|
5
|
0.139000
|
3.84e-01
|
0.670
|
|
NEGATIVE REGULATION OF PROTEIN BINDING
|
5
|
0.139000
|
3.84e-01
|
0.670
|
|
EPHRIN RECEPTOR SIGNALING PATHWAY
|
5
|
0.139000
|
-3.83e-01
|
0.670
|
|
REGULATION OF AUTOPHAGY OF MITOCHONDRION
|
5
|
0.140000
|
-3.83e-01
|
0.670
|
|
SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING
|
9
|
0.140000
|
2.86e-01
|
0.670
|
|
NEURON PROJECTION ORGANIZATION
|
7
|
0.140000
|
-3.23e-01
|
0.670
|
|
T CELL MIGRATION
|
12
|
0.140000
|
-2.48e-01
|
0.670
|
|
REGULATION OF CARDIAC MUSCLE CONTRACTION
|
9
|
0.141000
|
-2.85e-01
|
0.670
|
|
REGULATION OF STRIATED MUSCLE CONTRACTION
|
9
|
0.141000
|
-2.85e-01
|
0.670
|
|
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY
|
12
|
0.142000
|
-2.47e-01
|
0.672
|
|
REGULATION OF GLIOGENESIS
|
9
|
0.142000
|
-2.84e-01
|
0.672
|
|
REGULATION OF NERVOUS SYSTEM PROCESS
|
9
|
0.142000
|
-2.84e-01
|
0.672
|
|
MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS
|
13
|
0.143000
|
2.37e-01
|
0.672
|
|
POST GOLGI VESICLE MEDIATED TRANSPORT
|
7
|
0.143000
|
-3.21e-01
|
0.672
|
|
LEUKOCYTE MEDIATED CYTOTOXICITY
|
28
|
0.143000
|
-1.62e-01
|
0.673
|
|
POSITIVE REGULATION OF PROTEIN MATURATION
|
10
|
0.145000
|
-2.68e-01
|
0.677
|
|
STEROL TRANSPORT
|
26
|
0.145000
|
-1.68e-01
|
0.677
|
|
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
22
|
0.146000
|
-1.81e-01
|
0.679
|
|
MAINTENANCE OF BLOOD BRAIN BARRIER
|
9
|
0.147000
|
-2.81e-01
|
0.682
|
|
PROTEIN RNA COMPLEX ORGANIZATION
|
6
|
0.148000
|
-3.43e-01
|
0.684
|
|
REGULATION OF DEFENSE RESPONSE
|
93
|
0.148000
|
9.16e-02
|
0.684
|
|
COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY
|
14
|
0.148000
|
2.25e-01
|
0.684
|
|
TAXIS
|
69
|
0.149000
|
-1.05e-01
|
0.685
|
|
RENAL FILTRATION
|
7
|
0.150000
|
-3.15e-01
|
0.690
|
|
FOCAL ADHESION ASSEMBLY
|
17
|
0.151000
|
-2.03e-01
|
0.691
|
|
POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING
|
7
|
0.151000
|
3.15e-01
|
0.691
|
|
REGULATION OF LYMPHOCYTE MIGRATION
|
9
|
0.152000
|
-2.77e-01
|
0.693
|
|
T HELPER 17 TYPE IMMUNE RESPONSE
|
10
|
0.152000
|
-2.63e-01
|
0.693
|
|
NEGATIVE REGULATION OF CELL KILLING
|
8
|
0.153000
|
-2.93e-01
|
0.694
|
|
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT
|
8
|
0.153000
|
-2.93e-01
|
0.694
|
|
MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS
|
44
|
0.153000
|
-1.27e-01
|
0.694
|
|
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION
|
7
|
0.155000
|
-3.12e-01
|
0.699
|
|
HEART PROCESS
|
24
|
0.156000
|
-1.70e-01
|
0.699
|
|
POSITIVE REGULATION OF AXON EXTENSION
|
5
|
0.156000
|
3.68e-01
|
0.699
|
|
REGULATION OF CALCIUM ION TRANSPORT
|
22
|
0.156000
|
-1.77e-01
|
0.699
|
|
CYTOPLASMIC TRANSLATION
|
6
|
0.156000
|
3.36e-01
|
0.699
|
|
TISSUE REMODELING
|
28
|
0.157000
|
-1.57e-01
|
0.700
|
|
REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
12
|
0.158000
|
-2.37e-01
|
0.703
|
|
NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE
|
7
|
0.158000
|
3.09e-01
|
0.703
|
|
MEGAKARYOCYTE DEVELOPMENT
|
8
|
0.160000
|
-2.88e-01
|
0.705
|
|
INTRACELLULAR RECEPTOR SIGNALING PATHWAY
|
12
|
0.161000
|
2.35e-01
|
0.705
|
|
BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION
|
48
|
0.161000
|
-1.20e-01
|
0.705
|
|
ERYTHROCYTE HOMEOSTASIS
|
16
|
0.161000
|
2.04e-01
|
0.705
|
|
IMPORT ACROSS PLASMA MEMBRANE
|
10
|
0.161000
|
-2.57e-01
|
0.705
|
|
POSITIVE REGULATION OF PROTEOLYSIS
|
22
|
0.162000
|
-1.75e-01
|
0.705
|
|
COGNITION
|
17
|
0.162000
|
1.98e-01
|
0.705
|
|
PLASMINOGEN ACTIVATION
|
17
|
0.163000
|
1.98e-01
|
0.705
|
|
REGENERATION
|
25
|
0.163000
|
-1.63e-01
|
0.705
|
|
CELLULAR RESPONSE TO HEAT
|
6
|
0.163000
|
-3.30e-01
|
0.705
|
|
REGULATION OF OSTEOCLAST DIFFERENTIATION
|
5
|
0.164000
|
-3.61e-01
|
0.705
|
|
METAL ION TRANSPORT
|
54
|
0.164000
|
-1.13e-01
|
0.705
|
|
HORMONE TRANSPORT
|
24
|
0.164000
|
1.66e-01
|
0.705
|
|
PEPTIDYL AMINO ACID MODIFICATION
|
23
|
0.165000
|
-1.70e-01
|
0.705
|
|
REGULATION OF AXON EXTENSION
|
9
|
0.165000
|
2.69e-01
|
0.705
|
|
REGULATION OF EXTENT OF CELL GROWTH
|
9
|
0.165000
|
2.69e-01
|
0.705
|
|
VESICLE BUDDING FROM MEMBRANE
|
5
|
0.165000
|
-3.60e-01
|
0.705
|
|
NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS
|
7
|
0.165000
|
3.04e-01
|
0.705
|
|
CARBOHYDRATE HOMEOSTASIS
|
21
|
0.165000
|
1.77e-01
|
0.705
|
|
REGULATION OF VIRAL GENOME REPLICATION
|
7
|
0.166000
|
-3.04e-01
|
0.705
|
|
NATURAL KILLER CELL MEDIATED IMMUNITY
|
15
|
0.166000
|
-2.08e-01
|
0.707
|
|
GLUCAN METABOLIC PROCESS
|
8
|
0.167000
|
2.83e-01
|
0.707
|
|
NEGATIVE REGULATION OF CELL CYCLE
|
6
|
0.168000
|
-3.27e-01
|
0.707
|
|
AMINOGLYCAN CATABOLIC PROCESS
|
8
|
0.168000
|
2.83e-01
|
0.707
|
|
NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION
|
8
|
0.168000
|
-2.83e-01
|
0.708
|
|
REGULATION OF COMPLEMENT ACTIVATION
|
12
|
0.169000
|
2.31e-01
|
0.709
|
|
ASTROCYTE ACTIVATION
|
5
|
0.169000
|
3.56e-01
|
0.709
|
|
VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
6
|
0.170000
|
3.25e-01
|
0.709
|
|
NEGATIVE REGULATION OF CELL CELL ADHESION
|
28
|
0.170000
|
-1.52e-01
|
0.709
|
|
ENERGY RESERVE METABOLIC PROCESS
|
10
|
0.170000
|
2.52e-01
|
0.709
|
|
POSITIVE REGULATION OF TELOMERE MAINTENANCE
|
7
|
0.171000
|
-3.00e-01
|
0.711
|
|
DETECTION OF STIMULUS
|
26
|
0.172000
|
-1.57e-01
|
0.714
|
|
REGULATION OF LEUKOCYTE PROLIFERATION
|
28
|
0.173000
|
1.51e-01
|
0.716
|
|
POSITIVE REGULATION OF VIRAL PROCESS
|
9
|
0.173000
|
-2.64e-01
|
0.716
|
|
LYMPHOCYTE MIGRATION
|
14
|
0.174000
|
-2.12e-01
|
0.716
|
|
NEGATIVE REGULATION OF HORMONE SECRETION
|
5
|
0.175000
|
-3.52e-01
|
0.716
|
|
NEGATIVE REGULATION OF CELL COMMUNICATION
|
108
|
0.175000
|
-8.04e-02
|
0.716
|
|
APPENDAGE DEVELOPMENT
|
9
|
0.175000
|
-2.63e-01
|
0.716
|
|
CARBOHYDRATE METABOLIC PROCESS
|
67
|
0.176000
|
9.93e-02
|
0.716
|
|
PRESYNAPTIC ENDOCYTOSIS
|
6
|
0.176000
|
-3.20e-01
|
0.716
|
|
PERIPHERAL NERVOUS SYSTEM AXON REGENERATION
|
5
|
0.176000
|
-3.50e-01
|
0.716
|
|
PANCREAS DEVELOPMENT
|
7
|
0.176000
|
2.96e-01
|
0.716
|
|
REGULATION OF FAT CELL DIFFERENTIATION
|
5
|
0.177000
|
3.50e-01
|
0.716
|
|
PROTEIN LOCALIZATION TO NUCLEUS
|
26
|
0.177000
|
-1.55e-01
|
0.716
|
|
NEGATIVE REGULATION OF SECRETION
|
15
|
0.177000
|
-2.03e-01
|
0.716
|
|
POSITIVE REGULATION OF PROTEIN LOCALIZATION
|
53
|
0.177000
|
-1.10e-01
|
0.716
|
|
EPITHELIUM DEVELOPMENT
|
115
|
0.178000
|
7.77e-02
|
0.717
|
|
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
7
|
0.179000
|
2.95e-01
|
0.719
|
|
REGULATION OF DEVELOPMENTAL GROWTH
|
22
|
0.180000
|
1.67e-01
|
0.724
|
|
RESPONSE TO PLATELET DERIVED GROWTH FACTOR
|
5
|
0.181000
|
-3.47e-01
|
0.724
|
|
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION
|
49
|
0.182000
|
-1.13e-01
|
0.728
|
|
DENDRITE MORPHOGENESIS
|
8
|
0.183000
|
-2.73e-01
|
0.729
|
|
PROTEIN CONTAINING COMPLEX LOCALIZATION
|
6
|
0.184000
|
-3.15e-01
|
0.729
|
|
AMINO SUGAR METABOLIC PROCESS
|
6
|
0.184000
|
3.14e-01
|
0.729
|
|
MESENCHYMAL CELL MIGRATION
|
9
|
0.184000
|
2.57e-01
|
0.729
|
|
APOPTOTIC MITOCHONDRIAL CHANGES
|
10
|
0.185000
|
-2.44e-01
|
0.729
|
|
N GLYCAN PROCESSING
|
6
|
0.185000
|
3.14e-01
|
0.729
|
|
RESPONSE TO STEROID HORMONE
|
28
|
0.185000
|
1.47e-01
|
0.731
|
|
RESPONSE TO AMYLOID BETA
|
11
|
0.187000
|
2.31e-01
|
0.735
|
|
ENDODERM DEVELOPMENT
|
10
|
0.188000
|
-2.42e-01
|
0.737
|
|
STEROID METABOLIC PROCESS
|
31
|
0.188000
|
-1.39e-01
|
0.738
|
|
ATP METABOLIC PROCESS
|
32
|
0.189000
|
-1.37e-01
|
0.740
|
|
RESPONSE TO PEPTIDE
|
82
|
0.190000
|
-8.77e-02
|
0.741
|
|
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS
|
5
|
0.190000
|
-3.39e-01
|
0.741
|
|
NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS
|
30
|
0.191000
|
-1.40e-01
|
0.741
|
|
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION
|
8
|
0.191000
|
-2.68e-01
|
0.741
|
|
T CELL ACTIVATION
|
61
|
0.192000
|
-9.99e-02
|
0.744
|
|
STEROL METABOLIC PROCESS
|
24
|
0.193000
|
-1.55e-01
|
0.745
|
|
VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION
|
5
|
0.193000
|
-3.37e-01
|
0.745
|
|
LYMPHOCYTE HOMEOSTASIS
|
10
|
0.194000
|
-2.39e-01
|
0.745
|
|
EPITHELIAL CELL MORPHOGENESIS
|
7
|
0.194000
|
-2.85e-01
|
0.745
|
|
ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION
|
9
|
0.195000
|
-2.51e-01
|
0.745
|
|
CELL JUNCTION ORGANIZATION
|
87
|
0.196000
|
-8.43e-02
|
0.745
|
|
CELL CHEMOTAXIS
|
49
|
0.196000
|
-1.10e-01
|
0.745
|
|
BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS
|
5
|
0.196000
|
3.35e-01
|
0.745
|
|
DEFENSE RESPONSE TO BACTERIUM
|
57
|
0.197000
|
-1.02e-01
|
0.745
|
|
ONE CARBON COMPOUND TRANSPORT
|
6
|
0.197000
|
3.05e-01
|
0.745
|
|
SEXUAL REPRODUCTION
|
53
|
0.197000
|
-1.06e-01
|
0.745
|
|
REGULATION OF PROTEIN CATABOLIC PROCESS
|
45
|
0.197000
|
-1.14e-01
|
0.745
|
|
POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
6
|
0.197000
|
-3.05e-01
|
0.745
|
|
CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION
|
5
|
0.198000
|
3.34e-01
|
0.745
|
|
POSITIVE REGULATION OF CELL ACTIVATION
|
45
|
0.198000
|
-1.14e-01
|
0.746
|
|
BONE RESORPTION
|
7
|
0.199000
|
-2.82e-01
|
0.746
|
|
ADAPTIVE IMMUNE RESPONSE
|
157
|
0.199000
|
-6.52e-02
|
0.746
|
|
TEMPERATURE HOMEOSTASIS
|
10
|
0.200000
|
-2.36e-01
|
0.748
|
|
REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
10
|
0.200000
|
-2.35e-01
|
0.749
|
|
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
8
|
0.201000
|
-2.63e-01
|
0.749
|
|
KIDNEY EPITHELIUM DEVELOPMENT
|
11
|
0.202000
|
-2.24e-01
|
0.751
|
|
TISSUE REGENERATION
|
10
|
0.202000
|
-2.34e-01
|
0.751
|
|
ESTABLISHMENT OF SKIN BARRIER
|
7
|
0.203000
|
2.79e-01
|
0.751
|
|
ERYTHROCYTE DEVELOPMENT
|
10
|
0.204000
|
2.34e-01
|
0.751
|
|
RESPONSE TO PEPTIDE HORMONE
|
42
|
0.204000
|
1.16e-01
|
0.751
|
|
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
111
|
0.206000
|
-7.41e-02
|
0.751
|
|
NEGATIVE REGULATION OF T CELL PROLIFERATION
|
6
|
0.206000
|
-2.99e-01
|
0.751
|
|
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION
|
8
|
0.207000
|
-2.59e-01
|
0.751
|
|
DIGESTIVE SYSTEM PROCESS
|
12
|
0.207000
|
-2.12e-01
|
0.751
|
|
MEGAKARYOCYTE DIFFERENTIATION
|
10
|
0.208000
|
-2.32e-01
|
0.751
|
|
RESPONSE TO TEMPERATURE STIMULUS
|
11
|
0.208000
|
-2.21e-01
|
0.751
|
|
RESPONSE TO OSMOTIC STRESS
|
5
|
0.208000
|
-3.26e-01
|
0.751
|
|
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS
|
6
|
0.208000
|
-2.98e-01
|
0.751
|
|
PROTEIN MODIFICATION PROCESS
|
83
|
0.208000
|
-8.38e-02
|
0.751
|
|
MIRNA METABOLIC PROCESS
|
7
|
0.209000
|
-2.75e-01
|
0.751
|
|
GLYCEROLIPID METABOLIC PROCESS
|
27
|
0.209000
|
-1.42e-01
|
0.751
|
|
POSITIVE REGULATION OF GLIOGENESIS
|
6
|
0.210000
|
-2.97e-01
|
0.751
|
|
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION
|
10
|
0.211000
|
-2.30e-01
|
0.751
|
|
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
6
|
0.211000
|
-2.96e-01
|
0.751
|
|
NUCLEAR RECEPTOR MEDIATED SIGNALING PATHWAY
|
8
|
0.211000
|
2.57e-01
|
0.751
|
|
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS
|
39
|
0.211000
|
-1.18e-01
|
0.751
|
|
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
7
|
0.211000
|
2.74e-01
|
0.751
|
|
NEGATIVE REGULATION OF PROTEIN LOCALIZATION
|
20
|
0.212000
|
-1.63e-01
|
0.751
|
|
MORPHOGENESIS OF AN EPITHELIAL SHEET
|
11
|
0.212000
|
-2.19e-01
|
0.751
|
|
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY
|
8
|
0.213000
|
-2.56e-01
|
0.751
|
|
POSITIVE REGULATION OF GENE EXPRESSION
|
106
|
0.213000
|
-7.44e-02
|
0.751
|
|
PROTEIN CATABOLIC PROCESS IN THE VACUOLE
|
5
|
0.213000
|
3.23e-01
|
0.751
|
|
POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
7
|
0.214000
|
2.72e-01
|
0.751
|
|
DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS
|
6
|
0.214000
|
2.94e-01
|
0.751
|
|
REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
45
|
0.215000
|
-1.10e-01
|
0.751
|
|
MICROTUBULE CYTOSKELETON ORGANIZATION
|
28
|
0.215000
|
-1.38e-01
|
0.751
|
|
CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION
|
7
|
0.215000
|
-2.72e-01
|
0.751
|
|
CD8 POSITIVE ALPHA BETA T CELL HOMEOSTASIS
|
7
|
0.215000
|
-2.72e-01
|
0.751
|
|
NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION
|
7
|
0.215000
|
-2.72e-01
|
0.751
|
|
REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
19
|
0.215000
|
-1.66e-01
|
0.751
|
|
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
24
|
0.215000
|
-1.48e-01
|
0.751
|
|
FOREBRAIN GENERATION OF NEURONS
|
5
|
0.215000
|
3.21e-01
|
0.751
|
|
CYTOKINE MEDIATED SIGNALING PATHWAY
|
30
|
0.216000
|
-1.33e-01
|
0.751
|
|
POSITIVE REGULATION OF PROTEIN SECRETION
|
14
|
0.216000
|
1.93e-01
|
0.751
|
|
GLYCOPROTEIN CATABOLIC PROCESS
|
5
|
0.216000
|
3.21e-01
|
0.751
|
|
AXON DEVELOPMENT
|
49
|
0.217000
|
-1.05e-01
|
0.751
|
|
POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
5
|
0.218000
|
-3.19e-01
|
0.754
|
|
LEUKOCYTE MEDIATED IMMUNITY
|
115
|
0.218000
|
-7.10e-02
|
0.754
|
|
SENSORY PERCEPTION OF LIGHT STIMULUS
|
6
|
0.219000
|
2.91e-01
|
0.754
|
|
ERBB SIGNALING PATHWAY
|
15
|
0.219000
|
1.85e-01
|
0.754
|
|
STEROID HORMONE RECEPTOR SIGNALING PATHWAY
|
5
|
0.219000
|
3.18e-01
|
0.754
|
|
RESPONSE TO AMINE
|
5
|
0.221000
|
-3.17e-01
|
0.759
|
|
REGULATION OF CILIUM ASSEMBLY
|
5
|
0.222000
|
3.17e-01
|
0.760
|
|
LAMELLIPODIUM ASSEMBLY
|
13
|
0.223000
|
-1.97e-01
|
0.762
|
|
APPENDAGE MORPHOGENESIS
|
6
|
0.223000
|
-2.88e-01
|
0.762
|
|
NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
6
|
0.225000
|
-2.87e-01
|
0.764
|
|
REGULATION OF HETEROTYPIC CELL CELL ADHESION
|
6
|
0.226000
|
2.87e-01
|
0.764
|
|
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
12
|
0.226000
|
-2.03e-01
|
0.764
|
|
NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
20
|
0.226000
|
-1.58e-01
|
0.764
|
|
NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS
|
8
|
0.226000
|
-2.48e-01
|
0.764
|
|
PROTEIN REFOLDING
|
8
|
0.226000
|
-2.48e-01
|
0.764
|
|
NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY
|
5
|
0.226000
|
3.13e-01
|
0.764
|
|
CELL JUNCTION ASSEMBLY
|
50
|
0.227000
|
-1.01e-01
|
0.765
|
|
PRIMARY ALCOHOL METABOLIC PROCESS
|
9
|
0.228000
|
2.34e-01
|
0.765
|
|
PROTEIN PROCESSING
|
60
|
0.228000
|
9.31e-02
|
0.765
|
|
MACROAUTOPHAGY
|
21
|
0.228000
|
-1.54e-01
|
0.765
|
|
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
175
|
0.229000
|
-5.86e-02
|
0.765
|
|
GENERATION OF NEURONS
|
92
|
0.229000
|
-7.64e-02
|
0.766
|
|
REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
14
|
0.230000
|
-1.87e-01
|
0.766
|
|
DETECTION OF EXTERNAL BIOTIC STIMULUS
|
6
|
0.231000
|
-2.84e-01
|
0.766
|
|
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS
|
5
|
0.231000
|
-3.10e-01
|
0.766
|
|
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION
|
37
|
0.231000
|
-1.16e-01
|
0.766
|
|
CAMERA TYPE EYE MORPHOGENESIS
|
7
|
0.232000
|
-2.62e-01
|
0.766
|
|
DEVELOPMENTAL CELL GROWTH
|
16
|
0.233000
|
1.74e-01
|
0.766
|
|
PROTEIN LIPID COMPLEX ASSEMBLY
|
9
|
0.233000
|
-2.31e-01
|
0.766
|
|
REPRODUCTIVE PROCESS
|
83
|
0.233000
|
-7.94e-02
|
0.766
|
|
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY
|
22
|
0.233000
|
-1.49e-01
|
0.766
|
|
PROTEIN TARGETING
|
20
|
0.233000
|
-1.56e-01
|
0.766
|
|
VACUOLAR LOCALIZATION
|
12
|
0.234000
|
2.00e-01
|
0.766
|
|
MONOATOMIC ION TRANSPORT
|
66
|
0.234000
|
-8.79e-02
|
0.766
|
|
ENDOTHELIAL CELL DEVELOPMENT
|
17
|
0.234000
|
-1.68e-01
|
0.766
|
|
REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
15
|
0.235000
|
1.79e-01
|
0.766
|
|
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT
|
8
|
0.235000
|
2.44e-01
|
0.766
|
|
REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
13
|
0.235000
|
-1.92e-01
|
0.766
|
|
POST TRANSLATIONAL PROTEIN MODIFICATION
|
21
|
0.236000
|
-1.51e-01
|
0.766
|
|
CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY
|
12
|
0.237000
|
-1.99e-01
|
0.766
|
|
REGULATION OF LIPID LOCALIZATION
|
26
|
0.237000
|
-1.36e-01
|
0.766
|
|
CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
21
|
0.237000
|
-1.51e-01
|
0.766
|
|
REGULATION OF T CELL MIGRATION
|
8
|
0.237000
|
-2.42e-01
|
0.767
|
|
REGULATION OF EPITHELIAL CELL MIGRATION
|
12
|
0.239000
|
-1.98e-01
|
0.768
|
|
REGULATION OF GLIAL CELL DIFFERENTIATION
|
7
|
0.240000
|
-2.58e-01
|
0.768
|
|
BONE CELL DEVELOPMENT
|
6
|
0.241000
|
-2.77e-01
|
0.768
|
|
REGULATION OF NEURON APOPTOTIC PROCESS
|
19
|
0.242000
|
1.57e-01
|
0.768
|
|
CELLULAR COMPONENT MAINTENANCE
|
11
|
0.242000
|
2.05e-01
|
0.768
|
|
NEUTROPHIL CHEMOTAXIS
|
17
|
0.242000
|
-1.66e-01
|
0.768
|
|
PEPTIDYL TYROSINE MODIFICATION
|
12
|
0.242000
|
-1.97e-01
|
0.768
|
|
REGULATION OF KINASE ACTIVITY
|
18
|
0.242000
|
1.61e-01
|
0.768
|
|
REGULATION OF TRANSFERASE ACTIVITY
|
18
|
0.242000
|
1.61e-01
|
0.768
|
|
REGULATION OF PROTEIN UBIQUITINATION
|
10
|
0.242000
|
-2.15e-01
|
0.768
|
|
BONE REMODELING
|
9
|
0.243000
|
-2.26e-01
|
0.768
|
|
FAT CELL DIFFERENTIATION
|
10
|
0.243000
|
2.15e-01
|
0.768
|
|
MITOTIC CELL CYCLE PROCESS
|
37
|
0.243000
|
-1.13e-01
|
0.768
|
|
LEARNING OR MEMORY
|
16
|
0.243000
|
1.70e-01
|
0.768
|
|
PHAGOCYTOSIS
|
60
|
0.245000
|
-8.98e-02
|
0.768
|
|
REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
25
|
0.245000
|
-1.36e-01
|
0.768
|
|
DESMOSOME ORGANIZATION
|
7
|
0.245000
|
2.55e-01
|
0.768
|
|
MEMBRANE LIPID METABOLIC PROCESS
|
9
|
0.245000
|
2.25e-01
|
0.768
|
|
APICAL JUNCTION ASSEMBLY
|
9
|
0.246000
|
-2.25e-01
|
0.768
|
|
REGULATION OF MEMBRANE PERMEABILITY
|
5
|
0.246000
|
-3.01e-01
|
0.768
|
|
T HELPER 1 CELL DIFFERENTIATION
|
8
|
0.246000
|
-2.38e-01
|
0.768
|
|
T HELPER 1 TYPE IMMUNE RESPONSE
|
8
|
0.246000
|
-2.38e-01
|
0.768
|
|
DNA RECOMBINATION
|
6
|
0.247000
|
-2.74e-01
|
0.768
|
|
GAS TRANSPORT
|
6
|
0.248000
|
2.74e-01
|
0.768
|
|
SKIN DEVELOPMENT
|
42
|
0.248000
|
1.06e-01
|
0.768
|
|
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES
|
22
|
0.248000
|
1.44e-01
|
0.768
|
|
EMBRYONIC APPENDAGE MORPHOGENESIS
|
5
|
0.248000
|
-2.99e-01
|
0.768
|
|
REGULATION OF HEART RATE
|
9
|
0.249000
|
2.23e-01
|
0.768
|
|
REGULATION OF RECEPTOR CLUSTERING
|
5
|
0.250000
|
-2.98e-01
|
0.768
|
|
CEREBELLAR CORTEX DEVELOPMENT
|
5
|
0.250000
|
2.98e-01
|
0.768
|
|
MUSCLE CELL CELLULAR HOMEOSTASIS
|
6
|
0.251000
|
2.72e-01
|
0.768
|
|
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
9
|
0.252000
|
2.22e-01
|
0.768
|
|
HYPERSENSITIVITY
|
5
|
0.253000
|
-2.97e-01
|
0.768
|
|
TYPE II HYPERSENSITIVITY
|
5
|
0.253000
|
-2.97e-01
|
0.768
|
|
PROTEASOMAL PROTEIN CATABOLIC PROCESS
|
33
|
0.253000
|
-1.17e-01
|
0.768
|
|
ACUTE INFLAMMATORY RESPONSE
|
37
|
0.253000
|
1.11e-01
|
0.768
|
|
RESPONSE TO STEROL
|
5
|
0.254000
|
-2.96e-01
|
0.768
|
|
EXECUTION PHASE OF APOPTOSIS
|
6
|
0.254000
|
-2.70e-01
|
0.768
|
|
SENSORY PERCEPTION OF MECHANICAL STIMULUS
|
11
|
0.254000
|
-2.00e-01
|
0.768
|
|
RESPONSE TO REACTIVE OXYGEN SPECIES
|
32
|
0.255000
|
1.18e-01
|
0.768
|
|
POSITIVE REGULATION OF SIGNALING
|
150
|
0.255000
|
-5.88e-02
|
0.768
|
|
RESPONSE TO HYDROGEN PEROXIDE
|
16
|
0.255000
|
1.66e-01
|
0.768
|
|
REGULATION OF NEURONAL SYNAPTIC PLASTICITY
|
6
|
0.255000
|
-2.69e-01
|
0.768
|
|
FATTY ACID METABOLIC PROCESS
|
26
|
0.255000
|
-1.31e-01
|
0.768
|
|
POSITIVE REGULATION OF MIRNA METABOLIC PROCESS
|
5
|
0.255000
|
-2.95e-01
|
0.768
|
|
NEGATIVE REGULATION OF PROTEIN SECRETION
|
6
|
0.256000
|
-2.69e-01
|
0.768
|
|
HINDBRAIN DEVELOPMENT
|
13
|
0.256000
|
1.83e-01
|
0.768
|
|
SCHWANN CELL DIFFERENTIATION
|
7
|
0.256000
|
2.49e-01
|
0.768
|
|
REGULATION OF LYMPHOCYTE ACTIVATION
|
51
|
0.256000
|
-9.45e-02
|
0.768
|
|
CELLULAR RESPONSE TO ALDEHYDE
|
8
|
0.257000
|
2.32e-01
|
0.768
|
|
ICOSANOID METABOLIC PROCESS
|
11
|
0.258000
|
-1.98e-01
|
0.768
|
|
POSITIVE REGULATION OF ORGANELLE ASSEMBLY
|
6
|
0.258000
|
-2.68e-01
|
0.768
|
|
GLIAL CELL ACTIVATION
|
10
|
0.259000
|
2.08e-01
|
0.768
|
|
PROTEIN FOLDING
|
37
|
0.259000
|
-1.10e-01
|
0.768
|
|
POSITIVE REGULATION OF CELL CYCLE PROCESS
|
9
|
0.259000
|
-2.19e-01
|
0.768
|
|
REGULATION OF STEROL TRANSPORT
|
17
|
0.260000
|
-1.59e-01
|
0.770
|
|
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS
|
6
|
0.260000
|
2.67e-01
|
0.770
|
|
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND
|
5
|
0.261000
|
-2.91e-01
|
0.770
|
|
CELLULAR RESPONSE TO AMYLOID BETA
|
9
|
0.262000
|
2.17e-01
|
0.770
|
|
REGULATION OF NOTCH SIGNALING PATHWAY
|
6
|
0.262000
|
-2.66e-01
|
0.770
|
|
NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS
|
34
|
0.262000
|
-1.13e-01
|
0.770
|
|
REGULATION OF CELLULAR RESPONSE TO STRESS
|
27
|
0.263000
|
-1.26e-01
|
0.771
|
|
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION
|
27
|
0.263000
|
-1.26e-01
|
0.771
|
|
MYELOID LEUKOCYTE MIGRATION
|
40
|
0.264000
|
-1.04e-01
|
0.773
|
|
ANIMAL ORGAN MORPHOGENESIS
|
65
|
0.266000
|
8.28e-02
|
0.773
|
|
NEGATIVE REGULATION OF CYTOKINE PRODUCTION
|
33
|
0.266000
|
-1.14e-01
|
0.773
|
|
RESPONSE TO PAIN
|
5
|
0.266000
|
-2.88e-01
|
0.773
|
|
DNA DAMAGE RESPONSE
|
25
|
0.267000
|
-1.30e-01
|
0.773
|
|
POSITIVE REGULATION OF CHEMOKINE PRODUCTION
|
10
|
0.268000
|
2.04e-01
|
0.773
|
|
CHOLESTEROL EFFLUX
|
19
|
0.269000
|
-1.48e-01
|
0.773
|
|
RESPONSE TO INTERLEUKIN 6
|
6
|
0.269000
|
2.62e-01
|
0.773
|
|
RESPONSE TO LIPOPROTEIN PARTICLE
|
10
|
0.269000
|
-2.03e-01
|
0.773
|
|
NEGATIVE REGULATION OF STEROL TRANSPORT
|
8
|
0.269000
|
2.27e-01
|
0.773
|
|
PHOSPHORUS METABOLIC PROCESS
|
130
|
0.270000
|
-6.05e-02
|
0.773
|
|
PURINE CONTAINING COMPOUND METABOLIC PROCESS
|
55
|
0.270000
|
-8.87e-02
|
0.773
|
|
MONOAMINE TRANSPORT
|
6
|
0.270000
|
-2.61e-01
|
0.773
|
|
ESTABLISHMENT OF ENDOTHELIAL BARRIER
|
13
|
0.270000
|
-1.78e-01
|
0.773
|
|
PROTEIN POLYUBIQUITINATION
|
5
|
0.271000
|
-2.85e-01
|
0.773
|
|
PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION
|
18
|
0.271000
|
-1.51e-01
|
0.773
|
|
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
6
|
0.271000
|
-2.61e-01
|
0.773
|
|
REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
9
|
0.271000
|
-2.13e-01
|
0.773
|
|
MODIFIED AMINO ACID BIOSYNTHETIC PROCESS
|
5
|
0.272000
|
2.85e-01
|
0.773
|
|
POSITIVE REGULATION OF AXONOGENESIS
|
6
|
0.272000
|
2.60e-01
|
0.773
|
|
POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION
|
14
|
0.272000
|
1.71e-01
|
0.773
|
|
MICROTUBULE BASED MOVEMENT
|
25
|
0.272000
|
-1.29e-01
|
0.773
|
|
EPIDERMIS DEVELOPMENT
|
45
|
0.274000
|
9.67e-02
|
0.773
|
|
NUCLEOTIDE SUGAR METABOLIC PROCESS
|
5
|
0.274000
|
2.84e-01
|
0.773
|
|
POSITIVE REGULATION OF PROTEIN TRANSPORT
|
25
|
0.274000
|
1.28e-01
|
0.773
|
|
ANIMAL ORGAN REGENERATION
|
8
|
0.274000
|
-2.25e-01
|
0.773
|
|
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
15
|
0.274000
|
-1.65e-01
|
0.773
|
|
ACUTE PHASE RESPONSE
|
22
|
0.275000
|
1.36e-01
|
0.773
|
|
NEGATIVE REGULATION OF CELL ACTIVATION
|
32
|
0.275000
|
-1.13e-01
|
0.773
|
|
IMMUNE SYSTEM DEVELOPMENT
|
12
|
0.276000
|
1.83e-01
|
0.773
|
|
REGULATION OF HORMONE SECRETION
|
17
|
0.276000
|
1.54e-01
|
0.773
|
|
MITOTIC CELL CYCLE
|
46
|
0.276000
|
-9.52e-02
|
0.773
|
|
ENSHEATHMENT OF NEURONS
|
15
|
0.277000
|
1.64e-01
|
0.773
|
|
RESPONSE TO ESTRADIOL
|
13
|
0.277000
|
-1.75e-01
|
0.773
|
|
RESPONSE TO VITAMIN
|
13
|
0.278000
|
-1.75e-01
|
0.773
|
|
ORGANELLE MEMBRANE FUSION
|
10
|
0.279000
|
-1.99e-01
|
0.773
|
|
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
10
|
0.279000
|
1.99e-01
|
0.773
|
|
RESPONSE TO RETINOIC ACID
|
7
|
0.280000
|
2.37e-01
|
0.773
|
|
AMYLOID BETA FORMATION
|
7
|
0.280000
|
-2.37e-01
|
0.773
|
|
REGULATION OF CALCIUM MEDIATED SIGNALING
|
10
|
0.280000
|
1.98e-01
|
0.773
|
|
PHOSPHOLIPID BIOSYNTHETIC PROCESS
|
8
|
0.280000
|
-2.22e-01
|
0.773
|
|
SKELETAL MUSCLE ORGAN DEVELOPMENT
|
11
|
0.281000
|
-1.89e-01
|
0.773
|
|
POSITIVE REGULATION OF CATABOLIC PROCESS
|
26
|
0.281000
|
-1.24e-01
|
0.773
|
|
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN
|
13
|
0.281000
|
-1.74e-01
|
0.773
|
|
NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS
|
22
|
0.282000
|
1.34e-01
|
0.773
|
|
NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS
|
22
|
0.282000
|
1.34e-01
|
0.773
|
|
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT
|
6
|
0.282000
|
-2.55e-01
|
0.773
|
|
SUPRAMOLECULAR FIBER ORGANIZATION
|
109
|
0.283000
|
-6.34e-02
|
0.773
|
|
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE
|
5
|
0.283000
|
-2.78e-01
|
0.773
|
|
REGULATION OF CELLULAR EXTRAVASATION
|
6
|
0.284000
|
2.54e-01
|
0.773
|
|
AUTOPHAGOSOME ORGANIZATION
|
6
|
0.284000
|
-2.54e-01
|
0.773
|
|
REGULATION OF PROTEIN POLYMERIZATION
|
21
|
0.284000
|
-1.37e-01
|
0.773
|
|
REGULATION OF CATABOLIC PROCESS
|
80
|
0.284000
|
-7.25e-02
|
0.773
|
|
POSITIVE REGULATION OF CYTOKINE PRODUCTION
|
62
|
0.284000
|
-8.14e-02
|
0.773
|
|
LEUKOCYTE APOPTOTIC PROCESS
|
7
|
0.285000
|
-2.34e-01
|
0.773
|
|
NEGATIVE REGULATION OF PHOSPHORYLATION
|
12
|
0.286000
|
-1.79e-01
|
0.773
|
|
INSULIN SECRETION
|
12
|
0.286000
|
1.79e-01
|
0.773
|
|
POSITIVE REGULATION OF CHOLESTEROL EFFLUX
|
7
|
0.287000
|
-2.34e-01
|
0.774
|
|
PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS
|
7
|
0.289000
|
2.33e-01
|
0.774
|
|
TETRAPYRROLE METABOLIC PROCESS
|
7
|
0.289000
|
2.33e-01
|
0.774
|
|
NEGATIVE REGULATION OF CELL GROWTH
|
13
|
0.289000
|
1.71e-01
|
0.774
|
|
ORGANOPHOSPHATE METABOLIC PROCESS
|
80
|
0.290000
|
-7.17e-02
|
0.774
|
|
STEROL HOMEOSTASIS
|
20
|
0.290000
|
-1.38e-01
|
0.774
|
|
GLUCOSE METABOLIC PROCESS
|
33
|
0.290000
|
1.08e-01
|
0.774
|
|
REGULATION OF BODY FLUID LEVELS
|
94
|
0.291000
|
-6.66e-02
|
0.774
|
|
CHONDROCYTE DIFFERENTIATION
|
10
|
0.291000
|
-1.94e-01
|
0.774
|
|
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
7
|
0.291000
|
2.31e-01
|
0.774
|
|
RETINOL METABOLIC PROCESS
|
5
|
0.291000
|
2.73e-01
|
0.774
|
|
MAST CELL ACTIVATION
|
10
|
0.292000
|
1.94e-01
|
0.774
|
|
MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
10
|
0.292000
|
1.94e-01
|
0.774
|
|
SPHINGOLIPID METABOLIC PROCESS
|
7
|
0.293000
|
2.31e-01
|
0.774
|
|
SYNAPTIC VESICLE RECYCLING
|
6
|
0.293000
|
-2.49e-01
|
0.774
|
|
REGULATION OF CELLULAR LOCALIZATION
|
49
|
0.293000
|
-8.93e-02
|
0.774
|
|
MESENCHYMAL CELL DIFFERENTIATION
|
23
|
0.293000
|
1.28e-01
|
0.774
|
|
REGULATION OF ACTIN FILAMENT LENGTH
|
20
|
0.294000
|
-1.37e-01
|
0.774
|
|
NUCLEAR CHROMOSOME SEGREGATION
|
13
|
0.294000
|
-1.69e-01
|
0.774
|
|
POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
8
|
0.295000
|
-2.15e-01
|
0.774
|
|
REGULATION OF HEART RATE BY CARDIAC CONDUCTION
|
7
|
0.295000
|
2.30e-01
|
0.774
|
|
ACTIN POLYMERIZATION OR DEPOLYMERIZATION
|
24
|
0.295000
|
-1.25e-01
|
0.774
|
|
EPIDERMIS MORPHOGENESIS
|
9
|
0.295000
|
2.03e-01
|
0.774
|
|
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE
|
11
|
0.295000
|
-1.84e-01
|
0.774
|
|
NEGATIVE REGULATION OF MITOTIC CELL CYCLE
|
5
|
0.295000
|
-2.71e-01
|
0.774
|
|
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS
|
90
|
0.297000
|
6.70e-02
|
0.776
|
|
AXONAL FASCICULATION
|
5
|
0.298000
|
-2.70e-01
|
0.778
|
|
PROTEIN TARGETING TO MEMBRANE
|
6
|
0.298000
|
-2.46e-01
|
0.778
|
|
REGULATION OF MUSCLE CONTRACTION
|
17
|
0.298000
|
-1.47e-01
|
0.778
|
|
DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM
|
20
|
0.300000
|
1.36e-01
|
0.780
|
|
ORGANELLE FUSION
|
12
|
0.300000
|
-1.74e-01
|
0.780
|
|
RESPONSE TO MECHANICAL STIMULUS
|
25
|
0.300000
|
-1.21e-01
|
0.780
|
|
CYTOSKELETON ORGANIZATION
|
138
|
0.301000
|
-5.52e-02
|
0.781
|
|
MESONEPHROS DEVELOPMENT
|
6
|
0.301000
|
2.45e-01
|
0.781
|
|
LIPID HOMEOSTASIS
|
24
|
0.303000
|
-1.23e-01
|
0.784
|
|
REGULATION OF EMBRYONIC DEVELOPMENT
|
6
|
0.305000
|
-2.43e-01
|
0.789
|
|
CHEMOKINE PRODUCTION
|
14
|
0.306000
|
1.59e-01
|
0.789
|
|
CELLULAR DEFENSE RESPONSE
|
5
|
0.307000
|
-2.65e-01
|
0.790
|
|
AMEBOIDAL TYPE CELL MIGRATION
|
38
|
0.307000
|
-9.78e-02
|
0.790
|
|
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS
|
6
|
0.308000
|
2.41e-01
|
0.791
|
|
HYALURONAN CATABOLIC PROCESS
|
5
|
0.308000
|
2.64e-01
|
0.791
|
|
REGULATION OF CELL SUBSTRATE ADHESION
|
36
|
0.309000
|
-1.00e-01
|
0.791
|
|
REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
47
|
0.309000
|
-8.81e-02
|
0.791
|
|
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION
|
20
|
0.309000
|
-1.33e-01
|
0.791
|
|
MORPHOGENESIS OF AN EPITHELIUM
|
54
|
0.311000
|
8.22e-02
|
0.794
|
|
NEUROGENESIS
|
114
|
0.312000
|
-5.86e-02
|
0.795
|
|
POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY
|
7
|
0.312000
|
-2.22e-01
|
0.796
|
|
BONE MORPHOGENESIS
|
6
|
0.313000
|
-2.39e-01
|
0.796
|
|
MYELOID CELL HOMEOSTASIS
|
21
|
0.314000
|
1.28e-01
|
0.796
|
|
APOPTOTIC CELL CLEARANCE
|
15
|
0.314000
|
-1.51e-01
|
0.796
|
|
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY
|
6
|
0.315000
|
-2.38e-01
|
0.796
|
|
MONOCARBOXYLIC ACID TRANSPORT
|
10
|
0.315000
|
-1.85e-01
|
0.796
|
|
MIRNA TRANSCRIPTION
|
6
|
0.316000
|
-2.38e-01
|
0.796
|
|
REGULATION OF MIRNA METABOLIC PROCESS
|
6
|
0.316000
|
-2.38e-01
|
0.796
|
|
CELL MATRIX ADHESION
|
49
|
0.316000
|
-8.52e-02
|
0.796
|
|
REGULATION OF PEPTIDE TRANSPORT
|
15
|
0.316000
|
1.51e-01
|
0.797
|
|
REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
42
|
0.317000
|
-9.14e-02
|
0.798
|
|
NEGATIVE REGULATION OF FIBRINOLYSIS
|
8
|
0.319000
|
-2.05e-01
|
0.800
|
|
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
17
|
0.320000
|
-1.41e-01
|
0.800
|
|
REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
25
|
0.321000
|
-1.16e-01
|
0.800
|
|
REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
9
|
0.321000
|
-1.92e-01
|
0.800
|
|
GLIAL CELL PROLIFERATION
|
7
|
0.322000
|
-2.17e-01
|
0.800
|
|
ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE
|
31
|
0.322000
|
-1.05e-01
|
0.800
|
|
REGULATION OF VIRAL LIFE CYCLE
|
9
|
0.322000
|
-1.92e-01
|
0.800
|
|
CELLULAR HOMEOSTASIS
|
73
|
0.323000
|
-6.97e-02
|
0.800
|
|
RESPONSE TO TYPE II INTERFERON
|
20
|
0.323000
|
-1.29e-01
|
0.800
|
|
TISSUE MORPHOGENESIS
|
63
|
0.324000
|
7.45e-02
|
0.800
|
|
BONE MINERALIZATION
|
11
|
0.324000
|
-1.73e-01
|
0.800
|
|
REGULATION OF LEUKOCYTE DEGRANULATION
|
5
|
0.324000
|
2.56e-01
|
0.800
|
|
POSITIVE REGULATION OF ORGANELLE ORGANIZATION
|
44
|
0.325000
|
-8.79e-02
|
0.800
|
|
COMPLEMENT DEPENDENT CYTOTOXICITY
|
5
|
0.325000
|
-2.55e-01
|
0.800
|
|
REGULATION OF PROTEIN TARGETING
|
5
|
0.325000
|
-2.55e-01
|
0.800
|
|
REGULATION OF PROTEIN TARGETING TO MEMBRANE
|
5
|
0.325000
|
-2.55e-01
|
0.800
|
|
T HELPER 17 CELL DIFFERENTIATION
|
9
|
0.326000
|
-1.90e-01
|
0.800
|
|
NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
7
|
0.327000
|
2.15e-01
|
0.800
|
|
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS
|
7
|
0.327000
|
2.15e-01
|
0.800
|
|
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY
|
10
|
0.327000
|
-1.80e-01
|
0.800
|
|
INTRACELLULAR PROTEIN TRANSPORT
|
44
|
0.327000
|
-8.76e-02
|
0.800
|
|
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
27
|
0.327000
|
-1.11e-01
|
0.800
|
|
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION
|
8
|
0.327000
|
2.01e-01
|
0.800
|
|
POSITIVE REGULATION OF PEPTIDE SECRETION
|
10
|
0.328000
|
1.80e-01
|
0.801
|
|
TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
8
|
0.329000
|
-2.00e-01
|
0.802
|
|
HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY
|
5
|
0.329000
|
-2.53e-01
|
0.802
|
|
HEMOSTASIS
|
89
|
0.330000
|
-6.29e-02
|
0.802
|
|
NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION
|
5
|
0.331000
|
2.52e-01
|
0.803
|
|
REGULATION OF TRANSMEMBRANE TRANSPORTER ACTIVITY
|
5
|
0.331000
|
2.52e-01
|
0.803
|
|
PROTEIN LOCALIZATION TO MEMBRANE
|
42
|
0.331000
|
-8.88e-02
|
0.803
|
|
TRANSLATIONAL ELONGATION
|
5
|
0.332000
|
-2.52e-01
|
0.804
|
|
POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION
|
5
|
0.333000
|
-2.51e-01
|
0.805
|
|
CARDIAC MUSCLE CONTRACTION
|
15
|
0.333000
|
-1.46e-01
|
0.805
|
|
MONOSACCHARIDE METABOLIC PROCESS
|
40
|
0.334000
|
9.03e-02
|
0.805
|
|
SUPEROXIDE METABOLIC PROCESS
|
19
|
0.334000
|
1.29e-01
|
0.805
|
|
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS
|
112
|
0.336000
|
-5.62e-02
|
0.808
|
|
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS
|
14
|
0.337000
|
1.50e-01
|
0.808
|
|
BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS
|
234
|
0.337000
|
-4.21e-02
|
0.808
|
|
MORPHOGENESIS OF A BRANCHING STRUCTURE
|
18
|
0.337000
|
1.32e-01
|
0.808
|
|
REGULATION OF MUSCLE SYSTEM PROCESS
|
27
|
0.337000
|
-1.08e-01
|
0.808
|
|
REGULATION OF GLUCOSE METABOLIC PROCESS
|
9
|
0.338000
|
1.86e-01
|
0.808
|
|
RESPONSE TO METAL ION
|
36
|
0.339000
|
9.40e-02
|
0.808
|
|
POSITIVE REGULATION OF HEMOPOIESIS
|
14
|
0.339000
|
-1.49e-01
|
0.808
|
|
LONG TERM SYNAPTIC POTENTIATION
|
5
|
0.339000
|
2.48e-01
|
0.808
|
|
POSITIVE REGULATION OF PROTEIN POLYMERIZATION
|
7
|
0.340000
|
-2.09e-01
|
0.808
|
|
LIPOPROTEIN BIOSYNTHETIC PROCESS
|
5
|
0.340000
|
-2.47e-01
|
0.808
|
|
AXON EXTENSION
|
12
|
0.341000
|
1.60e-01
|
0.808
|
|
NEURON PROJECTION EXTENSION
|
12
|
0.341000
|
1.60e-01
|
0.808
|
|
MEMBRANE RAFT ORGANIZATION
|
5
|
0.341000
|
-2.47e-01
|
0.808
|
|
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND
|
8
|
0.341000
|
-1.95e-01
|
0.808
|
|
ACTIN FILAMENT BUNDLE ORGANIZATION
|
30
|
0.342000
|
-1.02e-01
|
0.808
|
|
SUBSTRATE DEPENDENT CELL MIGRATION
|
7
|
0.342000
|
-2.08e-01
|
0.808
|
|
INTRACELLULAR IRON ION HOMEOSTASIS
|
12
|
0.342000
|
1.60e-01
|
0.808
|
|
RENAL ABSORPTION
|
5
|
0.344000
|
-2.45e-01
|
0.811
|
|
WOUND HEALING
|
115
|
0.344000
|
-5.46e-02
|
0.811
|
|
DENDRITIC CELL DIFFERENTIATION
|
5
|
0.345000
|
-2.45e-01
|
0.811
|
|
EXTRACELLULAR MATRIX ASSEMBLY
|
11
|
0.345000
|
-1.65e-01
|
0.812
|
|
PROTEIN FOLDING IN ENDOPLASMIC RETICULUM
|
6
|
0.347000
|
-2.23e-01
|
0.812
|
|
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT
|
13
|
0.347000
|
-1.52e-01
|
0.812
|
|
REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY
|
5
|
0.347000
|
2.44e-01
|
0.812
|
|
NEGATIVE REGULATION OF PROGRAMMED CELL DEATH
|
88
|
0.348000
|
-6.09e-02
|
0.812
|
|
REGULATION OF INTRACELLULAR TRANSPORT
|
23
|
0.348000
|
-1.15e-01
|
0.812
|
|
REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION
|
15
|
0.348000
|
-1.41e-01
|
0.812
|
|
CELL DIVISION
|
31
|
0.349000
|
9.89e-02
|
0.813
|
|
REGULATION OF TRANS SYNAPTIC SIGNALING
|
32
|
0.349000
|
-9.73e-02
|
0.813
|
|
NEURON PROJECTION REGENERATION
|
10
|
0.351000
|
-1.72e-01
|
0.813
|
|
MULTICELLULAR ORGANISMAL MOVEMENT
|
7
|
0.351000
|
-2.05e-01
|
0.813
|
|
AMINO ACID BIOSYNTHETIC PROCESS
|
5
|
0.351000
|
2.42e-01
|
0.813
|
|
PROTEIN LOCALIZATION TO CELL PERIPHERY
|
35
|
0.351000
|
-9.29e-02
|
0.813
|
|
REGULATION OF OSSIFICATION
|
10
|
0.353000
|
-1.71e-01
|
0.817
|
|
REGULATION OF RESPIRATORY BURST
|
6
|
0.353000
|
-2.20e-01
|
0.817
|
|
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
17
|
0.355000
|
1.31e-01
|
0.818
|
|
NEGATIVE CHEMOTAXIS
|
5
|
0.355000
|
-2.40e-01
|
0.818
|
|
RESPONSE TO COPPER ION
|
5
|
0.356000
|
2.39e-01
|
0.818
|
|
NEURAL NUCLEUS DEVELOPMENT
|
10
|
0.356000
|
-1.70e-01
|
0.818
|
|
REGULATION OF ENDOTHELIAL CELL MIGRATION
|
27
|
0.356000
|
-1.04e-01
|
0.818
|
|
EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
30
|
0.357000
|
-9.89e-02
|
0.818
|
|
HEART TRABECULA MORPHOGENESIS
|
5
|
0.357000
|
-2.39e-01
|
0.818
|
|
FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY
|
6
|
0.357000
|
-2.18e-01
|
0.818
|
|
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION
|
10
|
0.357000
|
-1.69e-01
|
0.818
|
|
CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT
|
13
|
0.359000
|
1.48e-01
|
0.819
|
|
REGULATION OF CELL ADHESION
|
112
|
0.359000
|
-5.35e-02
|
0.819
|
|
REACTIVE NITROGEN SPECIES METABOLIC PROCESS
|
15
|
0.359000
|
-1.38e-01
|
0.819
|
|
REGULATION OF STEROID METABOLIC PROCESS
|
10
|
0.360000
|
-1.68e-01
|
0.819
|
|
REGULATION OF PROTEOLYSIS
|
58
|
0.361000
|
-7.17e-02
|
0.819
|
|
POSITIVE REGULATION OF CELL DEVELOPMENT
|
32
|
0.361000
|
-9.50e-02
|
0.819
|
|
HOMOTYPIC CELL CELL ADHESION
|
36
|
0.361000
|
-8.97e-02
|
0.819
|
|
ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE
|
20
|
0.362000
|
1.19e-01
|
0.819
|
|
HOST MEDIATED PERTURBATION OF VIRAL PROCESS
|
11
|
0.362000
|
1.60e-01
|
0.819
|
|
CELLULAR RESPONSE TO ALCOHOL
|
7
|
0.363000
|
2.00e-01
|
0.821
|
|
NEGATIVE REGULATION OF TRANSLATION
|
6
|
0.363000
|
2.15e-01
|
0.821
|
|
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
73
|
0.364000
|
-6.41e-02
|
0.821
|
|
FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS
|
6
|
0.365000
|
2.15e-01
|
0.822
|
|
NEURON DEVELOPMENT
|
74
|
0.365000
|
-6.35e-02
|
0.822
|
|
HETEROTYPIC CELL CELL ADHESION
|
16
|
0.366000
|
1.32e-01
|
0.822
|
|
ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE
|
6
|
0.366000
|
2.14e-01
|
0.822
|
|
PROTEIN TARGETING TO LYSOSOME
|
6
|
0.366000
|
2.14e-01
|
0.822
|
|
PROTEIN TARGETING TO VACUOLE
|
6
|
0.366000
|
2.14e-01
|
0.822
|
|
ACTIN FILAMENT POLYMERIZATION
|
22
|
0.367000
|
-1.13e-01
|
0.822
|
|
PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
36
|
0.368000
|
-8.86e-02
|
0.822
|
|
CELL CYCLE PROCESS
|
48
|
0.368000
|
-7.72e-02
|
0.822
|
|
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH
|
10
|
0.368000
|
1.65e-01
|
0.822
|
|
RIBONUCLEOTIDE CATABOLIC PROCESS
|
24
|
0.369000
|
1.07e-01
|
0.822
|
|
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS
|
6
|
0.370000
|
-2.12e-01
|
0.822
|
|
EMBRYONIC PLACENTA DEVELOPMENT
|
5
|
0.371000
|
2.32e-01
|
0.822
|
|
REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
18
|
0.371000
|
-1.23e-01
|
0.822
|
|
CENTRAL NERVOUS SYSTEM DEVELOPMENT
|
69
|
0.372000
|
-6.47e-02
|
0.822
|
|
PROSTANOID METABOLIC PROCESS
|
5
|
0.373000
|
-2.31e-01
|
0.822
|
|
CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS
|
5
|
0.373000
|
2.31e-01
|
0.822
|
|
PROSTATE GLAND DEVELOPMENT
|
6
|
0.373000
|
2.11e-01
|
0.822
|
|
UROGENITAL SYSTEM DEVELOPMENT
|
6
|
0.373000
|
2.11e-01
|
0.822
|
|
CHRONIC INFLAMMATORY RESPONSE
|
7
|
0.374000
|
-1.95e-01
|
0.822
|
|
OLEFINIC COMPOUND METABOLIC PROCESS
|
13
|
0.374000
|
-1.44e-01
|
0.822
|
|
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
10
|
0.374000
|
-1.63e-01
|
0.822
|
|
NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION
|
5
|
0.374000
|
-2.30e-01
|
0.822
|
|
NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION
|
5
|
0.374000
|
-2.30e-01
|
0.822
|
|
PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS
|
22
|
0.374000
|
1.11e-01
|
0.822
|
|
REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
90
|
0.375000
|
-5.70e-02
|
0.822
|
|
LEUKOCYTE CHEMOTAXIS
|
40
|
0.375000
|
-8.29e-02
|
0.822
|
|
ALDEHYDE METABOLIC PROCESS
|
14
|
0.376000
|
1.38e-01
|
0.824
|
|
REGULATION OF LEUKOCYTE CHEMOTAXIS
|
21
|
0.377000
|
1.13e-01
|
0.824
|
|
ALCOHOL METABOLIC PROCESS
|
39
|
0.378000
|
-8.35e-02
|
0.824
|
|
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION
|
50
|
0.378000
|
-7.41e-02
|
0.824
|
|
POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
6
|
0.379000
|
-2.08e-01
|
0.824
|
|
CARDIAC MUSCLE CELL ACTION POTENTIAL
|
7
|
0.379000
|
1.93e-01
|
0.824
|
|
REGULATION OF T CELL ACTIVATION
|
46
|
0.379000
|
-7.69e-02
|
0.824
|
|
TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
35
|
0.379000
|
-8.76e-02
|
0.824
|
|
HORMONE METABOLIC PROCESS
|
22
|
0.381000
|
1.09e-01
|
0.824
|
|
REGULATION OF LAMELLIPODIUM ORGANIZATION
|
12
|
0.381000
|
-1.47e-01
|
0.824
|
|
METENCEPHALON DEVELOPMENT
|
9
|
0.381000
|
1.70e-01
|
0.824
|
|
SULFUR COMPOUND METABOLIC PROCESS
|
19
|
0.381000
|
-1.17e-01
|
0.824
|
|
POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE
|
6
|
0.382000
|
2.07e-01
|
0.824
|
|
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION
|
6
|
0.383000
|
2.06e-01
|
0.824
|
|
TYPE I INTERFERON PRODUCTION
|
6
|
0.383000
|
-2.06e-01
|
0.824
|
|
MICROTUBULE BASED TRANSPORT
|
10
|
0.384000
|
-1.60e-01
|
0.824
|
|
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
6
|
0.384000
|
-2.06e-01
|
0.824
|
|
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE
|
6
|
0.384000
|
-2.06e-01
|
0.824
|
|
INTEGRIN ACTIVATION
|
7
|
0.385000
|
-1.91e-01
|
0.824
|
|
REGULATION OF VASCULATURE DEVELOPMENT
|
42
|
0.386000
|
-7.92e-02
|
0.824
|
|
LYSOSOMAL TRANSPORT
|
14
|
0.386000
|
1.35e-01
|
0.824
|
|
VACUOLAR TRANSPORT
|
14
|
0.386000
|
1.35e-01
|
0.824
|
|
NEGATIVE REGULATION OF VIRAL PROCESS
|
6
|
0.386000
|
2.05e-01
|
0.824
|
|
REGULATION OF PROTEIN SECRETION
|
22
|
0.386000
|
1.08e-01
|
0.824
|
|
MONONUCLEAR CELL MIGRATION
|
34
|
0.387000
|
-8.75e-02
|
0.824
|
|
REGULATION OF STEROID BIOSYNTHETIC PROCESS
|
7
|
0.387000
|
-1.90e-01
|
0.824
|
|
SISTER CHROMATID SEGREGATION
|
10
|
0.388000
|
-1.59e-01
|
0.824
|
|
MODIFICATION OF POSTSYNAPTIC STRUCTURE
|
6
|
0.389000
|
2.04e-01
|
0.824
|
|
MODIFICATION OF SYNAPTIC STRUCTURE
|
6
|
0.389000
|
2.04e-01
|
0.824
|
|
OLIGODENDROCYTE DIFFERENTIATION
|
11
|
0.389000
|
-1.51e-01
|
0.824
|
|
MESENCHYME DEVELOPMENT
|
25
|
0.389000
|
1.01e-01
|
0.824
|
|
NERVE DEVELOPMENT
|
7
|
0.390000
|
1.88e-01
|
0.826
|
|
FC RECEPTOR SIGNALING PATHWAY
|
7
|
0.390000
|
-1.88e-01
|
0.826
|
|
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
10
|
0.391000
|
-1.58e-01
|
0.826
|
|
REGULATION OF PHOSPHORYLATION
|
38
|
0.392000
|
8.20e-02
|
0.827
|
|
CELLULAR RESPONSE TO OXYGEN LEVELS
|
11
|
0.392000
|
-1.50e-01
|
0.827
|
|
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION
|
6
|
0.393000
|
2.02e-01
|
0.827
|
|
POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS
|
7
|
0.394000
|
-1.87e-01
|
0.827
|
|
NEGATIVE REGULATION OF TRANSPORT
|
47
|
0.394000
|
-7.39e-02
|
0.827
|
|
EPITHELIAL CELL PROLIFERATION
|
45
|
0.395000
|
-7.53e-02
|
0.827
|
|
NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS
|
27
|
0.395000
|
9.61e-02
|
0.827
|
|
REGULATION OF MUSCLE ORGAN DEVELOPMENT
|
5
|
0.395000
|
2.20e-01
|
0.827
|
|
REGULATION OF CELL MORPHOGENESIS
|
31
|
0.395000
|
-8.98e-02
|
0.827
|
|
CILIUM ORGANIZATION
|
15
|
0.396000
|
-1.28e-01
|
0.827
|
|
CORTICAL CYTOSKELETON ORGANIZATION
|
9
|
0.397000
|
-1.64e-01
|
0.827
|
|
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS
|
17
|
0.398000
|
1.20e-01
|
0.827
|
|
SMALL MOLECULE CATABOLIC PROCESS
|
35
|
0.399000
|
8.40e-02
|
0.827
|
|
POSITIVE REGULATION OF IMMUNE RESPONSE
|
102
|
0.400000
|
5.12e-02
|
0.827
|
|
REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN
|
5
|
0.400000
|
-2.18e-01
|
0.827
|
|
NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE
|
11
|
0.400000
|
-1.48e-01
|
0.827
|
|
PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS
|
45
|
0.400000
|
-7.43e-02
|
0.827
|
|
REGULATION OF INFLAMMATORY RESPONSE
|
51
|
0.401000
|
7.00e-02
|
0.827
|
|
EPITHELIAL TUBE MORPHOGENESIS
|
25
|
0.401000
|
9.85e-02
|
0.827
|
|
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION
|
6
|
0.401000
|
1.99e-01
|
0.827
|
|
ELECTRON TRANSPORT CHAIN
|
5
|
0.401000
|
-2.18e-01
|
0.827
|
|
MUSCLE CELL MIGRATION
|
17
|
0.401000
|
1.19e-01
|
0.827
|
|
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS
|
16
|
0.401000
|
-1.22e-01
|
0.827
|
|
MYOBLAST DIFFERENTIATION
|
11
|
0.402000
|
-1.47e-01
|
0.827
|
|
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
6
|
0.402000
|
-1.99e-01
|
0.827
|
|
GROWTH
|
68
|
0.403000
|
-6.10e-02
|
0.828
|
|
REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY
|
10
|
0.404000
|
-1.53e-01
|
0.829
|
|
PEPTIDE TRANSPORT
|
19
|
0.404000
|
1.12e-01
|
0.829
|
|
REGULATION OF LIPID CATABOLIC PROCESS
|
10
|
0.404000
|
1.53e-01
|
0.829
|
|
MORPHOGENESIS OF A POLARIZED EPITHELIUM
|
5
|
0.405000
|
-2.16e-01
|
0.829
|
|
FERROPTOSIS
|
5
|
0.409000
|
-2.14e-01
|
0.835
|
|
RESPONSE TO NICOTINE
|
5
|
0.409000
|
2.14e-01
|
0.835
|
|
SMOOTH MUSCLE CONTRACTION
|
6
|
0.410000
|
-1.95e-01
|
0.837
|
|
GLUTATHIONE METABOLIC PROCESS
|
11
|
0.410000
|
-1.44e-01
|
0.837
|
|
REGULATION OF TRANSMEMBRANE TRANSPORT
|
36
|
0.412000
|
-8.07e-02
|
0.838
|
|
RESPONSE TO VIRUS
|
20
|
0.412000
|
-1.07e-01
|
0.838
|
|
CARBOHYDRATE BIOSYNTHETIC PROCESS
|
25
|
0.412000
|
9.62e-02
|
0.838
|
|
NEGATIVE REGULATION OF PROTEOLYSIS
|
24
|
0.412000
|
9.80e-02
|
0.838
|
|
SIGNAL RELEASE
|
25
|
0.413000
|
9.59e-02
|
0.839
|
|
REGULATION OF SYNAPTIC PLASTICITY
|
16
|
0.415000
|
-1.19e-01
|
0.840
|
|
PEPTIDE METABOLIC PROCESS
|
15
|
0.415000
|
1.23e-01
|
0.840
|
|
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
63
|
0.415000
|
-6.15e-02
|
0.840
|
|
REGULATION OF ENDOTHELIAL CELL DEVELOPMENT
|
5
|
0.415000
|
-2.11e-01
|
0.840
|
|
REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
6
|
0.417000
|
-1.92e-01
|
0.842
|
|
PIGMENTATION
|
7
|
0.418000
|
-1.78e-01
|
0.844
|
|
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
17
|
0.420000
|
1.14e-01
|
0.845
|
|
INCLUSION BODY ASSEMBLY
|
5
|
0.420000
|
-2.09e-01
|
0.845
|
|
SKELETAL MUSCLE CONTRACTION
|
5
|
0.420000
|
-2.09e-01
|
0.845
|
|
POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
18
|
0.421000
|
-1.11e-01
|
0.845
|
|
POSTSYNAPSE ORGANIZATION
|
21
|
0.422000
|
-1.03e-01
|
0.845
|
|
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT
|
122
|
0.422000
|
-4.52e-02
|
0.845
|
|
GLIAL CELL DIFFERENTIATION
|
29
|
0.422000
|
8.75e-02
|
0.845
|
|
POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
9
|
0.423000
|
-1.55e-01
|
0.845
|
|
GRANULOCYTE MIGRATION
|
29
|
0.423000
|
-8.74e-02
|
0.845
|
|
SKELETAL MUSCLE TISSUE REGENERATION
|
5
|
0.423000
|
-2.08e-01
|
0.845
|
|
MITOTIC CYTOKINESIS
|
8
|
0.423000
|
1.64e-01
|
0.845
|
|
REGULATION OF PLATELET AGGREGATION
|
6
|
0.424000
|
-1.89e-01
|
0.845
|
|
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS
|
86
|
0.425000
|
-5.23e-02
|
0.845
|
|
HEART VALVE DEVELOPMENT
|
7
|
0.425000
|
-1.75e-01
|
0.845
|
|
HEART VALVE MORPHOGENESIS
|
7
|
0.425000
|
-1.75e-01
|
0.845
|
|
NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE
|
5
|
0.425000
|
2.07e-01
|
0.845
|
|
NEGATIVE REGULATION OF CELL DEVELOPMENT
|
33
|
0.426000
|
8.17e-02
|
0.845
|
|
SMALL MOLECULE METABOLIC PROCESS
|
140
|
0.428000
|
-4.21e-02
|
0.848
|
|
SKIN EPIDERMIS DEVELOPMENT
|
18
|
0.428000
|
1.09e-01
|
0.848
|
|
ADAPTIVE THERMOGENESIS
|
9
|
0.431000
|
-1.53e-01
|
0.851
|
|
POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION
|
5
|
0.431000
|
-2.04e-01
|
0.851
|
|
NEGATIVE REGULATION OF KINASE ACTIVITY
|
9
|
0.432000
|
-1.52e-01
|
0.851
|
|
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II
|
7
|
0.432000
|
1.72e-01
|
0.851
|
|
REGULATION OF ACTIN FILAMENT ORGANIZATION
|
33
|
0.432000
|
-8.06e-02
|
0.851
|
|
REGULATION OF IMMUNE RESPONSE
|
124
|
0.433000
|
4.38e-02
|
0.851
|
|
EPITHELIAL CELL DIFFERENTIATION
|
78
|
0.434000
|
5.36e-02
|
0.851
|
|
FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
7
|
0.434000
|
-1.72e-01
|
0.851
|
|
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN
|
8
|
0.434000
|
-1.60e-01
|
0.851
|
|
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN
|
8
|
0.434000
|
-1.60e-01
|
0.851
|
|
GASTRULATION
|
14
|
0.435000
|
-1.22e-01
|
0.851
|
|
NERVOUS SYSTEM PROCESS
|
55
|
0.435000
|
6.28e-02
|
0.852
|
|
POSITIVE REGULATION OF ENDOCYTOSIS
|
41
|
0.436000
|
7.20e-02
|
0.852
|
|
POSITIVE REGULATION OF INSULIN SECRETION
|
6
|
0.436000
|
1.84e-01
|
0.852
|
|
NEGATIVE REGULATION OF CATABOLIC PROCESS
|
29
|
0.437000
|
8.48e-02
|
0.852
|
|
MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
16
|
0.437000
|
1.13e-01
|
0.852
|
|
REGULATION OF BONE MINERALIZATION
|
7
|
0.438000
|
-1.70e-01
|
0.854
|
|
PYRUVATE METABOLIC PROCESS
|
22
|
0.439000
|
9.65e-02
|
0.854
|
|
MACROPHAGE DIFFERENTIATION
|
10
|
0.440000
|
1.42e-01
|
0.854
|
|
POSITIVE REGULATION OF LYMPHOCYTE MIGRATION
|
6
|
0.441000
|
-1.83e-01
|
0.854
|
|
POSITIVE REGULATION OF T CELL MIGRATION
|
6
|
0.441000
|
-1.83e-01
|
0.854
|
|
RESPONSE TO PROGESTERONE
|
6
|
0.441000
|
-1.82e-01
|
0.854
|
|
TISSUE MIGRATION
|
17
|
0.442000
|
-1.09e-01
|
0.854
|
|
TRABECULA MORPHOGENESIS
|
6
|
0.442000
|
-1.82e-01
|
0.854
|
|
CARDIAC MUSCLE CELL CONTRACTION
|
6
|
0.442000
|
1.82e-01
|
0.854
|
|
HETEROPHILIC CELL CELL ADHESION
|
11
|
0.442000
|
-1.35e-01
|
0.854
|
|
PROTEIN LOCALIZATION TO CELL CELL JUNCTION
|
8
|
0.443000
|
-1.58e-01
|
0.854
|
|
INORGANIC ION HOMEOSTASIS
|
46
|
0.443000
|
-6.71e-02
|
0.854
|
|
CELL ADHESION MEDIATED BY INTEGRIN
|
16
|
0.443000
|
-1.12e-01
|
0.854
|
|
PHOSPHOLIPID METABOLIC PROCESS
|
19
|
0.444000
|
-1.03e-01
|
0.854
|
|
POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
22
|
0.445000
|
-9.53e-02
|
0.854
|
|
REGULATION OF FATTY ACID METABOLIC PROCESS
|
9
|
0.445000
|
1.48e-01
|
0.854
|
|
REGULATION OF PROTEIN MATURATION
|
17
|
0.445000
|
-1.08e-01
|
0.854
|
|
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
|
15
|
0.446000
|
-1.15e-01
|
0.854
|
|
MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS
|
82
|
0.447000
|
-5.09e-02
|
0.855
|
|
POSITIVE REGULATION OF CALCIUM ION TRANSPORT
|
7
|
0.447000
|
-1.67e-01
|
0.855
|
|
PROTEOLYSIS
|
156
|
0.447000
|
3.87e-02
|
0.855
|
|
NEGATIVE REGULATION OF MOLECULAR FUNCTION
|
27
|
0.449000
|
-8.55e-02
|
0.856
|
|
RIBOSE PHOSPHATE METABOLIC PROCESS
|
40
|
0.449000
|
-7.08e-02
|
0.856
|
|
REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
7
|
0.450000
|
1.66e-01
|
0.856
|
|
MODULATION OF PROCESS OF ANOTHER ORGANISM
|
19
|
0.450000
|
1.01e-01
|
0.856
|
|
SUBSTANTIA NIGRA DEVELOPMENT
|
9
|
0.451000
|
-1.46e-01
|
0.858
|
|
ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II
|
5
|
0.452000
|
1.95e-01
|
0.858
|
|
LIMBIC SYSTEM DEVELOPMENT
|
7
|
0.453000
|
1.65e-01
|
0.858
|
|
CARBOHYDRATE CATABOLIC PROCESS
|
28
|
0.454000
|
8.32e-02
|
0.858
|
|
BONE DEVELOPMENT
|
22
|
0.454000
|
-9.34e-02
|
0.858
|
|
POSITIVE REGULATION OF MAPK CASCADE
|
49
|
0.454000
|
6.35e-02
|
0.858
|
|
REGULATION OF CELL MATRIX ADHESION
|
20
|
0.455000
|
-9.76e-02
|
0.858
|
|
ENDOTHELIAL CELL DIFFERENTIATION
|
22
|
0.456000
|
-9.31e-02
|
0.858
|
|
MYELOID LEUKOCYTE DIFFERENTIATION
|
27
|
0.456000
|
-8.43e-02
|
0.858
|
|
NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
19
|
0.456000
|
-1.00e-01
|
0.858
|
|
REGULATION OF BONE REMODELING
|
5
|
0.456000
|
-1.93e-01
|
0.858
|
|
CHROMOSOME LOCALIZATION
|
5
|
0.456000
|
-1.93e-01
|
0.858
|
|
NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS
|
37
|
0.458000
|
-7.20e-02
|
0.861
|
|
VASOCONSTRICTION
|
11
|
0.459000
|
1.30e-01
|
0.863
|
|
REGULATION OF MULTICELLULAR ORGANISM GROWTH
|
6
|
0.460000
|
1.75e-01
|
0.864
|
|
GLYCOSAMINOGLYCAN CATABOLIC PROCESS
|
6
|
0.462000
|
1.74e-01
|
0.867
|
|
PROTEIN DEPOLYMERIZATION
|
13
|
0.463000
|
1.19e-01
|
0.867
|
|
REGULATION OF NEUROTRANSMITTER TRANSPORT
|
5
|
0.463000
|
-1.90e-01
|
0.867
|
|
POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION
|
17
|
0.463000
|
1.04e-01
|
0.867
|
|
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS
|
11
|
0.464000
|
-1.28e-01
|
0.867
|
|
HOMEOSTATIC PROCESS
|
161
|
0.465000
|
-3.67e-02
|
0.868
|
|
POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY
|
6
|
0.466000
|
-1.73e-01
|
0.868
|
|
KETONE METABOLIC PROCESS
|
16
|
0.466000
|
1.06e-01
|
0.868
|
|
NUCLEOBASE CONTAINING COMPOUND CATABOLIC PROCESS
|
36
|
0.467000
|
7.16e-02
|
0.868
|
|
POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
6
|
0.468000
|
1.72e-01
|
0.868
|
|
NEGATIVE REGULATION OF CHEMOTAXIS
|
8
|
0.468000
|
-1.49e-01
|
0.868
|
|
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
9
|
0.468000
|
1.40e-01
|
0.868
|
|
MUSCLE TISSUE DEVELOPMENT
|
29
|
0.469000
|
-7.91e-02
|
0.868
|
|
CORTICAL ACTIN CYTOSKELETON ORGANIZATION
|
8
|
0.469000
|
-1.49e-01
|
0.868
|
|
POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION
|
9
|
0.469000
|
-1.40e-01
|
0.868
|
|
NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE
|
5
|
0.469000
|
1.88e-01
|
0.868
|
|
POSITIVE REGULATION OF STRESS FIBER ASSEMBLY
|
10
|
0.470000
|
1.33e-01
|
0.869
|
|
CELLULAR RESPONSE TO ACID CHEMICAL
|
5
|
0.473000
|
-1.86e-01
|
0.870
|
|
POLYSACCHARIDE METABOLIC PROCESS
|
11
|
0.473000
|
1.26e-01
|
0.870
|
|
CIRCADIAN RHYTHM
|
10
|
0.473000
|
1.32e-01
|
0.870
|
|
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
6
|
0.473000
|
1.70e-01
|
0.870
|
|
MONOATOMIC ANION TRANSPORT
|
7
|
0.474000
|
1.57e-01
|
0.871
|
|
MEMBRANE FUSION
|
13
|
0.474000
|
-1.16e-01
|
0.871
|
|
RESPONSE TO CORTICOSTEROID
|
15
|
0.475000
|
1.08e-01
|
0.871
|
|
ORGANOPHOSPHATE CATABOLIC PROCESS
|
36
|
0.475000
|
7.03e-02
|
0.871
|
|
INTRACELLULAR LIPID TRANSPORT
|
5
|
0.476000
|
-1.85e-01
|
0.871
|
|
INTRACELLULAR STEROL TRANSPORT
|
5
|
0.476000
|
-1.85e-01
|
0.871
|
|
MITOTIC SISTER CHROMATID SEGREGATION
|
9
|
0.476000
|
-1.38e-01
|
0.871
|
|
INTRACELLULAR GLUCOSE HOMEOSTASIS
|
9
|
0.476000
|
1.38e-01
|
0.871
|
|
ORGANOPHOSPHATE ESTER TRANSPORT
|
14
|
0.478000
|
-1.10e-01
|
0.872
|
|
PHOSPHOLIPID TRANSPORT
|
14
|
0.478000
|
-1.10e-01
|
0.872
|
|
PHENOL CONTAINING COMPOUND METABOLIC PROCESS
|
7
|
0.479000
|
-1.55e-01
|
0.873
|
|
PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS
|
35
|
0.480000
|
7.04e-02
|
0.873
|
|
REGULATION OF VASOCONSTRICTION
|
9
|
0.480000
|
1.37e-01
|
0.873
|
|
SULFUR COMPOUND BIOSYNTHETIC PROCESS
|
6
|
0.481000
|
-1.67e-01
|
0.873
|
|
ESTABLISHMENT OF ORGANELLE LOCALIZATION
|
28
|
0.481000
|
-7.83e-02
|
0.873
|
|
RESPONSE TO LIPID
|
84
|
0.482000
|
4.66e-02
|
0.874
|
|
EYE MORPHOGENESIS
|
9
|
0.482000
|
-1.36e-01
|
0.874
|
|
INFLAMMATORY RESPONSE
|
126
|
0.483000
|
3.89e-02
|
0.875
|
|
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
22
|
0.485000
|
-8.72e-02
|
0.877
|
|
POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
5
|
0.490000
|
1.79e-01
|
0.884
|
|
CELLULAR RESPONSE TO VIRUS
|
5
|
0.490000
|
-1.79e-01
|
0.884
|
|
VASCULOGENESIS
|
8
|
0.490000
|
1.42e-01
|
0.884
|
|
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS
|
10
|
0.491000
|
1.27e-01
|
0.884
|
|
REVERSE CHOLESTEROL TRANSPORT
|
12
|
0.491000
|
-1.16e-01
|
0.884
|
|
FOREBRAIN DEVELOPMENT
|
24
|
0.492000
|
-8.21e-02
|
0.884
|
|
EMBRYO DEVELOPMENT
|
60
|
0.493000
|
-5.30e-02
|
0.884
|
|
POSITIVE REGULATION OF BMP SIGNALING PATHWAY
|
7
|
0.493000
|
-1.51e-01
|
0.884
|
|
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE
|
17
|
0.494000
|
9.69e-02
|
0.884
|
|
ORGANIC ACID CATABOLIC PROCESS
|
14
|
0.494000
|
-1.07e-01
|
0.884
|
|
RESPONSE TO FUNGUS
|
15
|
0.494000
|
-1.03e-01
|
0.884
|
|
B CELL RECEPTOR SIGNALING PATHWAY
|
15
|
0.494000
|
-1.03e-01
|
0.884
|
|
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION
|
30
|
0.498000
|
-7.27e-02
|
0.889
|
|
FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS
|
6
|
0.498000
|
1.60e-01
|
0.889
|
|
MEIOTIC CELL CYCLE PROCESS
|
5
|
0.498000
|
-1.76e-01
|
0.889
|
|
REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
53
|
0.498000
|
5.54e-02
|
0.889
|
|
MULTI MULTICELLULAR ORGANISM PROCESS
|
25
|
0.499000
|
-7.93e-02
|
0.889
|
|
HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING
|
11
|
0.499000
|
-1.19e-01
|
0.889
|
|
NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY
|
5
|
0.501000
|
-1.75e-01
|
0.889
|
|
RAC PROTEIN SIGNAL TRANSDUCTION
|
5
|
0.501000
|
-1.75e-01
|
0.889
|
|
OSSIFICATION
|
39
|
0.501000
|
-6.37e-02
|
0.889
|
|
REGULATION OF VASCULAR PERMEABILITY
|
6
|
0.502000
|
-1.59e-01
|
0.889
|
|
CYTOSKELETON DEPENDENT CYTOKINESIS
|
10
|
0.502000
|
1.23e-01
|
0.889
|
|
PROTEIN CATABOLIC PROCESS
|
81
|
0.503000
|
-4.51e-02
|
0.889
|
|
TRICARBOXYLIC ACID METABOLIC PROCESS
|
5
|
0.503000
|
-1.74e-01
|
0.889
|
|
OXYGEN TRANSPORT
|
5
|
0.503000
|
1.74e-01
|
0.889
|
|
ACTIVATION OF MEMBRANE ATTACK COMPLEX
|
5
|
0.504000
|
1.73e-01
|
0.889
|
|
REGULATION OF CHOLESTEROL EFFLUX
|
9
|
0.505000
|
-1.29e-01
|
0.889
|
|
POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
5
|
0.505000
|
-1.73e-01
|
0.889
|
|
IN UTERO EMBRYONIC DEVELOPMENT
|
20
|
0.505000
|
-8.71e-02
|
0.889
|
|
NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION
|
6
|
0.505000
|
-1.58e-01
|
0.889
|
|
NEGATIVE REGULATION OF PROTEIN UBIQUITINATION
|
6
|
0.505000
|
-1.58e-01
|
0.889
|
|
REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
7
|
0.506000
|
-1.46e-01
|
0.889
|
|
POSITIVE REGULATION OF VASOCONSTRICTION
|
5
|
0.507000
|
1.72e-01
|
0.889
|
|
PROTEIN HOMOTETRAMERIZATION
|
6
|
0.507000
|
1.57e-01
|
0.889
|
|
CHROMOSOME SEGREGATION
|
17
|
0.508000
|
-9.37e-02
|
0.889
|
|
REGULATION OF CATALYTIC ACTIVITY
|
37
|
0.508000
|
-6.42e-02
|
0.889
|
|
SYNAPSE ORGANIZATION
|
49
|
0.508000
|
-5.62e-02
|
0.889
|
|
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS
|
13
|
0.508000
|
-1.07e-01
|
0.889
|
|
POSITIVE REGULATION OF CELL MATRIX ADHESION
|
10
|
0.509000
|
1.21e-01
|
0.889
|
|
CELL SURFACE TOLL LIKE RECEPTOR SIGNALING PATHWAY
|
6
|
0.509000
|
1.56e-01
|
0.889
|
|
PURINE CONTAINING COMPOUND CATABOLIC PROCESS
|
25
|
0.510000
|
7.73e-02
|
0.889
|
|
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS
|
18
|
0.511000
|
9.04e-02
|
0.891
|
|
RIBONUCLEOPROTEIN COMPLEX BIOGENESIS
|
8
|
0.512000
|
-1.34e-01
|
0.892
|
|
BASEMENT MEMBRANE ORGANIZATION
|
9
|
0.513000
|
-1.27e-01
|
0.892
|
|
FORMATION OF PRIMARY GERM LAYER
|
11
|
0.513000
|
-1.15e-01
|
0.892
|
|
SENSORY PERCEPTION OF CHEMICAL STIMULUS
|
5
|
0.514000
|
1.69e-01
|
0.892
|
|
BLOOD VESSEL MORPHOGENESIS
|
89
|
0.514000
|
-4.21e-02
|
0.892
|
|
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS
|
18
|
0.516000
|
-8.94e-02
|
0.892
|
|
AMIDE BIOSYNTHETIC PROCESS
|
8
|
0.516000
|
-1.33e-01
|
0.892
|
|
CELLULAR RESPONSE TO STARVATION
|
12
|
0.516000
|
-1.09e-01
|
0.892
|
|
RESPONSE TO STARVATION
|
12
|
0.516000
|
-1.09e-01
|
0.892
|
|
REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
16
|
0.518000
|
-9.42e-02
|
0.893
|
|
REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
10
|
0.520000
|
-1.18e-01
|
0.893
|
|
REGULATION OF NEURON PROJECTION DEVELOPMENT
|
24
|
0.520000
|
7.70e-02
|
0.893
|
|
SALIVARY GLAND DEVELOPMENT
|
5
|
0.520000
|
-1.67e-01
|
0.893
|
|
MRNA METABOLIC PROCESS
|
12
|
0.521000
|
-1.08e-01
|
0.893
|
|
MAINTENANCE OF CELL POLARITY
|
5
|
0.522000
|
-1.66e-01
|
0.893
|
|
POSITIVE REGULATION OF INFLAMMATORY RESPONSE
|
18
|
0.522000
|
8.82e-02
|
0.893
|
|
VASCULAR TRANSPORT
|
8
|
0.522000
|
-1.31e-01
|
0.893
|
|
NEGATIVE REGULATION OF HYDROLASE ACTIVITY
|
6
|
0.522000
|
-1.51e-01
|
0.893
|
|
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY
|
6
|
0.522000
|
-1.51e-01
|
0.893
|
|
NEUTRAL LIPID METABOLIC PROCESS
|
19
|
0.523000
|
-8.57e-02
|
0.893
|
|
TRIGLYCERIDE METABOLIC PROCESS
|
19
|
0.523000
|
-8.57e-02
|
0.893
|
|
POSITIVE REGULATION OF RESPONSE TO WOUNDING
|
16
|
0.523000
|
-9.32e-02
|
0.893
|
|
PROTEIN LOCALIZATION TO EXTRACELLULAR REGION
|
34
|
0.523000
|
6.45e-02
|
0.893
|
|
REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS
|
6
|
0.523000
|
1.51e-01
|
0.893
|
|
LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE
|
5
|
0.524000
|
-1.65e-01
|
0.893
|
|
REGULATION OF AXONOGENESIS
|
8
|
0.524000
|
1.31e-01
|
0.893
|
|
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH
|
7
|
0.524000
|
1.40e-01
|
0.893
|
|
RESPONSE TO TYPE I INTERFERON
|
10
|
0.525000
|
-1.17e-01
|
0.894
|
|
AMYLOID BETA METABOLIC PROCESS
|
9
|
0.528000
|
-1.22e-01
|
0.897
|
|
REGULATION OF EPIDERMIS DEVELOPMENT
|
7
|
0.528000
|
-1.38e-01
|
0.897
|
|
PIGMENT METABOLIC PROCESS
|
6
|
0.529000
|
1.49e-01
|
0.897
|
|
CARDIAC SEPTUM DEVELOPMENT
|
7
|
0.529000
|
-1.38e-01
|
0.897
|
|
RECEPTOR MEDIATED ENDOCYTOSIS
|
38
|
0.530000
|
6.02e-02
|
0.898
|
|
GLIAL CELL DEVELOPMENT
|
20
|
0.531000
|
8.19e-02
|
0.899
|
|
REPRODUCTIVE SYSTEM DEVELOPMENT
|
20
|
0.532000
|
8.18e-02
|
0.899
|
|
ESTABLISHMENT OF CELL POLARITY
|
14
|
0.532000
|
-9.73e-02
|
0.899
|
|
NITROGEN COMPOUND TRANSPORT
|
116
|
0.533000
|
-3.58e-02
|
0.900
|
|
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
11
|
0.533000
|
1.09e-01
|
0.900
|
|
GLUCOCORTICOID METABOLIC PROCESS
|
5
|
0.535000
|
-1.61e-01
|
0.902
|
|
REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS
|
7
|
0.536000
|
1.36e-01
|
0.902
|
|
REGULATION OF FIBRINOLYSIS
|
12
|
0.536000
|
-1.04e-01
|
0.903
|
|
REGULATION OF VESICLE MEDIATED TRANSPORT
|
80
|
0.537000
|
4.18e-02
|
0.903
|
|
REGULATION OF TRIGLYCERIDE METABOLIC PROCESS
|
9
|
0.538000
|
1.19e-01
|
0.903
|
|
DENDRITE DEVELOPMENT
|
11
|
0.538000
|
-1.08e-01
|
0.903
|
|
POSITIVE REGULATION OF TOR SIGNALING
|
5
|
0.538000
|
1.60e-01
|
0.903
|
|
CELL JUNCTION DISASSEMBLY
|
6
|
0.539000
|
-1.46e-01
|
0.903
|
|
REGULATION OF KERATINOCYTE DIFFERENTIATION
|
5
|
0.541000
|
-1.59e-01
|
0.905
|
|
CIRCULATORY SYSTEM PROCESS
|
66
|
0.541000
|
-4.51e-02
|
0.906
|
|
REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS
|
5
|
0.543000
|
1.58e-01
|
0.906
|
|
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS
|
5
|
0.543000
|
1.58e-01
|
0.906
|
|
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION
|
27
|
0.543000
|
-6.87e-02
|
0.906
|
|
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY
|
44
|
0.544000
|
5.42e-02
|
0.908
|
|
INTERLEUKIN 6 PRODUCTION
|
15
|
0.546000
|
-9.10e-02
|
0.909
|
|
SPINDLE ASSEMBLY
|
10
|
0.546000
|
-1.11e-01
|
0.909
|
|
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION
|
45
|
0.546000
|
-5.33e-02
|
0.909
|
|
NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS
|
6
|
0.547000
|
-1.43e-01
|
0.909
|
|
NEGATIVE REGULATION OF EXOCYTOSIS
|
7
|
0.547000
|
-1.32e-01
|
0.909
|
|
NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION
|
18
|
0.548000
|
-8.28e-02
|
0.909
|
|
CD4 POSITIVE ALPHA BETA T CELL ACTIVATION
|
11
|
0.548000
|
-1.05e-01
|
0.909
|
|
POSITIVE REGULATION OF RNA METABOLIC PROCESS
|
51
|
0.550000
|
-4.98e-02
|
0.911
|
|
REGULATION OF OSTEOBLAST DIFFERENTIATION
|
8
|
0.551000
|
-1.22e-01
|
0.911
|
|
MIDBRAIN DEVELOPMENT
|
11
|
0.551000
|
-1.05e-01
|
0.911
|
|
POSITIVE REGULATION OF DEFENSE RESPONSE
|
50
|
0.551000
|
5.01e-02
|
0.911
|
|
AMYLOID BETA CLEARANCE
|
10
|
0.552000
|
-1.09e-01
|
0.911
|
|
NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
7
|
0.552000
|
1.30e-01
|
0.911
|
|
MYELOID CELL DIFFERENTIATION
|
53
|
0.553000
|
-4.86e-02
|
0.911
|
|
VESICLE MEDIATED TRANSPORT
|
162
|
0.554000
|
2.97e-02
|
0.912
|
|
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE
|
11
|
0.554000
|
-1.04e-01
|
0.912
|
|
GLYCOSYL COMPOUND CATABOLIC PROCESS
|
5
|
0.556000
|
1.53e-01
|
0.912
|
|
T CELL RECEPTOR SIGNALING PATHWAY
|
9
|
0.556000
|
1.14e-01
|
0.912
|
|
NEURON RECOGNITION
|
8
|
0.556000
|
-1.21e-01
|
0.912
|
|
CELLULAR OXIDANT DETOXIFICATION
|
29
|
0.557000
|
-6.40e-02
|
0.912
|
|
CELL PROJECTION MORPHOGENESIS
|
49
|
0.557000
|
-4.98e-02
|
0.912
|
|
MULTICELLULAR ORGANISMAL RESPONSE TO STRESS
|
9
|
0.558000
|
-1.14e-01
|
0.912
|
|
PODOSOME ASSEMBLY
|
5
|
0.558000
|
-1.52e-01
|
0.912
|
|
DETECTION OF MECHANICAL STIMULUS
|
8
|
0.559000
|
-1.20e-01
|
0.912
|
|
REGULATION OF VIRAL PROCESS
|
13
|
0.559000
|
-9.44e-02
|
0.912
|
|
PROTEIN ACTIVATION CASCADE
|
25
|
0.560000
|
6.84e-02
|
0.912
|
|
MEMBRANE DEPOLARIZATION
|
11
|
0.560000
|
1.02e-01
|
0.912
|
|
PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
28
|
0.561000
|
-6.45e-02
|
0.912
|
|
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS
|
5
|
0.561000
|
1.51e-01
|
0.912
|
|
REGULATION OF WOUND HEALING
|
38
|
0.562000
|
-5.56e-02
|
0.912
|
|
REGULATION OF ACTION POTENTIAL
|
7
|
0.562000
|
1.27e-01
|
0.912
|
|
RESPONSE TO BACTERIUM
|
97
|
0.563000
|
-3.60e-02
|
0.912
|
|
EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS
|
10
|
0.563000
|
1.06e-01
|
0.912
|
|
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
15
|
0.564000
|
-8.69e-02
|
0.912
|
|
RESPONSE TO ACETYLCHOLINE
|
5
|
0.565000
|
-1.49e-01
|
0.912
|
|
RESPONSE TO FLUID SHEAR STRESS
|
5
|
0.565000
|
-1.49e-01
|
0.912
|
|
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
7
|
0.565000
|
-1.26e-01
|
0.912
|
|
RHO PROTEIN SIGNAL TRANSDUCTION
|
16
|
0.565000
|
-8.39e-02
|
0.912
|
|
EMBRYONIC HEART TUBE DEVELOPMENT
|
6
|
0.565000
|
-1.36e-01
|
0.912
|
|
EMBRYONIC HEART TUBE MORPHOGENESIS
|
6
|
0.565000
|
-1.36e-01
|
0.912
|
|
SPECIFICATION OF SYMMETRY
|
6
|
0.565000
|
-1.36e-01
|
0.912
|
|
CELLULAR RESPONSE TO CAMP
|
6
|
0.567000
|
-1.35e-01
|
0.914
|
|
RESPONSE TO CAMP
|
6
|
0.567000
|
-1.35e-01
|
0.914
|
|
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS
|
7
|
0.568000
|
1.25e-01
|
0.914
|
|
RESPONSE TO IRON ION
|
7
|
0.569000
|
1.25e-01
|
0.914
|
|
FATTY ACID BIOSYNTHETIC PROCESS
|
14
|
0.570000
|
-8.84e-02
|
0.916
|
|
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS
|
6
|
0.571000
|
1.34e-01
|
0.917
|
|
ENDOTHELIAL CELL APOPTOTIC PROCESS
|
9
|
0.572000
|
1.09e-01
|
0.917
|
|
INTERLEUKIN 2 PRODUCTION
|
10
|
0.572000
|
-1.04e-01
|
0.917
|
|
POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION
|
10
|
0.572000
|
-1.04e-01
|
0.917
|
|
SMOOTH MUSCLE CELL MIGRATION
|
14
|
0.574000
|
8.76e-02
|
0.917
|
|
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
10
|
0.574000
|
1.03e-01
|
0.917
|
|
REGULATION OF LIPID METABOLIC PROCESS
|
30
|
0.574000
|
6.03e-02
|
0.917
|
|
ENDOTHELIUM DEVELOPMENT
|
24
|
0.575000
|
-6.71e-02
|
0.917
|
|
ORGANELLE ASSEMBLY
|
46
|
0.576000
|
-4.90e-02
|
0.919
|
|
LIPID CATABOLIC PROCESS
|
29
|
0.577000
|
6.08e-02
|
0.919
|
|
MECHANORECEPTOR DIFFERENTIATION
|
5
|
0.578000
|
-1.44e-01
|
0.919
|
|
NEGATIVE REGULATION OF PROTEIN MATURATION
|
7
|
0.578000
|
1.22e-01
|
0.919
|
|
REGULATION OF MYELOID CELL DIFFERENTIATION
|
12
|
0.578000
|
-9.34e-02
|
0.919
|
|
CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN
|
20
|
0.579000
|
7.25e-02
|
0.920
|
|
MYELOID CELL DEVELOPMENT
|
25
|
0.580000
|
-6.49e-02
|
0.920
|
|
REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY
|
5
|
0.580000
|
-1.43e-01
|
0.920
|
|
CELL CELL SIGNALING
|
79
|
0.581000
|
-3.76e-02
|
0.920
|
|
NEGATIVE REGULATION OF LOCOMOTION
|
41
|
0.581000
|
-5.10e-02
|
0.920
|
|
PROTEIN IMPORT
|
5
|
0.581000
|
1.43e-01
|
0.920
|
|
REGULATION OF TRANSLATION
|
19
|
0.582000
|
7.38e-02
|
0.920
|
|
FEMALE GAMETE GENERATION
|
7
|
0.583000
|
-1.21e-01
|
0.921
|
|
CELL CELL ADHESION MEDIATED BY CADHERIN
|
10
|
0.583000
|
-1.01e-01
|
0.921
|
|
GLYCOSPHINGOLIPID METABOLIC PROCESS
|
5
|
0.583000
|
1.42e-01
|
0.921
|
|
POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
18
|
0.584000
|
7.54e-02
|
0.921
|
|
RECEPTOR METABOLIC PROCESS
|
7
|
0.587000
|
-1.19e-01
|
0.924
|
|
SEX DIFFERENTIATION
|
12
|
0.588000
|
9.10e-02
|
0.925
|
|
REGULATION OF LEUKOCYTE DIFFERENTIATION
|
33
|
0.589000
|
-5.54e-02
|
0.925
|
|
POSITIVE REGULATION OF LIPID CATABOLIC PROCESS
|
5
|
0.589000
|
-1.40e-01
|
0.925
|
|
DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM
|
18
|
0.590000
|
7.42e-02
|
0.925
|
|
TOR SIGNALING
|
9
|
0.590000
|
-1.04e-01
|
0.925
|
|
MALE SEX DIFFERENTIATION
|
5
|
0.591000
|
1.39e-01
|
0.925
|
|
MESODERM DEVELOPMENT
|
7
|
0.591000
|
1.18e-01
|
0.925
|
|
REGULATION OF MEMBRANE DEPOLARIZATION
|
7
|
0.591000
|
-1.18e-01
|
0.925
|
|
LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
6
|
0.592000
|
-1.27e-01
|
0.925
|
|
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION
|
14
|
0.593000
|
-8.31e-02
|
0.925
|
|
NEUROEPITHELIAL CELL DIFFERENTIATION
|
5
|
0.594000
|
1.38e-01
|
0.925
|
|
REGULATION OF NUCLEAR DIVISION
|
5
|
0.594000
|
1.38e-01
|
0.925
|
|
NADPPLUS METABOLIC PROCESS
|
11
|
0.595000
|
9.34e-02
|
0.925
|
|
MONOCARBOXYLIC ACID CATABOLIC PROCESS
|
7
|
0.595000
|
1.17e-01
|
0.925
|
|
GOLGI ORGANIZATION
|
8
|
0.595000
|
-1.09e-01
|
0.925
|
|
NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION
|
8
|
0.595000
|
1.09e-01
|
0.925
|
|
NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
8
|
0.595000
|
1.09e-01
|
0.925
|
|
POSITIVE REGULATION OF CELL GROWTH
|
15
|
0.596000
|
7.99e-02
|
0.925
|
|
RESPONSE TO NUTRIENT
|
19
|
0.596000
|
-7.11e-02
|
0.925
|
|
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION
|
11
|
0.597000
|
-9.27e-02
|
0.925
|
|
DEFENSE RESPONSE TO OTHER ORGANISM
|
157
|
0.597000
|
2.68e-02
|
0.925
|
|
MYOTUBE DIFFERENTIATION
|
8
|
0.598000
|
-1.08e-01
|
0.925
|
|
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
5
|
0.599000
|
-1.36e-01
|
0.925
|
|
NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION
|
5
|
0.599000
|
1.36e-01
|
0.925
|
|
PROTEIN TETRAMERIZATION
|
10
|
0.599000
|
9.66e-02
|
0.925
|
|
ANTIBACTERIAL HUMORAL RESPONSE
|
26
|
0.599000
|
-6.05e-02
|
0.925
|
|
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT
|
8
|
0.600000
|
1.08e-01
|
0.925
|
|
NUCLEAR TRANSPORT
|
15
|
0.601000
|
7.87e-02
|
0.926
|
|
REGULATION OF CYTOSKELETON ORGANIZATION
|
53
|
0.601000
|
-4.28e-02
|
0.926
|
|
REGULATION OF LIPID STORAGE
|
6
|
0.602000
|
-1.24e-01
|
0.926
|
|
ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT
|
11
|
0.604000
|
-9.09e-02
|
0.928
|
|
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION
|
23
|
0.605000
|
6.32e-02
|
0.928
|
|
ORGAN GROWTH
|
15
|
0.605000
|
7.79e-02
|
0.928
|
|
AMINE METABOLIC PROCESS
|
6
|
0.605000
|
-1.22e-01
|
0.928
|
|
POSITIVE REGULATION OF TRANSPORT
|
98
|
0.607000
|
3.19e-02
|
0.930
|
|
NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
7
|
0.608000
|
-1.13e-01
|
0.931
|
|
EXTRACELLULAR MATRIX DISASSEMBLY
|
15
|
0.609000
|
7.70e-02
|
0.931
|
|
NEGATIVE REGULATION OF GROWTH
|
16
|
0.610000
|
7.43e-02
|
0.931
|
|
NUCLEIC ACID CATABOLIC PROCESS
|
8
|
0.610000
|
-1.05e-01
|
0.931
|
|
CELLULAR RESPONSE TO METAL ION
|
11
|
0.611000
|
8.93e-02
|
0.931
|
|
MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS
|
16
|
0.611000
|
-7.42e-02
|
0.931
|
|
RESPONSE TO CARBOHYDRATE
|
21
|
0.611000
|
6.49e-02
|
0.931
|
|
REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY
|
10
|
0.612000
|
-9.33e-02
|
0.931
|
|
RESPONSE TO FIBROBLAST GROWTH FACTOR
|
10
|
0.612000
|
9.33e-02
|
0.931
|
|
POSITIVE REGULATION OF LIPID METABOLIC PROCESS
|
14
|
0.612000
|
7.90e-02
|
0.931
|
|
POSITIVE REGULATION OF DNA RECOMBINATION
|
5
|
0.613000
|
-1.31e-01
|
0.932
|
|
REGULATION OF DNA RECOMBINATION
|
5
|
0.613000
|
-1.31e-01
|
0.932
|
|
NEURAL PRECURSOR CELL PROLIFERATION
|
11
|
0.614000
|
-8.85e-02
|
0.932
|
|
DICARBOXYLIC ACID METABOLIC PROCESS
|
8
|
0.614000
|
-1.04e-01
|
0.932
|
|
ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
11
|
0.615000
|
8.83e-02
|
0.932
|
|
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT
|
15
|
0.615000
|
-7.57e-02
|
0.932
|
|
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
15
|
0.617000
|
7.54e-02
|
0.933
|
|
GLUCOSE CATABOLIC PROCESS
|
12
|
0.618000
|
-8.39e-02
|
0.934
|
|
SPINDLE ORGANIZATION
|
15
|
0.619000
|
-7.49e-02
|
0.935
|
|
CELLULAR RESPONSE TO LIPID
|
40
|
0.620000
|
4.64e-02
|
0.936
|
|
STRIATED MUSCLE CELL PROLIFERATION
|
5
|
0.621000
|
1.28e-01
|
0.937
|
|
POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
14
|
0.622000
|
-7.67e-02
|
0.938
|
|
POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II
|
38
|
0.624000
|
-4.69e-02
|
0.940
|
|
B CELL MEDIATED IMMUNITY
|
77
|
0.624000
|
-3.37e-02
|
0.940
|
|
RUFFLE ORGANIZATION
|
6
|
0.625000
|
1.16e-01
|
0.940
|
|
NEGATIVE REGULATION OF GENE EXPRESSION
|
72
|
0.625000
|
-3.47e-02
|
0.940
|
|
KERATINOCYTE MIGRATION
|
5
|
0.627000
|
1.26e-01
|
0.940
|
|
PHOSPHOLIPID EFFLUX
|
8
|
0.627000
|
-9.99e-02
|
0.940
|
|
PEPTIDE CROSS LINKING
|
8
|
0.628000
|
9.96e-02
|
0.940
|
|
REGULATION OF MOLECULAR FUNCTION
|
57
|
0.628000
|
3.83e-02
|
0.940
|
|
REGULATION OF SUPEROXIDE METABOLIC PROCESS
|
12
|
0.629000
|
8.13e-02
|
0.940
|
|
MUSCLE STRUCTURE DEVELOPMENT
|
54
|
0.629000
|
-3.92e-02
|
0.940
|
|
EMBRYONIC MORPHOGENESIS
|
38
|
0.629000
|
-4.63e-02
|
0.940
|
|
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION
|
17
|
0.630000
|
-6.82e-02
|
0.940
|
|
RESPONSE TO TESTOSTERONE
|
5
|
0.630000
|
-1.25e-01
|
0.940
|
|
PROTEIN POLYMERIZATION
|
32
|
0.631000
|
-5.00e-02
|
0.940
|
|
REGULATION OF REGULATED SECRETORY PATHWAY
|
10
|
0.631000
|
-8.84e-02
|
0.940
|
|
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION
|
9
|
0.631000
|
-9.30e-02
|
0.940
|
|
NEURON PROJECTION GUIDANCE
|
25
|
0.631000
|
-5.63e-02
|
0.940
|
|
NUCLEOTIDE METABOLIC PROCESS
|
54
|
0.632000
|
-3.89e-02
|
0.940
|
|
MUSCLE CELL PROLIFERATION
|
29
|
0.633000
|
5.21e-02
|
0.940
|
|
GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE
|
11
|
0.634000
|
-8.36e-02
|
0.940
|
|
MRNA CATABOLIC PROCESS
|
6
|
0.634000
|
-1.13e-01
|
0.940
|
|
T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE
|
13
|
0.634000
|
-7.69e-02
|
0.940
|
|
IMMUNOGLOBULIN PRODUCTION
|
7
|
0.634000
|
-1.04e-01
|
0.940
|
|
CELL FATE SPECIFICATION
|
6
|
0.635000
|
-1.12e-01
|
0.940
|
|
REGULATION OF HEART GROWTH
|
6
|
0.635000
|
-1.12e-01
|
0.940
|
|
REGULATION OF LAMELLIPODIUM ASSEMBLY
|
8
|
0.637000
|
-9.68e-02
|
0.942
|
|
AMIDE TRANSPORT
|
21
|
0.638000
|
6.01e-02
|
0.942
|
|
STRIATED MUSCLE CONTRACTION
|
17
|
0.638000
|
-6.65e-02
|
0.942
|
|
CHYLOMICRON REMODELING
|
5
|
0.639000
|
1.22e-01
|
0.942
|
|
GRANULOCYTE ACTIVATION
|
12
|
0.639000
|
7.88e-02
|
0.942
|
|
NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY
|
11
|
0.639000
|
-8.22e-02
|
0.943
|
|
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS
|
12
|
0.641000
|
7.83e-02
|
0.944
|
|
OUTFLOW TRACT MORPHOGENESIS
|
5
|
0.641000
|
1.21e-01
|
0.944
|
|
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS
|
24
|
0.642000
|
-5.57e-02
|
0.944
|
|
EAR DEVELOPMENT
|
12
|
0.643000
|
-7.79e-02
|
0.944
|
|
PHOSPHOLIPID CATABOLIC PROCESS
|
8
|
0.643000
|
9.51e-02
|
0.944
|
|
RESPONSE TO ABIOTIC STIMULUS
|
85
|
0.644000
|
-3.05e-02
|
0.944
|
|
ACTOMYOSIN STRUCTURE ORGANIZATION
|
29
|
0.644000
|
-5.04e-02
|
0.944
|
|
MUSCLE CELL DEVELOPMENT
|
21
|
0.644000
|
-5.89e-02
|
0.944
|
|
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
7
|
0.646000
|
1.01e-01
|
0.945
|
|
POSITIVE REGULATION OF CATALYTIC ACTIVITY
|
18
|
0.646000
|
6.32e-02
|
0.945
|
|
CARBOHYDRATE TRANSPORT
|
7
|
0.647000
|
-1.00e-01
|
0.945
|
|
MONOSACCHARIDE TRANSMEMBRANE TRANSPORT
|
7
|
0.647000
|
-1.00e-01
|
0.945
|
|
SECRETION
|
72
|
0.648000
|
-3.24e-02
|
0.946
|
|
IMPORT INTO CELL
|
111
|
0.650000
|
-2.66e-02
|
0.948
|
|
REGULATION OF CELLULAR COMPONENT SIZE
|
34
|
0.650000
|
-4.58e-02
|
0.948
|
|
THYMIC T CELL SELECTION
|
9
|
0.651000
|
-8.75e-02
|
0.949
|
|
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
23
|
0.652000
|
-5.50e-02
|
0.950
|
|
MYELOID CELL APOPTOTIC PROCESS
|
5
|
0.654000
|
1.16e-01
|
0.950
|
|
REGULATION OF MYELOID CELL APOPTOTIC PROCESS
|
5
|
0.654000
|
1.16e-01
|
0.950
|
|
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS
|
9
|
0.655000
|
8.65e-02
|
0.952
|
|
FATTY ACID TRANSPORT
|
8
|
0.656000
|
-9.15e-02
|
0.952
|
|
VASCULATURE DEVELOPMENT
|
99
|
0.657000
|
-2.73e-02
|
0.953
|
|
MODIFIED AMINO ACID METABOLIC PROCESS
|
20
|
0.658000
|
-5.79e-02
|
0.953
|
|
CELLULAR RESPONSE TO NUTRIENT LEVELS
|
15
|
0.658000
|
-6.67e-02
|
0.953
|
|
REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING
|
6
|
0.658000
|
-1.05e-01
|
0.953
|
|
REGULATION OF SODIUM ION TRANSPORT
|
8
|
0.659000
|
9.07e-02
|
0.953
|
|
REGULATION OF MUSCLE CELL DIFFERENTIATION
|
16
|
0.659000
|
6.43e-02
|
0.953
|
|
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY
|
12
|
0.660000
|
7.40e-02
|
0.953
|
|
CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY
|
65
|
0.660000
|
3.27e-02
|
0.953
|
|
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
29
|
0.661000
|
4.79e-02
|
0.953
|
|
RESPONSE TO TUMOR NECROSIS FACTOR
|
23
|
0.662000
|
-5.34e-02
|
0.953
|
|
POSITIVE REGULATION OF COAGULATION
|
12
|
0.662000
|
-7.34e-02
|
0.953
|
|
RESPONSE TO MANGANESE ION
|
5
|
0.662000
|
-1.13e-01
|
0.953
|
|
EPITHELIAL CELL CELL ADHESION
|
6
|
0.663000
|
1.03e-01
|
0.953
|
|
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY
|
30
|
0.663000
|
-4.68e-02
|
0.953
|
|
RESPONSE TO MONOSACCHARIDE
|
19
|
0.663000
|
5.83e-02
|
0.953
|
|
ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY
|
8
|
0.664000
|
8.93e-02
|
0.953
|
|
NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
11
|
0.665000
|
7.58e-02
|
0.953
|
|
REGULATION OF PROTEIN IMPORT INTO NUCLEUS
|
10
|
0.666000
|
7.94e-02
|
0.953
|
|
POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION
|
10
|
0.666000
|
7.94e-02
|
0.953
|
|
LEUKOCYTE DIFFERENTIATION
|
59
|
0.666000
|
-3.36e-02
|
0.953
|
|
RESPONSE TO NUTRIENT LEVELS
|
41
|
0.666000
|
-3.99e-02
|
0.953
|
|
REGULATION OF INSULIN SECRETION
|
10
|
0.668000
|
7.87e-02
|
0.955
|
|
ORGANELLE LOCALIZATION
|
35
|
0.669000
|
-4.26e-02
|
0.956
|
|
KIDNEY MORPHOGENESIS
|
5
|
0.670000
|
1.11e-01
|
0.956
|
|
CELL CELL JUNCTION ASSEMBLY
|
21
|
0.671000
|
5.42e-02
|
0.957
|
|
VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION
|
7
|
0.672000
|
9.28e-02
|
0.958
|
|
NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
6
|
0.673000
|
-9.99e-02
|
0.959
|
|
ADHERENS JUNCTION ORGANIZATION
|
9
|
0.674000
|
-8.16e-02
|
0.959
|
|
DEVELOPMENTAL MATURATION
|
21
|
0.674000
|
-5.37e-02
|
0.959
|
|
AXONAL TRANSPORT
|
5
|
0.676000
|
1.08e-01
|
0.959
|
|
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT
|
7
|
0.676000
|
9.16e-02
|
0.959
|
|
POSITIVE REGULATION OF PLASMINOGEN ACTIVATION
|
5
|
0.677000
|
-1.08e-01
|
0.959
|
|
RESPONSE TO INTERLEUKIN 4
|
7
|
0.677000
|
-9.13e-02
|
0.959
|
|
MUSCLE ADAPTATION
|
12
|
0.677000
|
-6.99e-02
|
0.959
|
|
NADPH REGENERATION
|
8
|
0.678000
|
8.54e-02
|
0.959
|
|
POST EMBRYONIC DEVELOPMENT
|
7
|
0.678000
|
9.09e-02
|
0.959
|
|
NEUROMUSCULAR JUNCTION DEVELOPMENT
|
6
|
0.679000
|
-9.80e-02
|
0.959
|
|
LYMPHOCYTE DIFFERENTIATION
|
35
|
0.679000
|
-4.12e-02
|
0.959
|
|
MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS
|
11
|
0.681000
|
-7.22e-02
|
0.959
|
|
ASTROCYTE DIFFERENTIATION
|
12
|
0.681000
|
6.91e-02
|
0.959
|
|
SYNAPSE PRUNING
|
5
|
0.681000
|
-1.07e-01
|
0.959
|
|
POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
5
|
0.681000
|
-1.07e-01
|
0.959
|
|
REGULATION OF TRANSLATIONAL INITIATION
|
5
|
0.681000
|
1.07e-01
|
0.959
|
|
CORNIFICATION
|
6
|
0.681000
|
9.73e-02
|
0.959
|
|
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
6
|
0.682000
|
9.69e-02
|
0.959
|
|
GLIOGENESIS
|
36
|
0.683000
|
4.02e-02
|
0.959
|
|
CELL FATE COMMITMENT
|
12
|
0.683000
|
-6.86e-02
|
0.959
|
|
HOST MEDIATED ACTIVATION OF VIRAL PROCESS
|
7
|
0.684000
|
8.93e-02
|
0.959
|
|
MACROPHAGE ACTIVATION
|
17
|
0.684000
|
5.76e-02
|
0.959
|
|
CALCIUM MEDIATED SIGNALING
|
13
|
0.684000
|
6.57e-02
|
0.959
|
|
INNATE IMMUNE RESPONSE IN MUCOSA
|
5
|
0.686000
|
-1.05e-01
|
0.959
|
|
SENSORY PERCEPTION
|
26
|
0.686000
|
4.64e-02
|
0.959
|
|
REGULATION OF HEART CONTRACTION
|
17
|
0.687000
|
-5.71e-02
|
0.959
|
|
DIGESTION
|
15
|
0.687000
|
-6.07e-02
|
0.959
|
|
HEMOPOIESIS
|
91
|
0.688000
|
-2.57e-02
|
0.959
|
|
EXOCRINE SYSTEM DEVELOPMENT
|
7
|
0.688000
|
8.81e-02
|
0.959
|
|
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS
|
98
|
0.688000
|
2.48e-02
|
0.959
|
|
T CELL DIFFERENTIATION IN THYMUS
|
14
|
0.688000
|
-6.24e-02
|
0.959
|
|
POLYSACCHARIDE BIOSYNTHETIC PROCESS
|
7
|
0.689000
|
8.78e-02
|
0.959
|
|
RESPIRATORY BURST
|
7
|
0.689000
|
-8.78e-02
|
0.959
|
|
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
9
|
0.690000
|
-7.73e-02
|
0.959
|
|
PROTEIN LOCALIZATION TO LYSOSOME
|
7
|
0.690000
|
8.74e-02
|
0.959
|
|
SODIUM ION TRANSPORT
|
10
|
0.691000
|
-7.32e-02
|
0.959
|
|
REGULATION OF ORGAN GROWTH
|
8
|
0.692000
|
8.12e-02
|
0.960
|
|
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE
|
24
|
0.693000
|
4.72e-02
|
0.960
|
|
REGULATION OF PLASMINOGEN ACTIVATION
|
10
|
0.693000
|
7.25e-02
|
0.960
|
|
REGULATION OF HOMOTYPIC CELL CELL ADHESION
|
7
|
0.693000
|
-8.65e-02
|
0.960
|
|
PROSTATE GLAND MORPHOGENESIS
|
5
|
0.694000
|
1.02e-01
|
0.960
|
|
MONOCARBOXYLIC ACID METABOLIC PROCESS
|
58
|
0.694000
|
3.09e-02
|
0.960
|
|
NEUTRAL LIPID CATABOLIC PROCESS
|
10
|
0.694000
|
-7.23e-02
|
0.960
|
|
ENDOTHELIAL CELL PROLIFERATION
|
17
|
0.695000
|
-5.55e-02
|
0.960
|
|
LOW DENSITY LIPOPROTEIN PARTICLE REMODELING
|
6
|
0.695000
|
-9.28e-02
|
0.960
|
|
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT
|
16
|
0.697000
|
-5.67e-02
|
0.960
|
|
CHAPERONE MEDIATED AUTOPHAGY
|
5
|
0.697000
|
-1.01e-01
|
0.960
|
|
PATTERN SPECIFICATION PROCESS
|
12
|
0.698000
|
-6.52e-02
|
0.960
|
|
HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN
|
33
|
0.698000
|
3.98e-02
|
0.960
|
|
POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY
|
9
|
0.698000
|
7.51e-02
|
0.960
|
|
IMMUNE EFFECTOR PROCESS
|
166
|
0.698000
|
-1.92e-02
|
0.960
|
|
NEGATIVE REGULATION OF ENDOCYTOSIS
|
11
|
0.699000
|
6.77e-02
|
0.960
|
|
REPRODUCTIVE BEHAVIOR
|
5
|
0.700000
|
-9.99e-02
|
0.960
|
|
COMPLEMENT ACTIVATION GZMK PATHWAY
|
11
|
0.700000
|
6.75e-02
|
0.960
|
|
ADHESION OF SYMBIONT TO HOST
|
5
|
0.701000
|
-9.94e-02
|
0.960
|
|
STRESS FIBER ASSEMBLY
|
18
|
0.702000
|
-5.27e-02
|
0.960
|
|
FERTILIZATION
|
16
|
0.703000
|
-5.56e-02
|
0.960
|
|
RESPONSE TO THYROID HORMONE
|
5
|
0.704000
|
-9.86e-02
|
0.960
|
|
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
26
|
0.704000
|
-4.37e-02
|
0.960
|
|
ALPHA BETA T CELL DIFFERENTIATION
|
15
|
0.705000
|
-5.71e-02
|
0.960
|
|
SKELETAL SYSTEM DEVELOPMENT
|
44
|
0.705000
|
3.38e-02
|
0.960
|
|
ICOSANOID BIOSYNTHETIC PROCESS
|
7
|
0.705000
|
8.30e-02
|
0.960
|
|
RENAL TUBULE DEVELOPMENT
|
8
|
0.706000
|
-7.76e-02
|
0.960
|
|
FEMALE SEX DIFFERENTIATION
|
8
|
0.706000
|
7.76e-02
|
0.960
|
|
CHLORIDE TRANSPORT
|
5
|
0.706000
|
-9.77e-02
|
0.960
|
|
INORGANIC ANION TRANSPORT
|
5
|
0.706000
|
-9.77e-02
|
0.960
|
|
RESPONSE TO RADIATION
|
28
|
0.707000
|
4.17e-02
|
0.960
|
|
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION
|
7
|
0.707000
|
8.23e-02
|
0.960
|
|
CELLULAR RESPONSE TO CHEMICAL STRESS
|
34
|
0.707000
|
-3.79e-02
|
0.960
|
|
REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
15
|
0.708000
|
-5.65e-02
|
0.960
|
|
REGULATION OF SYNAPSE ASSEMBLY
|
6
|
0.708000
|
-8.87e-02
|
0.960
|
|
REGULATION OF HEMOPOIESIS
|
35
|
0.709000
|
-3.73e-02
|
0.960
|
|
CIRCULATORY SYSTEM DEVELOPMENT
|
118
|
0.709000
|
-2.13e-02
|
0.960
|
|
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS
|
149
|
0.709000
|
1.93e-02
|
0.960
|
|
REGULATION OF RESPONSE TO WOUNDING
|
43
|
0.711000
|
-3.35e-02
|
0.961
|
|
POSITIVE REGULATION OF GROWTH
|
20
|
0.711000
|
4.84e-02
|
0.961
|
|
FOAM CELL DIFFERENTIATION
|
9
|
0.711000
|
-7.16e-02
|
0.961
|
|
REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION
|
12
|
0.712000
|
6.20e-02
|
0.961
|
|
VACUOLE ORGANIZATION
|
15
|
0.713000
|
-5.54e-02
|
0.961
|
|
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT
|
24
|
0.713000
|
4.40e-02
|
0.961
|
|
PROTEIN COMPLEX OLIGOMERIZATION
|
18
|
0.715000
|
-5.03e-02
|
0.963
|
|
PROTEIN CONTAINING COMPLEX REMODELING
|
19
|
0.716000
|
-4.88e-02
|
0.963
|
|
PROTEIN LIPID COMPLEX ORGANIZATION
|
19
|
0.716000
|
-4.88e-02
|
0.963
|
|
SPINDLE LOCALIZATION
|
6
|
0.716000
|
-8.61e-02
|
0.963
|
|
TUBE FORMATION
|
8
|
0.717000
|
-7.45e-02
|
0.963
|
|
LIPID OXIDATION
|
6
|
0.717000
|
8.57e-02
|
0.963
|
|
HOMEOSTASIS OF NUMBER OF CELLS
|
39
|
0.718000
|
3.42e-02
|
0.963
|
|
MUSCLE ORGAN DEVELOPMENT
|
25
|
0.719000
|
4.22e-02
|
0.964
|
|
POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY
|
6
|
0.720000
|
8.50e-02
|
0.964
|
|
NEGATIVE REGULATION OF IMMUNE RESPONSE
|
29
|
0.721000
|
-3.89e-02
|
0.965
|
|
RECEPTOR CATABOLIC PROCESS
|
5
|
0.722000
|
-9.23e-02
|
0.965
|
|
PROTEIN LOCALIZATION TO CELL SURFACE
|
8
|
0.722000
|
-7.31e-02
|
0.965
|
|
NEGATIVE REGULATION OF NEURON DIFFERENTIATION
|
6
|
0.724000
|
-8.35e-02
|
0.967
|
|
THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY
|
5
|
0.724000
|
-9.14e-02
|
0.967
|
|
ODONTOGENESIS
|
8
|
0.725000
|
-7.23e-02
|
0.967
|
|
JNK CASCADE
|
9
|
0.726000
|
-6.79e-02
|
0.967
|
|
REGULATION OF JNK CASCADE
|
9
|
0.726000
|
-6.79e-02
|
0.967
|
|
POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
40
|
0.727000
|
-3.26e-02
|
0.967
|
|
REGULATION OF TUBE SIZE
|
21
|
0.728000
|
4.44e-02
|
0.967
|
|
NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
5
|
0.728000
|
-9.01e-02
|
0.967
|
|
POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
5
|
0.728000
|
9.01e-02
|
0.967
|
|
POSITIVE REGULATION OF STEROID METABOLIC PROCESS
|
5
|
0.728000
|
9.01e-02
|
0.967
|
|
IMPORT INTO NUCLEUS
|
13
|
0.729000
|
5.60e-02
|
0.967
|
|
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION
|
6
|
0.729000
|
8.20e-02
|
0.967
|
|
RESPONSE TO HEAT
|
9
|
0.731000
|
-6.67e-02
|
0.967
|
|
CELL RECOGNITION
|
40
|
0.731000
|
3.22e-02
|
0.967
|
|
RESPIRATORY SYSTEM DEVELOPMENT
|
22
|
0.731000
|
4.29e-02
|
0.967
|
|
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY
|
26
|
0.731000
|
-3.95e-02
|
0.967
|
|
MOLTING CYCLE
|
15
|
0.731000
|
5.17e-02
|
0.967
|
|
REGULATION OF ALPHA BETA T CELL ACTIVATION
|
9
|
0.732000
|
6.64e-02
|
0.967
|
|
REGULATION OF MONOATOMIC ION TRANSPORT
|
39
|
0.732000
|
-3.24e-02
|
0.967
|
|
REGULATION OF POSTSYNAPSE ORGANIZATION
|
11
|
0.733000
|
-5.98e-02
|
0.967
|
|
POSITIVE REGULATION OF CELL CELL ADHESION
|
42
|
0.734000
|
3.10e-02
|
0.967
|
|
REGULATION OF CHEMOTAXIS
|
35
|
0.734000
|
-3.38e-02
|
0.967
|
|
POSITIVE REGULATION OF PHAGOCYTOSIS
|
27
|
0.735000
|
3.83e-02
|
0.967
|
|
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
5
|
0.735000
|
-8.79e-02
|
0.967
|
|
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION
|
6
|
0.735000
|
-8.02e-02
|
0.967
|
|
SMALL MOLECULE BIOSYNTHETIC PROCESS
|
51
|
0.736000
|
-2.81e-02
|
0.967
|
|
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY
|
6
|
0.736000
|
7.98e-02
|
0.967
|
|
RAS PROTEIN SIGNAL TRANSDUCTION
|
9
|
0.737000
|
-6.49e-02
|
0.967
|
|
ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE
|
8
|
0.738000
|
-6.86e-02
|
0.967
|
|
MAPK CASCADE
|
68
|
0.739000
|
2.43e-02
|
0.967
|
|
IMMUNE RESPONSE REGULATING SIGNALING PATHWAY
|
56
|
0.739000
|
2.66e-02
|
0.967
|
|
REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION
|
6
|
0.740000
|
-7.87e-02
|
0.967
|
|
NEGATIVE REGULATION OF RESPONSE TO STIMULUS
|
147
|
0.740000
|
-1.73e-02
|
0.967
|
|
LIPID LOCALIZATION
|
52
|
0.741000
|
-2.73e-02
|
0.967
|
|
OOGENESIS
|
5
|
0.741000
|
-8.57e-02
|
0.967
|
|
POSITIVE REGULATION OF CELL DIVISION
|
7
|
0.741000
|
7.25e-02
|
0.967
|
|
VESICLE MEDIATED TRANSPORT IN SYNAPSE
|
13
|
0.742000
|
-5.33e-02
|
0.967
|
|
EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION
|
51
|
0.742000
|
-2.75e-02
|
0.967
|
|
CELLULAR RESPONSE TO TOXIC SUBSTANCE
|
34
|
0.743000
|
3.32e-02
|
0.967
|
|
DETOXIFICATION
|
34
|
0.743000
|
3.32e-02
|
0.967
|
|
PENTOSE PHOSPHATE SHUNT
|
6
|
0.743000
|
-7.76e-02
|
0.967
|
|
DETECTION OF CHEMICAL STIMULUS
|
9
|
0.743000
|
6.34e-02
|
0.967
|
|
PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS
|
23
|
0.744000
|
-3.98e-02
|
0.967
|
|
NEURAL TUBE DEVELOPMENT
|
7
|
0.744000
|
-7.15e-02
|
0.967
|
|
REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
27
|
0.745000
|
3.68e-02
|
0.967
|
|
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
30
|
0.745000
|
3.49e-02
|
0.967
|
|
REGULATION OF ACUTE INFLAMMATORY RESPONSE
|
7
|
0.747000
|
7.09e-02
|
0.968
|
|
LIPOSACCHARIDE METABOLIC PROCESS
|
6
|
0.747000
|
7.65e-02
|
0.968
|
|
COLLAGEN FIBRIL ORGANIZATION
|
10
|
0.748000
|
-5.91e-02
|
0.968
|
|
MYOFIBRIL ASSEMBLY
|
9
|
0.748000
|
-6.22e-02
|
0.968
|
|
RETINA DEVELOPMENT IN CAMERA TYPE EYE
|
13
|
0.749000
|
5.17e-02
|
0.968
|
|
REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY
|
5
|
0.749000
|
8.30e-02
|
0.968
|
|
POLYSACCHARIDE CATABOLIC PROCESS
|
5
|
0.752000
|
8.21e-02
|
0.970
|
|
MEMBRANELESS ORGANELLE ASSEMBLY
|
26
|
0.752000
|
-3.64e-02
|
0.970
|
|
REGULATION OF ACTIN FILAMENT BASED PROCESS
|
46
|
0.753000
|
-2.76e-02
|
0.970
|
|
RESPONSE TO AXON INJURY
|
13
|
0.753000
|
5.09e-02
|
0.970
|
|
PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
18
|
0.753000
|
4.33e-02
|
0.970
|
|
ACTIN MEDIATED CELL CONTRACTION
|
11
|
0.754000
|
5.51e-02
|
0.970
|
|
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION
|
118
|
0.754000
|
-1.79e-02
|
0.970
|
|
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
|
6
|
0.754000
|
-7.42e-02
|
0.970
|
|
PROTEIN TRANSPORT
|
100
|
0.754000
|
-1.92e-02
|
0.970
|
|
REGULATION OF NEUTROPHIL MIGRATION
|
6
|
0.755000
|
-7.39e-02
|
0.970
|
|
COLLAGEN CATABOLIC PROCESS
|
9
|
0.756000
|
-6.02e-02
|
0.970
|
|
GENERATION OF PRECURSOR METABOLITES AND ENERGY
|
48
|
0.757000
|
-2.65e-02
|
0.971
|
|
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION
|
8
|
0.758000
|
6.33e-02
|
0.971
|
|
CELLULAR RESPONSE TO TYPE II INTERFERON
|
13
|
0.758000
|
-4.98e-02
|
0.971
|
|
MONONUCLEAR CELL DIFFERENTIATION
|
48
|
0.758000
|
2.64e-02
|
0.971
|
|
CELLULAR RESPONSE TO HYDROGEN PEROXIDE
|
8
|
0.759000
|
6.31e-02
|
0.971
|
|
DENDRITIC SPINE MAINTENANCE
|
5
|
0.759000
|
-7.94e-02
|
0.971
|
|
REGULATION OF PROTEIN METABOLIC PROCESS
|
145
|
0.760000
|
-1.60e-02
|
0.971
|
|
PLATELET MORPHOGENESIS
|
7
|
0.763000
|
-6.61e-02
|
0.975
|
|
HIPPOCAMPUS DEVELOPMENT
|
5
|
0.766000
|
7.72e-02
|
0.976
|
|
LIPID MODIFICATION
|
7
|
0.767000
|
6.51e-02
|
0.976
|
|
MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS
|
28
|
0.767000
|
-3.29e-02
|
0.976
|
|
CARDIAC MUSCLE CELL DIFFERENTIATION
|
9
|
0.767000
|
-5.75e-02
|
0.976
|
|
REGULATION OF CELL DIFFERENTIATION
|
114
|
0.767000
|
-1.71e-02
|
0.976
|
|
SMOOTH MUSCLE CELL PROLIFERATION
|
24
|
0.768000
|
3.53e-02
|
0.976
|
|
REGULATION OF SMALL MOLECULE METABOLIC PROCESS
|
35
|
0.769000
|
2.93e-02
|
0.976
|
|
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
14
|
0.770000
|
-4.56e-02
|
0.976
|
|
ENDOTHELIAL CELL MORPHOGENESIS
|
5
|
0.770000
|
-7.59e-02
|
0.976
|
|
ENDOCYTOSIS
|
104
|
0.771000
|
-1.76e-02
|
0.976
|
|
MORPHOGENESIS OF EMBRYONIC EPITHELIUM
|
6
|
0.771000
|
6.90e-02
|
0.976
|
|
POSITIVE REGULATION OF EXOCYTOSIS
|
11
|
0.771000
|
-5.10e-02
|
0.976
|
|
TUBE DEVELOPMENT
|
117
|
0.771000
|
1.66e-02
|
0.976
|
|
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
70
|
0.771000
|
-2.09e-02
|
0.976
|
|
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
65
|
0.772000
|
2.16e-02
|
0.976
|
|
HEPATICOBILIARY SYSTEM DEVELOPMENT
|
15
|
0.772000
|
-4.36e-02
|
0.976
|
|
REGULATION OF CIRCADIAN RHYTHM
|
5
|
0.774000
|
-7.45e-02
|
0.976
|
|
REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT
|
9
|
0.774000
|
-5.55e-02
|
0.976
|
|
COMPLEMENT ACTIVATION CLASSICAL PATHWAY
|
31
|
0.775000
|
3.02e-02
|
0.976
|
|
REGULATION OF LIPID BIOSYNTHETIC PROCESS
|
18
|
0.776000
|
3.93e-02
|
0.976
|
|
RENAL SYSTEM PROCESS
|
17
|
0.776000
|
-4.03e-02
|
0.976
|
|
T CELL SELECTION
|
12
|
0.777000
|
-4.76e-02
|
0.976
|
|
REGULATION OF CELL POPULATION PROLIFERATION
|
134
|
0.778000
|
-1.53e-02
|
0.976
|
|
SENSORY ORGAN MORPHOGENESIS
|
13
|
0.778000
|
-4.55e-02
|
0.976
|
|
REGULATION OF CELL DIVISION
|
9
|
0.778000
|
-5.45e-02
|
0.976
|
|
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
14
|
0.779000
|
-4.37e-02
|
0.976
|
|
IRON ION TRANSPORT
|
12
|
0.779000
|
4.71e-02
|
0.976
|
|
TRANSITION METAL ION TRANSPORT
|
12
|
0.779000
|
4.71e-02
|
0.976
|
|
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS
|
8
|
0.780000
|
-5.75e-02
|
0.976
|
|
AMINO ACID CATABOLIC PROCESS
|
5
|
0.780000
|
-7.23e-02
|
0.976
|
|
CELLULAR RESPONSE TO RADIATION
|
9
|
0.780000
|
-5.40e-02
|
0.976
|
|
ACTIVATED T CELL PROLIFERATION
|
9
|
0.780000
|
5.40e-02
|
0.976
|
|
REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT
|
7
|
0.781000
|
-6.10e-02
|
0.976
|
|
RESPONSE TO LIGHT STIMULUS
|
19
|
0.782000
|
-3.72e-02
|
0.976
|
|
LEARNING
|
8
|
0.782000
|
5.69e-02
|
0.976
|
|
REGULATION OF NEUTROPHIL CHEMOTAXIS
|
5
|
0.782000
|
7.19e-02
|
0.976
|
|
CELL CELL RECOGNITION
|
10
|
0.783000
|
-5.06e-02
|
0.976
|
|
STEM CELL PROLIFERATION
|
7
|
0.784000
|
6.00e-02
|
0.976
|
|
TRANSFORMING GROWTH FACTOR BETA PRODUCTION
|
7
|
0.784000
|
-6.00e-02
|
0.976
|
|
LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL
|
8
|
0.785000
|
5.61e-02
|
0.976
|
|
MEMBRANE LIPID CATABOLIC PROCESS
|
6
|
0.786000
|
6.42e-02
|
0.976
|
|
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION
|
51
|
0.786000
|
-2.26e-02
|
0.976
|
|
REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
143
|
0.787000
|
1.43e-02
|
0.976
|
|
RNA PROCESSING
|
8
|
0.787000
|
5.55e-02
|
0.976
|
|
CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA JAK STAT
|
9
|
0.787000
|
5.23e-02
|
0.976
|
|
RESPONSE TO WOUNDING
|
133
|
0.788000
|
-1.46e-02
|
0.976
|
|
ACTIVATION OF INNATE IMMUNE RESPONSE
|
29
|
0.788000
|
2.93e-02
|
0.976
|
|
CARDIAC VENTRICLE DEVELOPMENT
|
8
|
0.789000
|
5.50e-02
|
0.976
|
|
CARDIAC VENTRICLE MORPHOGENESIS
|
8
|
0.789000
|
5.50e-02
|
0.976
|
|
VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS
|
8
|
0.789000
|
5.50e-02
|
0.976
|
|
FIBROBLAST PROLIFERATION
|
10
|
0.790000
|
-4.90e-02
|
0.976
|
|
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION
|
7
|
0.791000
|
-5.81e-02
|
0.976
|
|
ACYLGLYCEROL HOMEOSTASIS
|
11
|
0.792000
|
4.63e-02
|
0.976
|
|
NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
6
|
0.792000
|
6.24e-02
|
0.976
|
|
CELLULAR RESPONSE TO XENOBIOTIC STIMULUS
|
10
|
0.793000
|
4.83e-02
|
0.976
|
|
REGULATION OF EPITHELIAL CELL DIFFERENTIATION
|
12
|
0.794000
|
-4.39e-02
|
0.976
|
|
ARTERY DEVELOPMENT
|
14
|
0.794000
|
4.06e-02
|
0.976
|
|
HYDROGEN PEROXIDE CATABOLIC PROCESS
|
12
|
0.795000
|
-4.37e-02
|
0.976
|
|
REGULATION OF RESPONSE TO STRESS
|
143
|
0.795000
|
-1.37e-02
|
0.976
|
|
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING
|
30
|
0.795000
|
-2.78e-02
|
0.976
|
|
DEVELOPMENTAL GROWTH
|
43
|
0.795000
|
-2.34e-02
|
0.976
|
|
EMBRYONIC ORGAN DEVELOPMENT
|
25
|
0.796000
|
3.04e-02
|
0.976
|
|
ANGIOTENSIN ACTIVATED SIGNALING PATHWAY
|
5
|
0.796000
|
6.70e-02
|
0.976
|
|
CELLULAR RESPONSE TO ANGIOTENSIN
|
5
|
0.796000
|
6.70e-02
|
0.976
|
|
RESPONSE TO ANGIOTENSIN
|
5
|
0.796000
|
6.70e-02
|
0.976
|
|
RELEASE OF CYTOCHROME C FROM MITOCHONDRIA
|
7
|
0.797000
|
-5.65e-02
|
0.976
|
|
METANEPHROS DEVELOPMENT
|
6
|
0.797000
|
6.09e-02
|
0.976
|
|
DETECTION OF ABIOTIC STIMULUS
|
10
|
0.797000
|
-4.72e-02
|
0.976
|
|
RESPONSE TO TOXIC SUBSTANCE
|
45
|
0.798000
|
2.26e-02
|
0.976
|
|
LEUKOCYTE DEGRANULATION
|
14
|
0.799000
|
3.96e-02
|
0.976
|
|
REGULATION OF CELL PROJECTION ASSEMBLY
|
20
|
0.799000
|
-3.33e-02
|
0.976
|
|
G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
41
|
0.800000
|
-2.34e-02
|
0.976
|
|
EMBRYONIC EPITHELIAL TUBE FORMATION
|
5
|
0.800000
|
-6.56e-02
|
0.976
|
|
NEURAL TUBE FORMATION
|
5
|
0.800000
|
-6.56e-02
|
0.976
|
|
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
16
|
0.801000
|
-3.67e-02
|
0.976
|
|
LYTIC VACUOLE ORGANIZATION
|
9
|
0.801000
|
4.88e-02
|
0.976
|
|
REGULATION OF MUSCLE HYPERTROPHY
|
9
|
0.801000
|
4.88e-02
|
0.976
|
|
ALPHA AMINO ACID METABOLIC PROCESS
|
10
|
0.804000
|
-4.56e-02
|
0.976
|
|
TRANSLATIONAL INITIATION
|
6
|
0.804000
|
5.86e-02
|
0.976
|
|
BLOOD COAGULATION FIBRIN CLOT FORMATION
|
24
|
0.806000
|
2.95e-02
|
0.976
|
|
NEGATIVE REGULATION OF CELL DIFFERENTIATION
|
54
|
0.806000
|
2.00e-02
|
0.976
|
|
NEGATIVE REGULATION OF HEMOPOIESIS
|
20
|
0.806000
|
3.21e-02
|
0.976
|
|
ORGANIC ACID BIOSYNTHETIC PROCESS
|
23
|
0.806000
|
3.00e-02
|
0.976
|
|
LONG CHAIN FATTY ACID TRANSPORT
|
7
|
0.807000
|
-5.37e-02
|
0.976
|
|
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS
|
96
|
0.807000
|
-1.53e-02
|
0.976
|
|
REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY
|
12
|
0.808000
|
-4.09e-02
|
0.976
|
|
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
5
|
0.808000
|
-6.30e-02
|
0.976
|
|
LIPID METABOLIC PROCESS
|
88
|
0.808000
|
1.57e-02
|
0.976
|
|
REGULATION OF NEURON DIFFERENTIATION
|
9
|
0.810000
|
-4.66e-02
|
0.976
|
|
REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION
|
7
|
0.810000
|
5.27e-02
|
0.976
|
|
NUTRIENT STORAGE
|
14
|
0.810000
|
-3.74e-02
|
0.976
|
|
POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING
|
12
|
0.811000
|
4.02e-02
|
0.976
|
|
REGULATION OF ERBB SIGNALING PATHWAY
|
8
|
0.812000
|
-4.88e-02
|
0.976
|
|
PROTEIN O LINKED GLYCOSYLATION
|
5
|
0.812000
|
6.16e-02
|
0.976
|
|
REGULATION OF SECRETION
|
44
|
0.813000
|
-2.12e-02
|
0.976
|
|
PLASMA LIPOPROTEIN PARTICLE CLEARANCE
|
15
|
0.813000
|
-3.56e-02
|
0.976
|
|
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION
|
5
|
0.813000
|
6.12e-02
|
0.976
|
|
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY
|
7
|
0.813000
|
-5.18e-02
|
0.976
|
|
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS
|
18
|
0.814000
|
3.24e-02
|
0.976
|
|
POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION
|
33
|
0.815000
|
-2.40e-02
|
0.976
|
|
RESPONSE TO ZINC ION
|
7
|
0.816000
|
5.11e-02
|
0.976
|
|
MAMMARY GLAND EPITHELIUM DEVELOPMENT
|
5
|
0.816000
|
-6.03e-02
|
0.976
|
|
ANATOMICAL STRUCTURE MATURATION
|
19
|
0.817000
|
-3.11e-02
|
0.976
|
|
CEREBRAL CORTEX DEVELOPMENT
|
7
|
0.817000
|
-5.08e-02
|
0.976
|
|
MAMMARY GLAND MORPHOGENESIS
|
5
|
0.819000
|
-5.94e-02
|
0.976
|
|
GLYCOSAMINOGLYCAN METABOLIC PROCESS
|
13
|
0.819000
|
-3.69e-02
|
0.976
|
|
RESPONSE TO ETHANOL
|
19
|
0.820000
|
-3.05e-02
|
0.976
|
|
MUSCLE CELL APOPTOTIC PROCESS
|
8
|
0.822000
|
4.63e-02
|
0.976
|
|
AMIDE METABOLIC PROCESS
|
46
|
0.822000
|
1.97e-02
|
0.976
|
|
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS
|
47
|
0.822000
|
-1.95e-02
|
0.976
|
|
CELLULAR COMPONENT DISASSEMBLY
|
40
|
0.823000
|
2.09e-02
|
0.976
|
|
LEUKOCYTE TETHERING OR ROLLING
|
5
|
0.823000
|
-5.81e-02
|
0.976
|
|
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION
|
7
|
0.824000
|
4.89e-02
|
0.976
|
|
RESPONSE TO KETONE
|
17
|
0.825000
|
3.14e-02
|
0.976
|
|
REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE
|
7
|
0.825000
|
4.86e-02
|
0.976
|
|
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN
|
38
|
0.825000
|
-2.12e-02
|
0.976
|
|
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION
|
10
|
0.827000
|
-4.03e-02
|
0.976
|
|
HYDROGEN PEROXIDE METABOLIC PROCESS
|
17
|
0.828000
|
3.08e-02
|
0.976
|
|
TRANSLATION
|
25
|
0.828000
|
-2.54e-02
|
0.976
|
|
B CELL DIFFERENTIATION
|
10
|
0.829000
|
3.98e-02
|
0.976
|
|
REGULATION OF BLOOD CIRCULATION
|
25
|
0.829000
|
-2.53e-02
|
0.976
|
|
CYTOKINESIS
|
12
|
0.829000
|
3.62e-02
|
0.976
|
|
BLOOD VESSEL REMODELING
|
8
|
0.830000
|
4.41e-02
|
0.976
|
|
REGULATION OF EPITHELIAL CELL PROLIFERATION
|
35
|
0.831000
|
-2.13e-02
|
0.976
|
|
POSITIVE REGULATION OF CELL ADHESION
|
70
|
0.831000
|
1.53e-02
|
0.976
|
|
POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY
|
13
|
0.831000
|
3.44e-02
|
0.976
|
|
REGULATION OF GROWTH
|
49
|
0.832000
|
-1.80e-02
|
0.976
|
|
MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON
|
5
|
0.832000
|
5.49e-02
|
0.976
|
|
REGULATION OF MUSCLE ADAPTATION
|
10
|
0.833000
|
-3.87e-02
|
0.976
|
|
NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT
|
10
|
0.833000
|
3.87e-02
|
0.976
|
|
PROTEOGLYCAN METABOLIC PROCESS
|
9
|
0.834000
|
-4.06e-02
|
0.976
|
|
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION
|
11
|
0.835000
|
3.65e-02
|
0.976
|
|
RESPONSE TO OXYGEN LEVELS
|
29
|
0.836000
|
2.26e-02
|
0.976
|
|
EXOCYTIC PROCESS
|
6
|
0.836000
|
-4.90e-02
|
0.976
|
|
NEGATIVE REGULATION OF MAPK CASCADE
|
15
|
0.836000
|
3.11e-02
|
0.976
|
|
RESPONSE TO ALCOHOL
|
29
|
0.837000
|
2.25e-02
|
0.976
|
|
POSITIVE REGULATION OF NEUROGENESIS
|
17
|
0.837000
|
-2.91e-02
|
0.976
|
|
POSITIVE REGULATION OF JNK CASCADE
|
5
|
0.838000
|
5.32e-02
|
0.976
|
|
SKELETAL SYSTEM MORPHOGENESIS
|
12
|
0.838000
|
-3.44e-02
|
0.976
|
|
NEGATIVE REGULATION OF WOUND HEALING
|
31
|
0.838000
|
-2.16e-02
|
0.976
|
|
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS
|
24
|
0.839000
|
2.42e-02
|
0.976
|
|
HEART GROWTH
|
8
|
0.840000
|
-4.16e-02
|
0.976
|
|
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS
|
37
|
0.840000
|
1.96e-02
|
0.976
|
|
AMINO ACID METABOLIC PROCESS
|
16
|
0.840000
|
2.94e-02
|
0.976
|
|
REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY
|
5
|
0.840000
|
-5.23e-02
|
0.976
|
|
REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY
|
5
|
0.840000
|
-5.23e-02
|
0.976
|
|
MOLTING CYCLE PROCESS
|
12
|
0.840000
|
3.38e-02
|
0.976
|
|
CELL MATURATION
|
11
|
0.841000
|
-3.51e-02
|
0.976
|
|
MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION
|
5
|
0.842000
|
5.18e-02
|
0.976
|
|
ARTERY MORPHOGENESIS
|
12
|
0.842000
|
3.34e-02
|
0.976
|
|
MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
21
|
0.843000
|
-2.53e-02
|
0.976
|
|
REGULATION OF CELL DEVELOPMENT
|
64
|
0.843000
|
-1.48e-02
|
0.976
|
|
REGULATION OF LEUKOCYTE MIGRATION
|
36
|
0.843000
|
1.95e-02
|
0.976
|
|
REGULATION OF CELL CELL ADHESION
|
66
|
0.843000
|
-1.46e-02
|
0.976
|
|
SENSORY ORGAN DEVELOPMENT
|
28
|
0.844000
|
-2.19e-02
|
0.976
|
|
REGULATION OF CELL JUNCTION ASSEMBLY
|
24
|
0.844000
|
-2.35e-02
|
0.976
|
|
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS
|
81
|
0.844000
|
1.32e-02
|
0.976
|
|
REGULATED EXOCYTOSIS
|
24
|
0.845000
|
-2.34e-02
|
0.976
|
|
NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION
|
59
|
0.845000
|
1.52e-02
|
0.976
|
|
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE
|
41
|
0.846000
|
-1.80e-02
|
0.976
|
|
RNA SPLICING
|
5
|
0.846000
|
5.05e-02
|
0.976
|
|
ACTIN FILAMENT DEPOLYMERIZATION
|
10
|
0.846000
|
3.58e-02
|
0.976
|
|
REGULATION OF PROTEIN DEPOLYMERIZATION
|
10
|
0.846000
|
3.58e-02
|
0.976
|
|
CARDIAC CONDUCTION
|
12
|
0.846000
|
3.27e-02
|
0.976
|
|
MITOTIC NUCLEAR DIVISION
|
12
|
0.846000
|
-3.27e-02
|
0.976
|
|
REGULATION OF MEMBRANE POTENTIAL
|
31
|
0.847000
|
-2.04e-02
|
0.976
|
|
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY
|
19
|
0.847000
|
-2.59e-02
|
0.976
|
|
REGULATION OF CELL SIZE
|
17
|
0.847000
|
2.73e-02
|
0.976
|
|
NEGATIVE REGULATION OF REPRODUCTIVE PROCESS
|
7
|
0.847000
|
4.22e-02
|
0.976
|
|
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION
|
7
|
0.847000
|
-4.22e-02
|
0.976
|
|
MONOSACCHARIDE CATABOLIC PROCESS
|
14
|
0.848000
|
2.99e-02
|
0.976
|
|
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION
|
22
|
0.848000
|
-2.39e-02
|
0.976
|
|
PLACENTA DEVELOPMENT
|
12
|
0.848000
|
-3.21e-02
|
0.976
|
|
TUBE MORPHOGENESIS
|
104
|
0.849000
|
-1.15e-02
|
0.976
|
|
SUPEROXIDE ANION GENERATION
|
11
|
0.849000
|
3.33e-02
|
0.976
|
|
COLLAGEN ACTIVATED SIGNALING PATHWAY
|
5
|
0.850000
|
-4.92e-02
|
0.976
|
|
LEUKOCYTE PROLIFERATION
|
39
|
0.850000
|
1.79e-02
|
0.976
|
|
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE
|
7
|
0.855000
|
4.00e-02
|
0.979
|
|
REGULATION OF EXOCYTOSIS
|
18
|
0.855000
|
-2.51e-02
|
0.979
|
|
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION
|
6
|
0.856000
|
4.31e-02
|
0.979
|
|
REGULATION OF IMMUNOGLOBULIN PRODUCTION
|
6
|
0.856000
|
4.31e-02
|
0.979
|
|
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
8
|
0.857000
|
-3.71e-02
|
0.979
|
|
REGULATION OF SMOOTHENED SIGNALING PATHWAY
|
6
|
0.857000
|
-4.27e-02
|
0.979
|
|
SMOOTHENED SIGNALING PATHWAY
|
6
|
0.857000
|
-4.27e-02
|
0.979
|
|
EAR MORPHOGENESIS
|
6
|
0.857000
|
4.27e-02
|
0.979
|
|
CARDIAC CHAMBER MORPHOGENESIS
|
12
|
0.857000
|
3.03e-02
|
0.979
|
|
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION
|
12
|
0.857000
|
3.03e-02
|
0.979
|
|
NEGATIVE REGULATION OF DEFENSE RESPONSE
|
36
|
0.859000
|
-1.74e-02
|
0.980
|
|
DIGESTIVE SYSTEM DEVELOPMENT
|
11
|
0.859000
|
-3.10e-02
|
0.980
|
|
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS
|
63
|
0.860000
|
1.33e-02
|
0.980
|
|
PLASMA MEMBRANE ORGANIZATION
|
18
|
0.862000
|
-2.40e-02
|
0.980
|
|
NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY
|
18
|
0.862000
|
-2.40e-02
|
0.980
|
|
TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING
|
12
|
0.862000
|
-2.91e-02
|
0.980
|
|
REGULATION OF LYMPHOCYTE DIFFERENTIATION
|
22
|
0.862000
|
-2.16e-02
|
0.980
|
|
EMBRYONIC PATTERN SPECIFICATION
|
5
|
0.863000
|
4.47e-02
|
0.980
|
|
NUCLEAR EXPORT
|
5
|
0.863000
|
4.47e-02
|
0.980
|
|
PROTEIN EXPORT FROM NUCLEUS
|
5
|
0.863000
|
4.47e-02
|
0.980
|
|
AORTA DEVELOPMENT
|
6
|
0.863000
|
4.08e-02
|
0.980
|
|
VASCULAR PROCESS IN CIRCULATORY SYSTEM
|
32
|
0.864000
|
-1.78e-02
|
0.980
|
|
REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY
|
8
|
0.864000
|
-3.52e-02
|
0.980
|
|
REGULATION OF IMMUNE SYSTEM PROCESS
|
193
|
0.866000
|
7.92e-03
|
0.980
|
|
REGULATION OF ENDOCYTOSIS
|
55
|
0.867000
|
1.35e-02
|
0.980
|
|
ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
15
|
0.867000
|
-2.51e-02
|
0.980
|
|
MACROMOLECULE CATABOLIC PROCESS
|
100
|
0.868000
|
-1.02e-02
|
0.980
|
|
REGULATION OF B CELL MEDIATED IMMUNITY
|
8
|
0.868000
|
-3.40e-02
|
0.980
|
|
NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION
|
5
|
0.868000
|
4.29e-02
|
0.980
|
|
SARCOMERE ORGANIZATION
|
7
|
0.869000
|
3.62e-02
|
0.980
|
|
HEAD DEVELOPMENT
|
53
|
0.869000
|
-1.35e-02
|
0.980
|
|
REGULATION OF ANATOMICAL STRUCTURE SIZE
|
54
|
0.870000
|
-1.33e-02
|
0.980
|
|
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
18
|
0.870000
|
-2.24e-02
|
0.980
|
|
AMINOGLYCAN METABOLIC PROCESS
|
17
|
0.871000
|
2.30e-02
|
0.980
|
|
CANONICAL WNT SIGNALING PATHWAY
|
19
|
0.871000
|
-2.17e-02
|
0.980
|
|
TELENCEPHALON DEVELOPMENT
|
15
|
0.871000
|
-2.44e-02
|
0.980
|
|
REGULATION OF PEPTIDASE ACTIVITY
|
7
|
0.871000
|
-3.55e-02
|
0.980
|
|
CARDIAC MUSCLE TISSUE DEVELOPMENT
|
19
|
0.872000
|
-2.16e-02
|
0.980
|
|
NEUTROPHIL MEDIATED IMMUNITY
|
10
|
0.872000
|
-2.95e-02
|
0.980
|
|
REGULATION OF CHOLESTEROL METABOLIC PROCESS
|
7
|
0.874000
|
-3.49e-02
|
0.981
|
|
REGULATION OF CELL PROJECTION ORGANIZATION
|
48
|
0.874000
|
1.36e-02
|
0.981
|
|
VASODILATION
|
7
|
0.876000
|
-3.42e-02
|
0.983
|
|
REGULATION OF RECEPTOR INTERNALIZATION
|
6
|
0.877000
|
3.67e-02
|
0.983
|
|
REGULATION OF NITRIC OXIDE METABOLIC PROCESS
|
13
|
0.878000
|
-2.48e-02
|
0.983
|
|
CHEMICAL HOMEOSTASIS
|
102
|
0.878000
|
9.31e-03
|
0.983
|
|
AXO DENDRITIC TRANSPORT
|
7
|
0.878000
|
-3.36e-02
|
0.983
|
|
REGULATION OF KETONE METABOLIC PROCESS
|
12
|
0.879000
|
2.56e-02
|
0.983
|
|
RHYTHMIC PROCESS
|
13
|
0.879000
|
-2.46e-02
|
0.983
|
|
HEART MORPHOGENESIS
|
20
|
0.880000
|
-1.98e-02
|
0.983
|
|
POSITIVE CHEMOTAXIS
|
13
|
0.881000
|
2.43e-02
|
0.983
|
|
REGULATION OF SUPEROXIDE ANION GENERATION
|
10
|
0.882000
|
-2.73e-02
|
0.984
|
|
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT
|
10
|
0.882000
|
-2.73e-02
|
0.984
|
|
ANTIGEN PROCESSING AND PRESENTATION
|
22
|
0.883000
|
1.83e-02
|
0.984
|
|
RESPONSE TO EPIDERMAL GROWTH FACTOR
|
5
|
0.883000
|
-3.80e-02
|
0.984
|
|
POSITIVE REGULATION OF CELL DIFFERENTIATION
|
62
|
0.884000
|
1.11e-02
|
0.985
|
|
SYNAPTIC SIGNALING
|
44
|
0.885000
|
1.29e-02
|
0.985
|
|
POSITIVE REGULATION OF WNT SIGNALING PATHWAY
|
9
|
0.885000
|
-2.79e-02
|
0.985
|
|
INTERLEUKIN 1 PRODUCTION
|
17
|
0.886000
|
-2.04e-02
|
0.985
|
|
RESPONSE TO BMP
|
11
|
0.886000
|
2.51e-02
|
0.985
|
|
PALLIUM DEVELOPMENT
|
10
|
0.889000
|
2.57e-02
|
0.986
|
|
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN
|
7
|
0.890000
|
-3.04e-02
|
0.986
|
|
POSITIVE REGULATION OF CHEMOTAXIS
|
27
|
0.890000
|
1.56e-02
|
0.986
|
|
RESPONSE TO IONIZING RADIATION
|
9
|
0.891000
|
2.64e-02
|
0.986
|
|
AMYLOID FIBRIL FORMATION
|
8
|
0.892000
|
2.79e-02
|
0.986
|
|
REGULATION OF MONONUCLEAR CELL MIGRATION
|
21
|
0.893000
|
1.72e-02
|
0.986
|
|
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION
|
5
|
0.893000
|
-3.49e-02
|
0.986
|
|
RESPONSE TO ENDOGENOUS STIMULUS
|
133
|
0.893000
|
7.30e-03
|
0.986
|
|
REGULATION OF MICROTUBULE BASED PROCESS
|
8
|
0.893000
|
-2.76e-02
|
0.986
|
|
RESPONSE TO ORGANOPHOSPHORUS
|
8
|
0.893000
|
-2.76e-02
|
0.986
|
|
RESPONSE TO PURINE CONTAINING COMPOUND
|
8
|
0.893000
|
-2.76e-02
|
0.986
|
|
CALCIUM ION REGULATED EXOCYTOSIS
|
8
|
0.895000
|
2.71e-02
|
0.988
|
|
VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT
|
9
|
0.895000
|
2.55e-02
|
0.988
|
|
PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE
|
13
|
0.897000
|
2.10e-02
|
0.988
|
|
POSITIVE REGULATION OF LEUKOCYTE MIGRATION
|
28
|
0.897000
|
1.44e-02
|
0.988
|
|
NEUROMUSCULAR PROCESS
|
10
|
0.897000
|
-2.37e-02
|
0.988
|
|
ANTIMICROBIAL HUMORAL RESPONSE
|
42
|
0.898000
|
-1.18e-02
|
0.988
|
|
PEPTIDE CATABOLIC PROCESS
|
7
|
0.898000
|
-2.82e-02
|
0.988
|
|
GLYCEROLIPID CATABOLIC PROCESS
|
13
|
0.898000
|
-2.06e-02
|
0.988
|
|
HEART DEVELOPMENT
|
42
|
0.898000
|
1.17e-02
|
0.988
|
|
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
8
|
0.899000
|
-2.59e-02
|
0.988
|
|
RECOGNITION OF APOPTOTIC CELL
|
5
|
0.900000
|
3.27e-02
|
0.988
|
|
CARDIAC CELL DEVELOPMENT
|
7
|
0.900000
|
-2.76e-02
|
0.988
|
|
RESPONSE TO ACID CHEMICAL
|
12
|
0.902000
|
-2.07e-02
|
0.988
|
|
POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION
|
5
|
0.902000
|
3.18e-02
|
0.988
|
|
MITOTIC SPINDLE ASSEMBLY
|
5
|
0.902000
|
-3.18e-02
|
0.988
|
|
EPITHELIAL TO MESENCHYMAL TRANSITION
|
14
|
0.902000
|
1.91e-02
|
0.988
|
|
WNT SIGNALING PATHWAY
|
26
|
0.904000
|
-1.39e-02
|
0.988
|
|
LIPOPROTEIN CATABOLIC PROCESS
|
5
|
0.904000
|
3.14e-02
|
0.988
|
|
MEMBRANE DOCKING
|
8
|
0.904000
|
2.48e-02
|
0.988
|
|
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE
|
6
|
0.904000
|
-2.86e-02
|
0.988
|
|
ORGANIC ACID METABOLIC PROCESS
|
79
|
0.905000
|
8.09e-03
|
0.989
|
|
CELLULAR RESPIRATION
|
35
|
0.906000
|
1.18e-02
|
0.989
|
|
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS
|
13
|
0.908000
|
-1.87e-02
|
0.989
|
|
ODONTOGENESIS OF DENTIN CONTAINING TOOTH
|
6
|
0.908000
|
2.75e-02
|
0.989
|
|
REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
58
|
0.908000
|
9.09e-03
|
0.989
|
|
REGULATION OF PROTEIN MODIFICATION PROCESS
|
44
|
0.908000
|
-1.03e-02
|
0.989
|
|
ANGIOGENESIS INVOLVED IN WOUND HEALING
|
7
|
0.910000
|
2.47e-02
|
0.990
|
|
PROTEOGLYCAN BIOSYNTHETIC PROCESS
|
5
|
0.911000
|
-2.91e-02
|
0.990
|
|
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY
|
93
|
0.911000
|
-7.09e-03
|
0.990
|
|
NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT
|
7
|
0.912000
|
-2.44e-02
|
0.991
|
|
CELL CELL JUNCTION ORGANIZATION
|
30
|
0.913000
|
-1.17e-02
|
0.991
|
|
SINGLE FERTILIZATION
|
15
|
0.913000
|
-1.64e-02
|
0.991
|
|
NEUROTRANSMITTER TRANSPORT
|
8
|
0.913000
|
2.23e-02
|
0.991
|
|
REGULATION OF BMP SIGNALING PATHWAY
|
9
|
0.915000
|
2.07e-02
|
0.991
|
|
CELLULAR RESPONSE TO OXIDATIVE STRESS
|
32
|
0.915000
|
-1.11e-02
|
0.991
|
|
SEMAPHORIN PLEXIN SIGNALING PATHWAY
|
7
|
0.916000
|
-2.31e-02
|
0.991
|
|
NEGATIVE REGULATION OF RESPONSE TO WOUNDING
|
33
|
0.916000
|
-1.08e-02
|
0.991
|
|
POSITIVE REGULATION OF CELL POPULATION PROLIFERATION
|
76
|
0.917000
|
-7.25e-03
|
0.991
|
|
MAMMARY GLAND DEVELOPMENT
|
9
|
0.917000
|
-2.02e-02
|
0.991
|
|
CARDIAC CHAMBER DEVELOPMENT
|
13
|
0.917000
|
-1.68e-02
|
0.991
|
|
REGULATION OF ORGANELLE ASSEMBLY
|
14
|
0.917000
|
-1.62e-02
|
0.991
|
|
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT
|
7
|
0.920000
|
2.21e-02
|
0.991
|
|
NEURON MIGRATION
|
9
|
0.920000
|
1.95e-02
|
0.991
|
|
GLUCOSE 6 PHOSPHATE METABOLIC PROCESS
|
8
|
0.920000
|
-2.06e-02
|
0.991
|
|
CELLULAR RESPONSE TO BIOTIC STIMULUS
|
24
|
0.920000
|
-1.20e-02
|
0.991
|
|
MONOSACCHARIDE BIOSYNTHETIC PROCESS
|
15
|
0.920000
|
1.51e-02
|
0.991
|
|
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT
|
5
|
0.921000
|
2.56e-02
|
0.992
|
|
REGULATION OF PROTEIN TRANSPORT
|
43
|
0.922000
|
8.83e-03
|
0.992
|
|
CELL GROWTH
|
40
|
0.923000
|
-9.09e-03
|
0.992
|
|
NEGATIVE REGULATION OF LIPID TRANSPORT
|
11
|
0.923000
|
1.70e-02
|
0.992
|
|
SMOOTH MUSCLE CELL DIFFERENTIATION
|
10
|
0.924000
|
1.74e-02
|
0.993
|
|
NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS
|
62
|
0.925000
|
-7.20e-03
|
0.993
|
|
MONOCYTE CHEMOTAXIS
|
10
|
0.925000
|
-1.72e-02
|
0.993
|
|
REGULATION OF WNT SIGNALING PATHWAY
|
22
|
0.926000
|
1.15e-02
|
0.993
|
|
HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE
|
7
|
0.927000
|
-2.02e-02
|
0.993
|
|
BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT
|
18
|
0.928000
|
-1.24e-02
|
0.994
|
|
MUSCLE CELL DIFFERENTIATION
|
38
|
0.929000
|
-8.57e-03
|
0.994
|
|
ENDOCRINE SYSTEM DEVELOPMENT
|
9
|
0.929000
|
1.73e-02
|
0.994
|
|
REGULATION OF CELL SHAPE
|
25
|
0.929000
|
-1.04e-02
|
0.994
|
|
CRANIAL SKELETAL SYSTEM DEVELOPMENT
|
5
|
0.930000
|
-2.29e-02
|
0.994
|
|
NEGATIVE REGULATION OF LIPID LOCALIZATION
|
13
|
0.931000
|
1.41e-02
|
0.994
|
|
POSITIVE REGULATION OF SECRETION
|
24
|
0.931000
|
1.04e-02
|
0.994
|
|
CARDIAC MUSCLE TISSUE MORPHOGENESIS
|
10
|
0.931000
|
-1.59e-02
|
0.994
|
|
MUSCLE ORGAN MORPHOGENESIS
|
10
|
0.931000
|
-1.59e-02
|
0.994
|
|
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT
|
11
|
0.932000
|
1.50e-02
|
0.994
|
|
REGULATION OF D GLUCOSE TRANSMEMBRANE TRANSPORT
|
5
|
0.932000
|
2.20e-02
|
0.994
|
|
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS
|
135
|
0.934000
|
4.48e-03
|
0.994
|
|
SENSORY SYSTEM DEVELOPMENT
|
21
|
0.934000
|
-1.05e-02
|
0.994
|
|
REGULATION OF TRANSPORT
|
156
|
0.935000
|
-4.18e-03
|
0.994
|
|
ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS
|
7
|
0.936000
|
-1.77e-02
|
0.994
|
|
MEMBRANE BIOGENESIS
|
5
|
0.936000
|
2.07e-02
|
0.994
|
|
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS
|
76
|
0.937000
|
-5.50e-03
|
0.994
|
|
T CELL PROLIFERATION
|
26
|
0.937000
|
9.11e-03
|
0.994
|
|
REGULATION OF MACROPHAGE ACTIVATION
|
7
|
0.937000
|
1.74e-02
|
0.994
|
|
L AMINO ACID METABOLIC PROCESS
|
8
|
0.937000
|
-1.62e-02
|
0.994
|
|
HYALURONAN METABOLIC PROCESS
|
10
|
0.938000
|
-1.43e-02
|
0.994
|
|
CELL KILLING
|
55
|
0.939000
|
6.19e-03
|
0.994
|
|
OSTEOBLAST DIFFERENTIATION
|
24
|
0.939000
|
9.19e-03
|
0.994
|
|
FIBRINOLYSIS
|
21
|
0.941000
|
-9.44e-03
|
0.995
|
|
CARDIOCYTE DIFFERENTIATION
|
14
|
0.942000
|
-1.14e-02
|
0.995
|
|
MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION
|
6
|
0.943000
|
-1.71e-02
|
0.995
|
|
REGULATION OF CANONICAL WNT SIGNALING PATHWAY
|
18
|
0.943000
|
-9.78e-03
|
0.995
|
|
EMBRYONIC ORGAN MORPHOGENESIS
|
18
|
0.943000
|
9.78e-03
|
0.995
|
|
ACTIN FILAMENT BASED MOVEMENT
|
12
|
0.944000
|
1.18e-02
|
0.995
|
|
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION
|
5
|
0.945000
|
1.80e-02
|
0.995
|
|
DENDRITIC SPINE DEVELOPMENT
|
5
|
0.945000
|
-1.80e-02
|
0.995
|
|
CALCIUM DEPENDENT CELL CELL ADHESION
|
8
|
0.945000
|
-1.42e-02
|
0.995
|
|
STRIATED MUSCLE CELL DIFFERENTIATION
|
24
|
0.945000
|
-8.24e-03
|
0.995
|
|
REGULATION OF INNATE IMMUNE RESPONSE
|
50
|
0.945000
|
-5.76e-03
|
0.995
|
|
NUCLEOBASE METABOLIC PROCESS
|
5
|
0.946000
|
-1.76e-02
|
0.995
|
|
T CELL DIFFERENTIATION
|
27
|
0.946000
|
7.64e-03
|
0.995
|
|
CARDIAC SEPTUM MORPHOGENESIS
|
5
|
0.947000
|
-1.71e-02
|
0.996
|
|
CELL CELL ADHESION MEDIATED BY INTEGRIN
|
9
|
0.947000
|
-1.28e-02
|
0.996
|
|
RESPONSE TO ESTROGEN
|
6
|
0.949000
|
-1.52e-02
|
0.997
|
|
VESICLE LOCALIZATION
|
11
|
0.950000
|
1.11e-02
|
0.997
|
|
MITOTIC SPINDLE ORGANIZATION
|
10
|
0.951000
|
-1.14e-02
|
0.997
|
|
PROTEIN LOCALIZATION TO VACUOLE
|
8
|
0.951000
|
-1.26e-02
|
0.997
|
|
REGULATION OF NEUROGENESIS
|
24
|
0.951000
|
-7.29e-03
|
0.997
|
|
REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY
|
11
|
0.952000
|
-1.05e-02
|
0.997
|
|
GLAND DEVELOPMENT
|
40
|
0.953000
|
-5.56e-03
|
0.997
|
|
ASTROCYTE DEVELOPMENT
|
7
|
0.953000
|
-1.29e-02
|
0.997
|
|
POSITIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS
|
9
|
0.953000
|
1.13e-02
|
0.997
|
|
CONNECTIVE TISSUE DEVELOPMENT
|
25
|
0.955000
|
6.69e-03
|
0.997
|
|
RESPONSE TO XENOBIOTIC STIMULUS
|
33
|
0.955000
|
5.81e-03
|
0.997
|
|
ERK1 AND ERK2 CASCADE
|
40
|
0.955000
|
5.27e-03
|
0.997
|
|
REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY
|
7
|
0.955000
|
1.23e-02
|
0.997
|
|
RENAL SYSTEM DEVELOPMENT
|
24
|
0.956000
|
-6.63e-03
|
0.997
|
|
NEGATIVE REGULATION OF PROTEIN POLYMERIZATION
|
10
|
0.957000
|
-9.84e-03
|
0.997
|
|
CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT
|
12
|
0.957000
|
-8.97e-03
|
0.997
|
|
RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM
|
8
|
0.959000
|
1.06e-02
|
0.997
|
|
B CELL ACTIVATION
|
19
|
0.959000
|
-6.84e-03
|
0.997
|
|
DEFENSE RESPONSE TO VIRUS
|
7
|
0.960000
|
1.10e-02
|
0.997
|
|
EMBRYO IMPLANTATION
|
10
|
0.960000
|
-9.17e-03
|
0.997
|
|
MYELOID LEUKOCYTE ACTIVATION
|
35
|
0.960000
|
-4.96e-03
|
0.997
|
|
CELLULAR EXTRAVASATION
|
13
|
0.961000
|
-7.86e-03
|
0.997
|
|
EXOCYTOSIS
|
36
|
0.962000
|
4.74e-03
|
0.997
|
|
REGULATION OF IMMUNE EFFECTOR PROCESS
|
63
|
0.963000
|
-3.49e-03
|
0.997
|
|
REGULATION OF COAGULATION
|
33
|
0.963000
|
-4.70e-03
|
0.997
|
|
GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE
|
12
|
0.964000
|
-7.66e-03
|
0.997
|
|
NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS
|
6
|
0.964000
|
1.08e-02
|
0.997
|
|
POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION
|
26
|
0.964000
|
-5.17e-03
|
0.997
|
|
RESPONSE TO CALCIUM ION
|
9
|
0.965000
|
-8.57e-03
|
0.997
|
|
POSITIVE REGULATION OF B CELL ACTIVATION
|
5
|
0.966000
|
1.09e-02
|
0.997
|
|
REGULATION OF B CELL ACTIVATION
|
5
|
0.966000
|
1.09e-02
|
0.997
|
|
CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY
|
5
|
0.966000
|
1.09e-02
|
0.997
|
|
POSTSYNAPTIC MEMBRANE ORGANIZATION
|
6
|
0.967000
|
9.65e-03
|
0.997
|
|
PROTEIN MATURATION
|
108
|
0.969000
|
2.33e-03
|
0.997
|
|
GRANULOCYTE CHEMOTAXIS
|
25
|
0.969000
|
4.60e-03
|
0.997
|
|
B CELL PROLIFERATION
|
5
|
0.971000
|
-9.57e-03
|
0.997
|
|
TRIGLYCERIDE CATABOLIC PROCESS
|
9
|
0.971000
|
-7.08e-03
|
0.997
|
|
CARTILAGE DEVELOPMENT
|
18
|
0.971000
|
-5.02e-03
|
0.997
|
|
POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
7
|
0.972000
|
7.80e-03
|
0.997
|
|
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION
|
7
|
0.972000
|
7.80e-03
|
0.997
|
|
BARBED END ACTIN FILAMENT CAPPING
|
5
|
0.972000
|
-9.12e-03
|
0.997
|
|
RESPONSE TO NITROGEN COMPOUND
|
93
|
0.972000
|
2.21e-03
|
0.997
|
|
MUSCLE HYPERTROPHY
|
11
|
0.973000
|
6.01e-03
|
0.997
|
|
HOMOPHILIC CELL CELL ADHESION
|
19
|
0.973000
|
4.58e-03
|
0.997
|
|
NEURON APOPTOTIC PROCESS
|
24
|
0.973000
|
3.98e-03
|
0.997
|
|
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS
|
6
|
0.974000
|
-7.80e-03
|
0.997
|
|
REGULATION OF MONOCYTE CHEMOTAXIS
|
6
|
0.974000
|
-7.80e-03
|
0.997
|
|
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY
|
10
|
0.974000
|
-6.04e-03
|
0.997
|
|
NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION
|
9
|
0.974000
|
-6.33e-03
|
0.997
|
|
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION
|
7
|
0.974000
|
7.17e-03
|
0.997
|
|
NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS
|
5
|
0.975000
|
8.23e-03
|
0.997
|
|
BLOOD COAGULATION INTRINSIC PATHWAY
|
12
|
0.975000
|
-5.23e-03
|
0.997
|
|
REGULATION OF CELL GROWTH
|
36
|
0.976000
|
3.01e-03
|
0.997
|
|
REGULATION OF AMIDE METABOLIC PROCESS
|
8
|
0.977000
|
5.86e-03
|
0.997
|
|
PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY
|
7
|
0.977000
|
6.21e-03
|
0.997
|
|
BINDING OF SPERM TO ZONA PELLUCIDA
|
7
|
0.979000
|
5.89e-03
|
0.997
|
|
SPERM EGG RECOGNITION
|
7
|
0.979000
|
5.89e-03
|
0.997
|
|
LUNG ALVEOLUS DEVELOPMENT
|
7
|
0.979000
|
-5.89e-03
|
0.997
|
|
OLIGODENDROCYTE DEVELOPMENT
|
6
|
0.979000
|
-6.31e-03
|
0.997
|
|
TRICARBOXYLIC ACID CYCLE
|
6
|
0.979000
|
6.31e-03
|
0.997
|
|
REGULATION OF PHAGOCYTOSIS
|
31
|
0.979000
|
-2.77e-03
|
0.997
|
|
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM
|
11
|
0.979000
|
4.58e-03
|
0.997
|
|
EPIBOLY
|
8
|
0.979000
|
-5.30e-03
|
0.997
|
|
CELLULAR RESPONSE TO KETONE
|
7
|
0.980000
|
-5.57e-03
|
0.997
|
|
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION
|
8
|
0.980000
|
-5.02e-03
|
0.997
|
|
RESPONSE TO UV
|
11
|
0.981000
|
4.17e-03
|
0.997
|
|
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS
|
15
|
0.981000
|
-3.52e-03
|
0.997
|
|
POSITIVE REGULATION OF TRANSLATION
|
7
|
0.982000
|
-4.94e-03
|
0.997
|
|
RECEPTOR CLUSTERING
|
10
|
0.983000
|
3.80e-03
|
0.997
|
|
ENERGY HOMEOSTASIS
|
6
|
0.984000
|
4.83e-03
|
0.997
|
|
CELLULAR RESPONSE TO LIGHT STIMULUS
|
5
|
0.984000
|
5.12e-03
|
0.997
|
|
CELLULAR RESPONSE TO UV
|
5
|
0.984000
|
5.12e-03
|
0.997
|
|
PROTEIN HOMOOLIGOMERIZATION
|
14
|
0.984000
|
-3.05e-03
|
0.997
|
|
ALPHA BETA T CELL ACTIVATION
|
19
|
0.985000
|
-2.56e-03
|
0.997
|
|
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION
|
7
|
0.987000
|
3.66e-03
|
0.997
|
|
MONOATOMIC ION HOMEOSTASIS
|
53
|
0.987000
|
1.35e-03
|
0.997
|
|
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION
|
6
|
0.987000
|
3.71e-03
|
0.997
|
|
EXPORT FROM CELL
|
67
|
0.989000
|
-1.05e-03
|
0.997
|
|
PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT
|
5
|
0.990000
|
3.34e-03
|
0.997
|
|
MAINTENANCE OF CELL NUMBER
|
7
|
0.990000
|
2.71e-03
|
0.997
|
|
PHOSPHORYLATION
|
50
|
0.991000
|
-9.84e-04
|
0.997
|
|
NEGATIVE REGULATION OF AUTOPHAGY
|
5
|
0.991000
|
2.89e-03
|
0.997
|
|
DEPHOSPHORYLATION
|
6
|
0.991000
|
-2.60e-03
|
0.997
|
|
REGULATION OF NUCLEOTIDE METABOLIC PROCESS
|
8
|
0.991000
|
2.23e-03
|
0.997
|
|
LIPOPROTEIN METABOLIC PROCESS
|
19
|
0.992000
|
1.37e-03
|
0.997
|
|
MULTICELLULAR ORGANISM GROWTH
|
11
|
0.992000
|
1.73e-03
|
0.997
|
|
NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS
|
17
|
0.992000
|
-1.39e-03
|
0.997
|
|
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION
|
10
|
0.992000
|
-1.79e-03
|
0.997
|
|
RESPONSE TO OXIDATIVE STRESS
|
62
|
0.993000
|
6.90e-04
|
0.997
|
|
NEGATIVE REGULATION OF COAGULATION
|
29
|
0.994000
|
-8.28e-04
|
0.998
|
|
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION
|
9
|
0.994000
|
1.37e-03
|
0.998
|
|
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION
|
8
|
0.996000
|
1.12e-03
|
0.999
|
|
RESPONSE TO ACTIVITY
|
17
|
0.997000
|
-4.64e-04
|
1.000
|
|
SYNAPSE ASSEMBLY
|
11
|
0.998000
|
5.09e-04
|
1.000
|
|
POSITIVE REGULATION OF MOLECULAR FUNCTION
|
28
|
0.999000
|
-1.63e-04
|
1.000
|
|
ENDODERMAL CELL DIFFERENTIATION
|
7
|
0.999000
|
1.59e-04
|
1.000
|
|
ENDODERM FORMATION
|
7
|
0.999000
|
1.59e-04
|
1.000
|
|
RECEPTOR INTERNALIZATION
|
13
|
1.000000
|
-8.63e-05
|
1.000
|